990-PF - Helmsley Charitable Trust

if the foundation is not required to attach Sch. B

OMB No. 1545-0047

Department of the TreasuryInternal Revenue Service Open to Public Inspection

Number and street (or P.O. box number if mail is not delivered to street address) Room/suite

If exemption application is pending, check here

Foreign organizations meeting the 85% test,check here and attach computation

(The total of amounts in columns (b), (c), and (d) may notnecessarily equal the amounts in column (a).)

Disbursementsfor charitable purposes

(cash basis only)

Check

Interest on savings and temporarycash investments

Net rental income or (loss)

Net gain or (loss) from sale of assets not on line 10Gross sales price for allassets on line 6a

Capital gain net income (from Part IV, line 2)

Gross sales less returnsand allowances

Less: Cost of goods sold

Compensation of officers, directors, trustees, etc.

Excess of revenue over expenses and disbursements

(if negative, enter -0-)

(if negative, enter -0-)

923501 12-17-19

or Section 4947(a)(1) Trust Treated as Private Foundation| Do not enter social security numbers on this form as it may be made public.| Go to www.irs.gov/Form990PF for instructions and the latest information.

For calendar year 2019 or tax year beginning , and ending

A

B

C

Employer identification number

G D 1.

2.

H E

I J F

Analysis of Revenue and Expenses (d)(a) (b) (c)

1

2

3

4

5

7

8

9

11

a

b

6a

b

10a

b

c

12 Total.

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

a

b

c

Total operating and administrative

expenses.

Total expenses and disbursements.

a

b

c

Net investment income

Adjusted net income

For Paperwork Reduction Act Notice, see instructions.

Re

ven

ue

Op

era

tin

g a

nd

Ad

min

istr

ati

ve E

xp

en

se

sForm

Name of foundation

Telephone number

City or town, state or province, country, and ZIP or foreign postal code ~ |

|

|

|

|

Check all that apply: Initial return Initial return of a former public charity Foreign organizations, check here ~~

Final return Amended return

Address change Name change ~~~~

Check type of organization: Section 501(c)(3) exempt private foundation If private foundation status was terminatedunder section 507(b)(1)(A), check hereSection 4947(a)(1) nonexempt charitable trust Other taxable private foundation ~

Fair market value of all assets at end of year Accounting method: Cash Accrual If the foundation is in a 60-month terminationunder section 507(b)(1)(B), check here(from Part II, col. (c), line 16) Other (specify) ~

(Part I, column (d), must be on cash basis.)$| Revenue and

expenses per books Net investment

income Adjusted net

income

Contributions, gifts, grants, etc., received ~~~

|

~~~~~~~~~~~~~~

Dividends and interest from securities

Gross rents

~~~~~

~~~~~~~~~~~~~~~~

~~

~~

~~~~~

Net short-term capital gain

Income modifications

~~~~~~~~~

~~~~~~~~~~~~

~~~~

~

Gross profit or (loss)

Other income

~~~~~~~~~~~~

~~~~~~~~~~~~~~~

Add lines 1 through 11 ��

~~~

Other employee salaries and wages

Pension plans, employee benefits

~~~~~~

~~~~~~

Legal fees

Accounting fees

~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~

Other professional fees ~~~~~~~~~~~

Interest

Taxes

~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~

Depreciation and depletion ~~~~~~~~~

Occupancy

Travel, conferences, and meetings

Printing and publications

Other expenses

~~~~~~~~~~~~~~~~

~~~~~~

~~~~~~~~~~

~~~~~~~~~~~~~~

Add lines 13 through 23 ~~~~~

Contributions, gifts, grants paid ~~~~~~~

Add lines 24 and 25 ��

Subtract line 26 from line 12:

~

~~~

��

Form (2019)LHA

Part I

990-PF

Return of Private Foundation990-PF 2019

STATEMENT 1STATEMENT 2

STATEMENT 3

STMT 4STMT 5STMT 6

STMT 7

STMT 8

THE LEONA M. AND HARRY B. HELMSLEY13-7184401

230 PARK AVENUE

X

X

5,911,771,397.

2,950.

1,503,764. 1,503,764. 41,142,199. 116,587,584.

670,660,129.

277,295,041.

29,996,765. 20,431,738. 743,305,807. 415,818,127. 3,466,982. 1,515,826. 1,911,487.14,238,665. 4,553,343. 9,442,792.6,740,019. 1,630,870. 5,050,174.308,610. 99,995. 191,450.530,056. 319,922. 163,447.

9,344,869. 6,611,813. 2,829,060.163,825. 2,685,367. 0.

14,094,834. 2,780,468. 0.242,416. 3,628.

1,466,247. 380,557. 1,040,690.1,820,594. 273,572. 1,746,033.

16,506,531. 49,380,793. 2,344,641.

68,923,648. 70,236,154. 24,719,774.304,668,142. 260,433,258.

373,591,790. 70,236,154. 285,153,032.

369,714,017.345,581,973.

659

EXTENDED TO FEBRUARY 16, 2021

CHARITABLE TRUST

N/A

N/A

212-679-3600

APR 1, 2019 MAR 31, 2020

2,251,935,173.

X

NEW YORK, NY 10169

1 11020115 756359 1622860.000 2019.05020 THE LEONA M. AND HARRY B. 16228601

Attached schedules and amounts in the descriptioncolumn should be for end-of-year amounts only.

Other notes and loans receivable

Investments - land, buildings, and equipment: basis

Less: accumulated depreciation

Less: accumulated depreciation

Loans from officers, directors, trustees, and other disqualified persons

923511 12-17-19

2

(a) (b) (c)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

a

b

c

Total assets

17

18

19

20

21

22

23 Total liabilities

Foundations that follow FASB ASC 958, check here

and complete lines 24, 25, 29, and 30.

24

25

26

27

28

29

30

Foundations that do not follow FASB ASC 958, check here

and complete lines 26 through 30.

Total net assets or fund balances

Total liabilities and net assets/fund balances

1

2

3

4

5

1

2

3

4

5

66

Asse

tsL

iab

iliti

es

Ne

t A

sse

ts o

r F

un

d B

ala

nc

es

Form 990-PF (2019) Page

Beginning of year End of year

Book Value Book Value Fair Market Value

Cash - non-interest-bearing

Savings and temporary cash investments

~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~

Accounts receivable

Less: allowance for doubtful accounts

Pledges receivable


Grants receivable

Receivables due from officers, directors, trustees, and other

disqualified persons

~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~


Inventories for sale or use

Prepaid expenses and deferred charges

~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~

Investments - U.S. and state government obligations ~~~~~~~

Investments - corporate stock

Investments - corporate bonds

~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~

~~

~~~~~~~~

Investments - mortgage loans

Investments - other

Land, buildings, and equipment: basis

~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~

Other assets (describe )

(to be completed by all filers - see the

instructions. Also, see page 1, item I) ��

Accounts payable and accrued expenses ~~~~~~~~~~~~~

Grants payable

Deferred revenue

~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~

~~~~

Mortgages and other notes payable

Other liabilities (describe

~~~~~~~~~~~~~~~

)

(add lines 17 through 22) ��

~~

Net assets without donor restrictions

Net assets with donor restrictions

~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~

Capital stock, trust principal, or current funds ~~~~~~~~~~~

Paid-in or capital surplus, or land, bldg., and equipment fund

Retained earnings, accumulated income, endowment, or other funds

~~~~

~

~~~~~~~~~~~~~~~~

��

Total net assets or fund balances at beginning of year - Part II, column (a), line 29

(must agree with end-of-year figure reported on prior year's return) ~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter amount from Part I, line 27a

Other increases not included in line 2 (itemize)

Add lines 1, 2, and 3

Decreases not included in line 2 (itemize)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Total net assets or fund balances at end of year (line 4 minus line 5) - Part II, column (b), line 29 ��

Form (2019)

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

|

Balance SheetsPart II

Analysis of Changes in Net Assets or Fund BalancesPart III

990-PF

STMT 9

STMT 10

STMT 11STATEMENT 12

STATEMENT 13

24,614,978. 10,602,008. 10,602,008.152,966,741. 77,680,854. 77,680,854.

923,848. 979,159. 979,159.

680,955,923. 524,476,973. 524,476,973.

5,159,812,338. 5,217,346,465. 5,217,346,465.

1,267,993. 1,025,578. 1,025,578.46,306,682. 79,660,360. 79,660,360.

6,066,848,503. 5,911,771,397. 5,911,771,397.6,167,560. 5,889,356.

335,580,118.

291,455,341. 335,690,225.

368,345,933.

5,731,268,385.

5,543,425,464.

37,957,217. 26,766,352.

5,731,268,385. 5,543,425,464.

6,066,848,503. 5,911,771,397.

5,731,268,385.369,714,017.11,378,714.

6,112,361,116.568,935,652.

5,543,425,464.

3,046,486.2,020,908.

X

DEFERRED FEDERAL EXCISE TAX BENEFIT

UNREALIZED LOSS ON INVESTMENTS

13-7184401CHARITABLE TRUSTTHE LEONA M. AND HARRY B. HELMSLEY


923521 12-17-19

3

(b)(a) (c) (d)

1a

b

c

d

e

(f) (g) (h)(e)

a

b

c

d

e

(l)or(j) (k)

(i)

a

b

c

d

e

2 2

3

3

Yes No

1

(a) (d)(b) (c)

2

3

4

5

6

7

8

Total 2

3

4

5

6

7

8


How acquiredP - PurchaseD - Donation

List and describe the kind(s) of property sold (for example, real estate,2-story brick warehouse; or common stock, 200 shs. MLC Co.)

Date acquired(mo., day, yr.)

Date sold(mo., day, yr.)

Depreciation allowed(or allowable)

Cost or other basisplus expense of sale

Gain or (loss)((e) plus (f) minus (g))

Gross sales price

Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69. Gains (Col. (h) gain minuscol. (k), but not less than -0-)

Losses (from col. (h)) Adjusted basis

as of 12/31/69 Excess of col. (i)

over col. (j), if any FMV as of 12/31/69

If gain, also enter in Part I, line 7If (loss), enter -0- in Part I, line 7Capital gain net income or (net capital loss) ~~~~~~

Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):If gain, also enter in Part I, line 8, column (c).If (loss), enter -0- in Part I, line 8��

(For optional use by domestic private foundations subject to the section 4940(a) tax on net investment income.)

If section 4940(d)(2) applies, leave this part blank.

Was the foundation liable for the section 4942 tax on the distributable amount of any year in the base period?

If "Yes," the foundation doesn't qualify under section 4940(e). Do not complete this part.

~~~~~~~~~~~~~~~~

Enter the appropriate amount in each column for each year; see the instructions before making any entries.

Base period yearsCalendar year (or tax year beginning in)

Distribution ratio(col. (b) divided by col. (c))Adjusted qualifying distributions Net value of noncharitable-use assets

2018

2017

2016

2015

2014

of line 1, column (d)

Average distribution ratio for the 5-year base period - divide the total on line 2 by 5.0, or by the number of years

the foundation has been in existence if less than 5 years

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter the net value of noncharitable-use assets for 2019 from Part X, line 5

Multiply line 4 by line 3

~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter 1% of net investment income (1% of Part I, line 27b) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Add lines 5 and 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter qualifying distributions from Part XII, line 4~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If line 8 is equal to or greater than line 7, check the box in Part VI, line 1b, and complete that part using a 1% tax rate.See the Part VI instructions.

Form (2019)

Capital Gains and Losses for Tax on Investment IncomePart IV

Qualification Under Section 4940(e) for Reduced Tax on Net Investment IncomePart V

990-PF

pmorqspmo

277,295,041.

X

SEE ATTACHED STATEMENTS

302,783,628. 5,812,303,727. .052094269,745,134. 5,603,912,972. .048135253,335,431. 5,221,400,007. .048519270,625,111. 5,302,240,883. .051040300,342,998. 5,514,578,026. .054463

.254251

.050850

6,073,048,063.

308,814,494.

3,455,820.

312,270,314.

288,912,532.


2,251,935,173. 1,478,858,598. 277,295,041.

277,295,041.

N/A


If "Yes," attach a schedule listing their names and addresses

923531 12-17-19

4

1

2

3

4

5

6

7

8

9

10

a

b

c

(attach copy of letter if necessary-see instructions)

1

2

3

4

5Tax based on investment income.

a

b

c

d

6a

6b

6c

6d

7

penalty 8

Tax due. amount owed 9

Overpayment. amount overpaid 10

11 Credited to 2020 estimated tax Refunded 11

1

2

3

4

a

b

c

d

e

1a

1b

1c

1a 1b

Form 1120-POL

(1) (2)

2

3

4a

4b

5

a

b Form 990-T

5

6

7

8

6

7

a

b

8b

9

10

9

10

General Instruction T.

General Instruction G?


Exempt operating foundations described in section 4940(d)(2), check here | and enter "N/A" on line 1.

Date of ruling or determination letter:

Domestic foundations that meet the section 4940(e) requirements in Part V, check here

of Part I, line 27b

| and enter 1%

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

All other domestic foundations enter 2% of line 27b. Exempt foreign organizations, enter 4% of Part I, line 12, col. (b)

Tax under section 511 (domestic section 4947(a)(1) trusts and taxable foundations only; others, enter -0-)

Add lines 1 and 2

~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Subtitle A (income) tax (domestic section 4947(a)(1) trusts and taxable foundations only; others, enter -0-) ~~~~~~~~

Subtract line 4 from line 3. If zero or less, enter -0- ~~~~~~~~~~~~~~~~~

Credits/Payments:

2019 estimated tax payments and 2018 overpayment credited to 2019 ~~~~~~~~

Exempt foreign organizations - tax withheld at source

Tax paid with application for extension of time to file (Form 8868)

Backup withholding erroneously withheld

~~~~~~~~~~~~~~~~

~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~

Total credits and payments. Add lines 6a through 6d ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter any for underpayment of estimated tax. Check here if Form 2220 is attached ~~~~~~~~~~~~~

If the total of lines 5 and 8 is more than line 7, enter ~~~~~~~~~~~~~~~~~~~~ |

|

|

If line 7 is more than the total of lines 5 and 8, enter the ��

Enter the amount of line 10 to be: |

During the tax year, did the foundation attempt to influence any national, state, or local legislation or did it participate or intervene in

any political campaign? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Did it spend more than $100 during the year (either directly or indirectly) for political purposes? See the instructions for the definition ~~~~

If the answer is "Yes" to or , attach a detailed description of the activities and copies of any materials published or

distributed by the foundation in connection with the activities.

Did the foundation file for this year? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Enter the amount (if any) of tax on political expenditures (section 4955) imposed during the year:

On the foundation. | $ On foundation managers. | $

Enter the reimbursement (if any) paid by the foundation during the year for political expenditure tax imposed on foundation

managers. | $

Has the foundation engaged in any activities that have not previously been reported to the IRS? ~~~~~~~~~~~~~~~~~~~~

If "Yes," attach a detailed description of the activities.

Has the foundation made any changes, not previously reported to the IRS, in its governing instrument, articles of incorporation, or

bylaws, or other similar instruments? If "Yes," attach a conformed copy of the changes ~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation have unrelated business gross income of $1,000 or more during the year?

If "Yes," has it filed a tax return on for this year?

~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Was there a liquidation, termination, dissolution, or substantial contraction during the year? ~~~~~~~~~~~~~~~~~~~~~~

If "Yes," attach the statement required by

Are the requirements of section 508(e) (relating to sections 4941 through 4945) satisfied either:

¥ By language in the governing instrument, or

¥ By state legislation that effectively amends the governing instrument so that no mandatory directions that conflict with the state law

remain in the governing instrument? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation have at least $5,000 in assets at any time during the year? If "Yes," complete Part II, col. (c), and Part XV ~~~~~~~~

Enter the states to which the foundation reports or with which it is registered. See instructions.

If the answer is "Yes" to line 7, has the foundation furnished a copy of Form 990-PF to the Attorney General (or designate)

of each state as required by If "No," attach explanation ~~~~~~~~~~~~~~~~~~~~~~~~~~~

Is the foundation claiming status as a private operating foundation within the meaning of section 4942(j)(3) or 4942(j)(5) for calendar

year 2019 or the tax year beginning in 2019? See the instructions for Part XIV. If "Yes," complete Part XIV ~~~~~~~~~~~~~~~~

Did any persons become substantial contributors during the tax year? ��

Form (2019)

Excise Tax Based on Investment Income (Section 4940(a), 4940(b), 4940(e), or 4948 - see instructions)Part VI

Statements Regarding ActivitiesPart VII-AYes No

990-PF

pnnnmnnno

9

X

14,138,500.

NY

6,911,639.

0.6,911,639.

0.6,911,639.

19,050,139.0.

2,000,000.0.

21,050,139.0.

14,138,500.0.

X

XX

XX

X

X

X

X

X

X

XX


0. 0.

0.


923541 12-17-19

5

11

12

13

14

15

16

11

12

13

Form 1041 -

15

16

1a

(1)

(2)

(3)

(4)

(5)

(6)

Yes

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

No

Exception.

b

c

any

1b

1c

2

a

b

c

Yes No

not

all

2b

any

3a

b

Yes No

(1)

(2)

(3)

3b

4a

4b

4a

b

File Form 4720 if any item is checked in the "Yes" column, unless an exception applies.

(continued)Form 990-PF (2019) Page

At any time during the year, did the foundation, directly or indirectly, own a controlled entity within the meaning of

section 512(b)(13)? If "Yes," attach schedule. See instructions ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation make a distribution to a donor advised fund over which the foundation or a disqualified person had advisory privileges?

If "Yes," attach statement. See instructions ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation comply with the public inspection requirements for its annual returns and exemption application? ~~~~~~~~~~~

Website address |

The books are in care of |

Located at |

Telephone no. |

ZIP+4 |

Section 4947(a)(1) nonexempt charitable trusts filing Form 990-PF in lieu of check here ~~~~~~~~~~~~~~~~~~~~~~~ |

and enter the amount of tax-exempt interest received or accrued during the year ~~~~~~~~~~~~~~~~~~~ |

At any time during calendar year 2019, did the foundation have an interest in or a signature or other authority over a bank,

securities, or other financial account in a foreign country?

See the instructions for exceptions and filing requirements for FinCEN Form 114. If "Yes," enter the name of the

foreign country

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

|

During the year, did the foundation (either directly or indirectly):

Engage in the sale or exchange, or leasing of property with a disqualified person?

Borrow money from, lend money to, or otherwise extend credit to (or accept it from)

a disqualified person?

~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Furnish goods, services, or facilities to (or accept them from) a disqualified person?

Pay compensation to, or pay or reimburse the expenses of, a disqualified person?

~~~~~~~~~~~~~

~~~~~~~~~~~~~~

Transfer any income or assets to a disqualified person (or make any of either available

for the benefit or use of a disqualified person)?~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Agree to pay money or property to a government official? ( Check "No"

if the foundation agreed to make a grant to or to employ the official for a period after

termination of government service, if terminating within 90 days.) ~~~~~~~~~~~~~~~~~~~~~

If any answer is "Yes" to 1a(1)-(6), did of the acts fail to qualify under the exceptions described in Regulations

section 53.4941(d)-3 or in a current notice regarding disaster assistance? See instructions ~~~~~~~~~~~~~~~~~~~~~~

|Organizations relying on a current notice regarding disaster assistance, check here ~~~~~~~~~~~~~~~~~~~~~

Did the foundation engage in a prior year in any of the acts described in 1a, other than excepted acts, that were not corrected

before the first day of the tax year beginning in 2019?~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Taxes on failure to distribute income (section 4942) (does not apply for years the foundation was a private operating foundation

defined in section 4942(j)(3) or 4942(j)(5)):

At the end of tax year 2019, did the foundation have any undistributed income (Part XIII, lines

6d and 6e) for tax year(s) beginning before 2019? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If "Yes," list the years | , , ,

Are there any years listed in 2a for which the foundation is applying the provisions of section 4942(a)(2) (relating to incorrect

valuation of assets) to the year's undistributed income? (If applying section 4942(a)(2) to years listed, answer "No" and attach

statement - see instructions.) ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If the provisions of section 4942(a)(2) are being applied to of the years listed in 2a, list the years here.

| , , ,

Did the foundation hold more than a 2% direct or indirect interest in any business enterprise at any time

during the year? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If "Yes," did it have excess business holdings in 2019 as a result of any purchase by the foundation or disqualified persons after

May 26, 1969; the lapse of the 5-year period (or longer period approved by the Commissioner under section 4943(c)(7)) to dispose

of holdings acquired by gift or bequest; or the lapse of the 10-, 15-, or 20-year first phase holding period? (Use Form 4720,

Schedule C, to determine if the foundation had excess business holdings in 2019.) ~~~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation invest during the year any amount in a manner that would jeopardize its charitable purposes? ~~~~~~~~~~~~~

Did the foundation make any investment in a prior year (but after December 31, 1969) that could jeopardize its charitable purpose that

had not been removed from jeopardy before the first day of the tax year beginning in 2019? ��

Form (2019)

Part VII-A Statements Regarding Activities

Yes No

Yes No

Part VII-B Statements Regarding Activities for Which Form 4720 May Be Required

Yes No

990-PF

SEE STATEMENT 14

STATEMENT 15 STATEMENT 16 STMT 17

X

XXX

X

X

X

X

X

X

XX

X

N/A


X

XX

HELMSLEYTRUST.ORGNICHOLAS J. SCHIAVO, CFO

230 PARK AVENUE, SUITE 659, NEW YORK, NY212-679-3600

10169

N/A

X


*

gmacari

Text Box

ALL TRANSACTIONS THAT REQUIRE COURT APPROVAL, HAVE RECEIVED COURT APPROVAL UNDER REG. §53.4941(d)-1(b)(3).

gmacari

Stamp

Contributions toemployee benefit plans

and deferredcompensation

Contributions toemployee benefit plans

and deferredcompensation

923551 12-17-19

5a

(1)

(2)

(3)

(4)

(5)

Yes

Yes

Yes

Yes

Yes

No

No

No

No

No

b

c

any

5b

6b

7b

Yes No

6

7

8

a

Yes No

b

Yes Noa

b

Yes No

(If not paid,enter -0-)

6

1 List all officers, directors, trustees, and foundation managers and their compensation.(d)(c) (e)(b)

(a)

2 Compensation of five highest-paid employees (other than those included on line 1). If none, enter "NONE."(d) (e)(b)

(a) (c)

Total

(continued)Form 990-PF (2019) Page

During the year, did the foundation pay or incur any amount to:

Carry on propaganda, or otherwise attempt to influence legislation (section 4945(e))?

Influence the outcome of any specific public election (see section 4955); or to carry on, directly or indirectly,

any voter registration drive?

~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Provide a grant to an individual for travel, study, or other similar purposes?

Provide a grant to an organization other than a charitable, etc., organization described in section

4945(d)(4)(A)? See instructions

~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Provide for any purpose other than religious, charitable, scientific, literary, or educational purposes, or for

the prevention of cruelty to children or animals? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If any answer is "Yes" to 5a(1)-(5), did of the transactions fail to qualify under the exceptions described in Regulations

section 53.4945 or in a current notice regarding disaster assistance? See instructions ~~~~~~~~~~~~~~~~~~~~~~~~

|Organizations relying on a current notice regarding disaster assistance, check here ~~~~~~~~~~~~~~~~~~~~~

If the answer is "Yes" to question 5a(4), does the foundation claim exemption from the tax because it maintained

expenditure responsibility for the grant?~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

If "Yes," attach the statement required by Regulations section 53.4945-5(d).

Did the foundation, during the year, receive any funds, directly or indirectly, to pay premiums on

a personal benefit contract? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Did the foundation, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ~~~~~~~~~~~~~~~~

If "Yes" to 6b, file Form 8870.

At any time during the tax year, was the foundation a party to a prohibited tax shelter transaction? ~~~~~~~~~

If "Yes," did the foundation receive any proceeds or have any net income attributable to the transaction?

Is the foundation subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or

excess parachute payment(s) during the year?

Compensation Expenseaccount, other

allowances

Title, and averagehours per week devoted

to position Name and address

Expenseaccount, other

allowances

Title, and averagehours per week

devoted to position Name and address of each employee paid more than $50,000 Compensation

number of other employees paid over $50,000 �� |

Form (2019)

��

��

Part VII-B Statements Regarding Activities for Which Form 4720 May Be Required Yes NoYes No

Part VIII Information About Officers, Directors, Trustees, Foundation Managers, HighlyPaid Employees, and Contractors

990-PF

SEE STATEMENT 18

SEE STATEMENT 19

807,079. 167,326. 0.DIRECTOR OF INVESTMENTS

40.00JOSHUA W. FENTON - C/O TRUST, 230PARK AVENUE, NEW YORK, NY 10169AL Y. KIM - C/O TRUST, 230 PARKAVENUE, NEW YORK, NY 10169CHRISTOPHER J. RAPCEWICZ - C/OTRUST, 230 PARK AVENUE, NEW YORK, NYMEENAKSHI C. LAKSHMAN - C/O TRUST,230 PARK AVENUE, NEW YORK, NY 10169

DIRECTOR OF INVESTMENTS40.00

DIR. OF RISK MNGMT. & OPERATIONS40.00

DIR. OF STRATEGY & RESEARCH40.00

167,326.

153,473.

167,326.

63,865.

0.

0.

796,196.

806,653.

792,051.GARABET S. YERETSSIAN - C/O TRUST,230 PARK AVENUE, NEW YORK, NY 10169

PROGRAM DIRECTOR40.00

0.

0.415,983.87

X


3918735 629999. 0.

X

XX

X

X

X

X

XX

XN/A


*

IN ADDITION TO THE ABOVE, THIS NUMBER ALSO INCLUDES PAYOUT OF ACCRUED BUT UNUSED VACATION.

**

**

923561 12-17-19

7

3 Five highest-paid independent contractors for professional services. If none, enter "NONE."

(a) (c)(b)

Total

1

2

3

4

1

2

3

Total.

(continued)


Name and address of each person paid more than $50,000 Compensation Type of service

number of others receiving over $50,000 for professional services ��

List the foundation's four largest direct charitable activities during the tax year. Include relevant statistical information such as thenumber of organizations and other beneficiaries served, conferences convened, research papers produced, etc. Expenses

Describe the two largest program-related investments made by the foundation during the tax year on lines 1 and 2. Amount

All other program-related investments. See instructions.

Form (2019)

Add lines 1 through 3 ��

Part VIII Information About Officers, Directors, Trustees, Foundation Managers, HighlyPaid Employees, and Contractors

Summary of Direct Charitable ActivitiesPart IX-A

Part IX-B Summary of Program-Related Investments

990-PFJ

9

AKSTON BIOSCIENCES CORPORATION - CLINICAL DEVELOPMENT OFINSULIN-FUSION PROTEIN TO PREVENT T1D

1,536,500.ZUCARA THERAPEUTICS - PRECLINICAL DEVELOPMENT OF DRUG TOPREVENT HYPOGLYCEMIA IN T1D

1,205,000.

DIABETOMICS, INC. - POINT-OF-CARE RAPID TESTS FOR TIDSCREENING AND INTERVENTION

1,018,000.3,759,500.

HIGHCLERE INTERNATIONAL INVESTORS, LLPINVESTMENT MANAGEMENT 2,541,259.2 MANCHESTER SQUARE, LONDON W1U 3PA

ACADIAN ASSET MANAGEMENT LLC260 FRANKLIN STREET, BOSTON, MA 02110IFP GLOBAL EQUITY LPLEVEL 1, 10 PORTMAN SQUARE, LONDON W1H 6AZEIG ENERGY FUND XVI, LP - 1700 PENNSYLVANIAAVE., NW, STE 800, WASHINGTON, DC 20006ORBIMED PRIVATE INVESTMENTS VII, LP - 601LEXINGTON AVE, 54TH FL., NY, NY 10022-4629

INVESTMENT MANAGEMENT




1,891,270.

1,676,537.

1,265,539.

1,127,079.40

N/A



923571 12-17-19

8

1

a

b

c

d

e

1a

1b

1c

1d

2

3

4

5

6

Total

1e

2

3

4

5 Net value of noncharitable-use assets.

6 Minimum investment return.

1

2

3

4

5

6

1

2c

3

4

5

6

7

a

b

c

2a

2b

7 Distributable amount

1

2

3

4

5

6

a

b

1a

1b

2

3a

3b

4

5

6

a

b

Qualifying distributions.

Adjusted qualifying distributions.

Note:


Fair market value of assets not used (or held for use) directly in carrying out charitable, etc., purposes:

Average monthly fair market value of securities

Average of monthly cash balances

Fair market value of all other assets

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

(add lines 1a, b, and c)

Reduction claimed for blockage or other factors reported on lines 1a and

1c (attach detailed explanation)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~

Acquisition indebtedness applicable to line 1 assets

Subtract line 2 from line 1d

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Cash deemed held for charitable activities. Enter 1 1/2% of line 3 (for greater amount, see instructions) ~~~~~~~~

Subtract line 4 from line 3. Enter here and on Part V, line 4 ~~~~~~~~~~

Enter 5% of line 5 ��

(Section 4942(j)(3) and (j)(5) private operating foundations and certain

foreign organizations, check here and do not complete this part.)

Minimum investment return from Part X, line 6

Tax on investment income for 2019 from Part VI, line 5

Income tax for 2019. (This does not include the tax from Part VI.)

Add lines 2a and 2b

��

~~~~~~~~~~~

~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Distributable amount before adjustments. Subtract line 2c from line 1

Recoveries of amounts treated as qualifying distributions

~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Add lines 3 and 4

Deduction from distributable amount (see instructions)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

as adjusted. Subtract line 6 from line 5. Enter here and on Part XIII, line 1 ��

Amounts paid (including administrative expenses) to accomplish charitable, etc., purposes:

Expenses, contributions, gifts, etc. - total from Part I, column (d), line 26

Program-related investments - total from Part IX-B

Amounts paid to acquire assets used (or held for use) directly in carrying out charitable, etc., purposes

~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~

Amounts set aside for specific charitable projects that satisfy the:

Suitability test (prior IRS approval required)

Cash distribution test (attach the required schedule)

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Add lines 1a through 3b. Enter here and on Part V, line 8; and Part XIII, line 4 ~~~~~~~~~

Foundations that qualify under section 4940(e) for the reduced rate of tax on net investment

income. Enter 1% of Part I, line 27b ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Subtract line 5 from line 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~

The amount on line 6 will be used in Part V, column (b), in subsequent years when calculating whether the foundation qualifies for the section

4940(e) reduction of tax in those years.

Form (2019)

(All domestic foundations must complete this part. Foreign foundations, see instructions.)

(see instructions)

(see instructions)

Minimum Investment ReturnPart X

Part XI Distributable Amount

Qualifying Distributions Part XII

990-PF

9

285,153,032.

0.

5,996,008,124.169,492,666.

30,238.6,165,531,028.

0.6,165,531,028.

92,482,965.6,073,048,063.303,652,403.

303,652,403.6,911,639.268,952.

7,180,591.296,471,812.

32,358.296,504,170.

0.296,504,170.

13-7184401CHARITABLE TRUST

3,759,500.

288,912,532.

THE LEONA M. AND HARRY B. HELMSLEY

0.288,912,532.


Undistributed income, if any, as of the end of 2019:

Excess distributions carryover applied to 2019(If an amount appears in column (d), the same amountmust be shown in column (a).)

Corpus. Add lines 3f, 4c, and 4e. Subtract line 5

923581 12-17-19

9

(a) (b) (c) (d)

1

2

3

a

b

a

b

c

d

e

f Total

4

a

b

c

d

e

5

6 Enter the net total of each column asindicated below:

a

b

c

d

e

f

7

8

9

10

Excess distributions carryover to 2020.

a

b

c

d

e


Corpus Years prior to 2018 2018 2019

Distributable amount for 2019 from Part XI,

line 7 ~~~~~~~~~~~~~~~~~

Enter amount for 2018 only ~~~~~~~

Total for prior years:

, ,

Excess distributions carryover, if any, to 2019:

From 2014

From 2015

From 2016

From 2017

From 2018

~~~

~~~

~~~

~~~

~~~

of lines 3a through e ~~~~~~~~

Qualifying distributions for 2019 from

$Part XII, line 4:

Applied to 2018, but not more than line 2a

Applied to undistributed income of prior

years (Election required - see instructions)

~

~

Treated as distributions out of corpus

(Election required - see instructions)

Applied to 2019 distributable amount

~~~

~~~

Remaining amount distributed out of corpus

~~~~~~~~

~~

Prior years' undistributed income. Subtract

line 4b from line 2b ~~~~~~~~~~~

Enter the amount of prior years'undistributed income for which a notice ofdeficiency has been issued, or on whichthe section 4942(a) tax has been previouslyassessed ~~~~~~~~~~~~~~~

Subtract line 6c from line 6b. Taxable

amount - see instructions ~~~~~~~~

Undistributed income for 2018. Subtract line

4a from line 2a. Taxable amount - see instr.~

Undistributed income for 2019. Subtract

lines 4d and 5 from line 1. This amount must

be distributed in 2020 ~~~~~~~~~~

Amounts treated as distributions out of

corpus to satisfy requirements imposed by

section 170(b)(1)(F) or 4942(g)(3) (Election

may be required - see instructions) ~~~~

Excess distributions carryover from 2014

not applied on line 5 or line 7 ~~~~~~~

Subtract lines 7 and 8 from line 6a ~~~~

Analysis of line 9:

Excess from 2015

Excess from 2016

Excess from 2017

Excess from 2018

Excess from 2019

~

~

~

~

�

Form (2019)

(see instructions)Undistributed IncomePart XIII

990-PF

9 288,912,532.

296,504,170.

0.

75,489,513.

0.

0.213,423,019.

0.

0. 0.

0.

0.

0.

0.

83,081,151.

0.

0.

75,489,513.

0.

0.


0.


923601 12-17-19

10

1 a

b

a

b

c

d

e

2(a) (b) (c) (d) (e) Total

3

a(1)

(2)

b

c

(1)

(2)

(3)

(4)

1

a

b

2

a

b

c

d

Information Regarding Foundation Managers:

Information Regarding Contribution, Grant, Gift, Loan, Scholarship, etc., Programs:


If the foundation has received a ruling or determination letter that it is a private operating

foundation, and the ruling is effective for 2019, enter the date of the ruling ~~~~~~~~~~~~~~Check box to indicate whether the foundation is a private operating foundation described in section 4942(j)(3) or 4942(j)(5)

Prior 3 yearsTax yearEnter the lesser of the adjusted net

income from Part I or the minimum

investment return from Part X for

each year listed

2019 2018 2017 2016

~~~~~~~~~

85% of line 2a ~~~~~~~~~~

Qualifying distributions from Part XII,

line 4, for each year listed ~~~~~

Amounts included in line 2c not

used directly for active conduct of

exempt activities ~~~~~~~~~

Qualifying distributions made directly

for active conduct of exempt activities.

Subtract line 2d from line 2c~~~~Complete 3a, b, or c for thealternative test relied upon:"Assets" alternative test - enter:

Value of all assets ~~~~~~

Value of assets qualifyingunder section 4942(j)(3)(B)(i) ~

"Endowment" alternative test - enter2/3 of minimum investment returnshown in Part X, line 6, for each yearlisted ~~~~~~~~~~~~~~

"Support" alternative test - enter:

Total support other than grossinvestment income (interest,dividends, rents, payments onsecurities loans (section512(a)(5)), or royalties) ~~~~

Support from general publicand 5 or more exemptorganizations as provided insection 4942(j)(3)(B)(iii) ~~~

Largest amount of support from

an exempt organization

Gross investment income

~~~~

��

List any managers of the foundation who have contributed more than 2% of the total contributions received by the foundation before the close of any taxyear (but only if they have contributed more than $5,000). (See section 507(d)(2).)

List any managers of the foundation who own 10% or more of the stock of a corporation (or an equally large portion of the ownership of a partnership orother entity) of which the foundation has a 10% or greater interest.

Check here if the foundation only makes contributions to preselected charitable organizations and does not accept unsolicited requests for funds. Ifthe foundation makes gifts, grants, etc., to individuals or organizations under other conditions, complete items 2a, b, c, and d.

The name, address, and telephone number or email address of the person to whom applications should be addressed:

The form in which applications should be submitted and information and materials they should include:

Any submission deadlines:

Any restrictions or limitations on awards, such as by geographical areas, charitable fields, kinds of institutions, or other factors:

Form (2019)

(see instructions and Part VII-A, question 9)Part XIV Private Operating Foundations

Part XV Supplementary Information (Complete this part only if the foundation had $5,000 or more in assetsat any time during the year-see instructions.)

990-PF

9

9

X

NONE

NONE

N/A13-7184401CHARITABLE TRUST



923611 12-17-19

11

3

a

Total 3a

b

Total 3b

Grants and Contributions Paid During the Year or Approved for Future Payment

(continued)

Paid during the year

Approved for future payment

Page Form 990-PF (2019)

If recipient is an individual,show any relationship toany foundation manageror substantial contributor

RecipientFoundation

status ofrecipient

Purpose of grant orcontribution Amount

Name and address (home or business)

��

��

Form (2019)

Part XV Supplementary Information

990-PF

9

9

A GLIMMER OF HOPE FOUNDATION3600 N CAPITAL OF TEXAS HWY

A GLIMMER OF HOPE FOUNDATION

1,174,138.

NA PF INTEGRATED COMMUNITYDEVELOPMENT IN AMHARA,

260,433,258.

667,500.

4YOUANDME NA PC LEVERAGING WEARABLES2901 THIRD AVENUE TO TREAT CROHN'S

335,690,225.

ADAIR COUNTY MEMORIAL HOSPITAL609 SE KENT

SEATTLE, WA 98121

AGRICULTURAL RESEARCH ORGANIZATIONDERECH HAMACCABIM 68, RISHON LETSIYON

AGRICULTURAL RESEARCH ORGANIZATIONDERECH HAMACCABIM 68, RISHON LETSIYON

NA

3600 N CAPITAL OF TEXAS HWYNA PF INTEGRATED COMMUNITY

DEVELOPMENT IN ODA2,561,121.

1,628,077.

13,399.

2,783,559.

AUSTIN, TX 78746

A GLIMMER OF HOPE FOUNDATION NA PF INTEGRATED COMMUNITY3600 N CAPITAL OF TEXAS HWY

NA

DEVELOPMENT IN ODA

2,579,190.

A GLIMMER OF HOPE FOUNDATION NA PF INTEGRATED COMMUNITY3600 N CAPITAL OF TEXAS HWY DEVELOPMENT IN ODA

ETHIOPIA

AUSTIN, TX 78746

NA

GOV

BULTUM, ETHIOPIA

GREENFIELD, IA 50849

PC

PC

RISHON LETSIYON, ISRAEL

DISEASE

EEMERGENCY AT ADAIRCOUNTY HEALTH SYSTEM

MODEL FARM FORSUSTAINABLEAGRICULTURE

RISHON LETSIYON, ISRAEL

MODEL FARM FORSUSTAINABLE

AUSTIN, TX 78746

AGRICULTURE

848,312.

BULTUM, ETHIOPIA

AUSTIN, TX 78746 BULTUM, ETHIOPIA

SEE CONTINUATION SHEET(S)

SEE CONTINUATION SHEET(S)



Excluded by section 512, 513, or 514

Exclu-sioncode

923621 12-17-19

12

(e)(c)(a) (b) (d)

1

a

b

c

d

e

f

g

2

3

4

5

6

7

8

9

10

a

b

11

12

13

a

b

c

d

e

Total. 13

Line No.


Unrelated business incomeEnter gross amounts unless otherwise indicated.Related or exemptfunction income

Businesscode Amount AmountProgram service revenue:

Fees and contracts from government agencies ~~~

Membership dues and assessments

Interest on savings and temporary cash

investments

~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~

Dividends and interest from securities

Net rental income or (loss) from real estate:

~~~~~~~~

Debt-financed property

Not debt-financed property

~~~~~~~~~~~~~

~~~~~~~~~~~~

Net rental income or (loss) from personal

property ~~~~~~~~~~~~~~~~~~~~~

Other investment income

Gain or (loss) from sales of assets other

than inventory

~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~

Net income or (loss) from special events

Gross profit or (loss) from sales of inventory

Other revenue:

~~~~~~~

~~~~~

Subtotal. Add columns (b), (d), and (e)

Add line 12, columns (b), (d), and (e)

~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

(See worksheet in line 13 instructions to verify calculations.)

Explain below how each activity for which income is reported in column (e) of Part XVI-A contributed importantly to the accomplishment ofthe foundation's exempt purposes (other than by providing funds for such purposes).

Form (2019)

Part XVI-A Analysis of Income-Producing Activities

Part XVI-B Relationship of Activities to the Accomplishment of Exempt Purposes

990-PF

<

PRI LOAN INTEREST

GRANT RECOVERIESOTHER TAXABLE INCOMERENTAL INCOME SUBTENANT

743,302,857.

1A PRI LOAN INTEREST EARNED THROUGH STRATEGIC PHILANTHROPIC INVESTMENTS1A

525990

525990

525990

857,240.

240,227.

945,571.

2,043,038.

1414

14

18

010116

1,503,764.40,284,959.

29,393,865.

669,714,558.

32,358.16,116.305,476.

741,251,096.

8,723.

8,723.



92359104-01-19

Capital Gains and Losses for Tax on Investment Income(b) (a) (c) (d)

(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3


List and describe the kind(s) of property sold, e.g., real estate,2-story brick warehouse; or common stock, 200 shs. MLC Co.



1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o



Gain or (loss)(e) plus (f) minus (g)

Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o

Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69 Losses (from col. (h))Gains (excess of col. (h) gain over col. (k),

but not less than "-0-")Adjusted basis

as of 12/31/69Excess of col. (i)

over col. (j), if anyF.M.V. as of 12/31/69

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o

If gain, also enter in Part I, line 7If (loss), enter "-0-" in Part I, line 7

~~~~~~~~Capital gain net income or (net capital loss)

Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):If gain, also enter in Part I, line 8, column (c).If (loss), enter "-0-" in Part I, line 8 ��

Part IV

i jpmo

SALE OF PUBLICLY TRADED SECURITIESEPIRIS IIYORK EUROPEANYORK EUROPEANYORK EUROPEAN

PPPPP

VARIOUSVARIOUSVARIOUSVARIOUSVARIOUS

10/16/1911/07/1901/03/2004/18/19

983,569,195.57,499.

2,071,376.432,355.619,325.

788,151,463.

195,417,732.57,499.

2,071,376.432,355.619,325.

195,417,732.57,499.

2,071,376.432,355.619,325.

YORK EUROPEANYORK EUROPEAN

HORSEMAN GLB BHORSEMAN GLB BHORSEMAN GLB BSEQUOIA CAP GLOBALHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMID

PPPPPPPPPP

VARIOUSVARIOUSVARIOUSVARIOUSVARIOUSVARIOUSVARIOUSVARIOUSVARIOUSVARIOUS

08/01/1909/10/1904/01/1907/01/1905/01/1901/27/2004/30/1903/06/2002/29/2001/31/20

969,016.1,116,778.38,000,000.74,090,304.30,000,000.20,000,000.

101,158.10,000,000.

91,373.100,750.

45,966,994.92,676,163.41,356,843.9,270,849.

969,016.1,116,778.-7,966,994.-18,585,859.-11,356,843.10,729,151.

101,158.10,000,000.

91,373.100,750.

969,016.1,116,778.-7,966,994.-18,585,859.-11,356,843.10,729,151.

101,158.10,000,000.

91,373.100,750.

13-7184401CHARITABLE TRUSTTHE LEONA M. AND HARRY B. HELMSLEY CONTINUATION FOR 990-PF, PART IV

PAGE 1 OF 22


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

HIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMID

PPPPP


12/31/1911/30/1910/31/1909/30/1908/31/19

104,622.100,334.99,177.94,226.90,976.

104,622.100,334.99,177.94,226.90,976.

104,622.100,334.99,177.94,226.90,976.

HIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SMIDHIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SC

PPPPPPPPPP


07/31/1906/30/1905/31/1905/01/1903/31/2003/31/2003/06/2002/29/2001/31/2012/31/19

93,308.93,532.88,933.

10,000,000.72,203.94,130.

5,000,000.113,764.126,657.131,105.

93,308.93,532.88,933.

10,000,000.72,203.94,130.

5,000,000.113,764.126,657.131,105.

93,308.93,532.88,933.

10,000,000.72,203.94,130.

5,000,000.113,764.126,657.131,105.


2 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

HIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SC

PPPPP


11/30/1910/31/1909/30/1908/31/1907/31/19

125,444.123,508.117,009.113,189.116,646.

125,444.123,508.117,009.113,189.116,646.

125,444.123,508.117,009.113,189.116,646.

HIGHCLERE INTL SCHIGHCLERE INTL SCHIGHCLERE INTL SCACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIER

PPPPPPPPPP


06/30/1905/31/1904/30/1907/01/1907/01/1907/01/1907/01/1907/01/1907/01/1905/01/19

117,146.113,180.118,889.

2,591,926.13,615,243.

774,445.140,846.574,050.

2,303,491.2,707,215.

117,146.113,180.118,889.

2,591,926.13,615,243.

774,445.140,846.574,050.

2,303,491.2,707,215.

117,146.113,180.118,889.

2,591,926.13,615,243.

774,445.140,846.574,050.

2,303,491.2,707,215.


3 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

ACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIERACADIAN FRONTIER

PPPPP


04/01/1904/01/1905/01/1906/03/1906/03/19

7,725,759.2,274,241.7,292,785.3,946,542.6,053,458.

18,135,120.

-10,409,361.2,274,241.7,292,785.3,946,542.6,053,458.

-10,409,361.2,274,241.7,292,785.3,946,542.6,053,458.

KILTEARNKILTEARNKILTEARNKILTEARNKILTEARNKILTEARNKILTEARNKILTEARNKILTEARNKILTEARN

PPPPPPPPPP


06/30/1905/06/1904/30/1905/31/1908/31/1907/31/1909/30/1910/01/1910/01/1910/01/19

95,433.15,000,000.

103,140.91,105.90,493.94,430.93,728.

2,712,783.1,710,311.

162,811,000.

4,572.705,607.4,849.4,646.4,649.4,585.4,591.

133,844.84,384.

8,032,789.

90,861.14,294,393.

98,291.86,459.85,844.89,845.89,137.

2,578,939.1,625,927.

154,778,211.

90,861.14,294,393.

98,291.86,459.85,844.89,845.89,137.

2,578,939.1,625,927.

154,778,211.


4 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

KILTEARNBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBT

PPPPP


10/01/1912/16/1911/25/1911/18/1901/24/20

406,588.44,608.

70,000,000.70,000,000.

30,741.

20,060.40,293.

63,866,394.64,170,664.

27,368.

386,528.4,315.

6,133,606.5,829,336.

3,373.

386,528.4,315.

6,133,606.5,829,336.

3,373.

BLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTBLACKROCK US DEBTGOLDENTREE OFFSHOREGOLDENTREE OFFSHOREGOLDENTREE OFFSHORE

PPPPPPPPPP


11/12/1907/09/1911/05/1911/08/1912/09/1912/02/1904/15/1907/18/1907/31/1912/31/19

70,000,000.38,397.

70,000,000.40,596.

60,000,000.60,000,000.

38,170.264,884.14,658.

4,131,643.

65,196,827.38,459.

68,670,336.37,347.

54,453,410.54,810,660.

37,069.471,097.28,403.

8,757,566.

4,803,173.-62.

1,329,664.3,249.

5,546,590.5,189,340.

1,101.-206,213.-13,745.

-4,625,923.

4,803,173.-62.

1,329,664.3,249.

5,546,590.5,189,340.

1,101.-206,213.-13,745.

-4,625,923.


5 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

MARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTL

PPPPP


09/30/1908/30/1907/31/1906/28/1905/31/19

61,144,216.74,795.75,898.76,715.74,256.

28,592,753.38,849.38,591.38,414.39,064.

32,551,463.35,946.37,307.38,301.35,192.

32,551,463.35,946.37,307.38,301.35,192.

MARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTLMARATHON LONDON INTLLA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBAL

PPPPPPPPPP


04/30/1904/30/1908/30/1904/30/1909/30/1905/31/1910/31/1911/30/1912/31/1901/31/20

93,334.33,754.

60,000,000.40,000,000.

15,334.27,340.29,478.29,780.30,580.30,603.

46,857.16,946.

29,507,485.24,484,501.

7,171.

46,477.16,808.

30,492,515.15,515,499.

8,163.27,340.29,478.29,780.30,580.30,603.

46,477.16,808.

30,492,515.15,515,499.

8,163.27,340.29,478.29,780.30,580.30,603.


6 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

LA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBALLA CAPITAL GLOBAL

PPPPP


02/29/2003/31/2006/30/1908/31/1909/30/19

28,292.25,181.29,149.28,822.29,106.

28,292.25,181.29,149.28,822.29,106.

28,292.25,181.29,149.28,822.29,106.

LA CAPITAL GLOBALLA CAPITAL GLOBALMARATHON GLOBALMARATHON GLOBALMARATHON GLOBALMARATHON GLOBALMARATHON GLOBALMARATHON GLOBALJPM PEG SECONDARYJPM PEG SECONDARY

PPPPPPPPPP


04/30/1907/31/1902/28/2001/31/2010/31/1911/29/1912/31/1903/31/2007/25/1911/25/19

28,450.28,997.88,866.94,266.169,283.94,553.96,379.82,190.630,903.646,799.

93,853.91,847.167,610.91,850.91,177.96,879.

28,450.28,997.-4,987.2,419.1,673.2,703.5,202.

-14,689.630,903.646,799.

28,450.28,997.-4,987.2,419.1,673.2,703.5,202.

-14,689.630,903.646,799.


7 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

ORBIMED ROYALTY IIORBIMED ROYALTY IIYORK EUROPEAN IIYORK EUROPEAN IIYORK EUROPEAN II

PPPPP


12/30/1903/27/2004/10/1905/13/1907/08/19

105,636.

3,547,263.89,261.

1,004,468.

1,526,507.

105,636.-1,526,507.3,547,263.

89,261.1,004,468.

105,636.-1,526,507.3,547,263.

89,261.1,004,468.

YORK EUROPEAN IIYORK EUROPEAN IIFORTISSIMO IVIDG CHINA CAP IIIORBIMED PI VISEQUOIA US GRWTH VIISEQUOIA US GRWTH VIISEQUOIA GLB GRWTH IIACCEL GROWTH FUND IVGSO CAPITAL SOLUTION

PPPPPPPPPP


08/14/1910/16/1912/26/1904/10/1910/01/1905/22/1908/20/1905/22/1903/09/2005/20/19

5,592,836.1,650,204.1,025,974.1,585,196.460,979.38,137.538,734.31,815.137,101.154,924.

5,592,836.1,650,204.1,025,974.1,585,196.460,979.38,137.538,734.31,815.137,101.154,924.

5,592,836.1,650,204.1,025,974.1,585,196.460,979.38,137.538,734.31,815.137,101.154,924.


8 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

GSO CAPITAL SOLUTIONEIG ENERGY XVEIG ENERGY XVEIG ENERGY XVEIG ENERGY XV

PPPPP


11/12/1910/24/1909/06/1907/15/1903/06/20

17,779.3,711.76,229.4,624.44,449.

17,779.3,711.76,229.4,624.44,449.

17,779.3,711.76,229.4,624.44,449.

ARBORETUM IIIHIG BIOVENTURE IIIDG-ACCEL CHINA GWTHIDG-ACCEL CHINA GWTHIDG-ACCEL CHINA CAPHIG GROWTH IIGAVEA INV FND IV LPSEQUOIA US GROWTH VSEQUOIA US GROWTH VCOLLER VI

PPPPPPPPPP


01/09/2007/29/1912/20/1901/31/2012/26/1902/14/2006/24/1910/10/1904/26/1904/24/19

845,381.6,401,450.492,272.

1,746,832.245,137.

5,234,946.710,306.196,309.71,083.515,637.

845,381.6,401,450.492,272.

1,746,832.245,137.

5,234,946.710,306.196,309.71,083.515,637.

845,381.6,401,450.492,272.

1,746,832.245,137.

5,234,946.710,306.196,309.71,083.515,637.


9 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

COLLER VICOLLER VICOLLER VICOLLER VICOLLER VI

PPPPP


09/17/1908/05/1906/18/1912/09/1910/11/19

508,695.576,680.341,268.375,110.320,741.

508,695.576,680.341,268.375,110.320,741.

508,695.576,680.341,268.375,110.320,741.

GOLDEN GATE OPPSGOLDEN GATE OPPSGOLDEN GATE OPPSSEQUOIA CHINA VTR IVSEQUOIA ISRAEL VSEQUOIA ISRAEL VGSO CAPITAL SOLS IIGSO CAPITAL SOLS IIGSO CAPITAL SOLS IIGSO CAPITAL SOLS II

PPPPPPPPPP


01/30/2012/24/1911/21/1905/14/1902/18/2004/29/1906/10/1911/15/1904/15/1910/15/19

665,183.5,361,531.9,316,285.113,269.

2,134,242.279,976.32,658.537,862.280,775.196,568.

665,183.5,361,531.9,316,285.113,269.

2,134,242.279,976.32,658.537,862.280,775.196,568.

665,183.5,361,531.9,316,285.113,269.

2,134,242.279,976.32,658.537,862.280,775.196,568.


10 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

HIG BAYSIDE IIIHIG BAYSIDE IIIHIG BAYSIDE IIIHIG BAYSIDE IIIHIG BAYSIDE III

PPPPP


04/17/1903/06/2011/25/1908/28/1905/30/19

722,340.387,709.22,835.799,587.169,933.

722,340.387,709.22,835.799,587.169,933.

722,340.387,709.22,835.799,587.169,933.

GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013

PPPPPPPPPP


01/30/2002/06/2012/17/1912/11/1912/10/1911/22/1911/14/1912/26/1902/13/2003/06/20

225,120.2,544,275.2,113,509.710,270.114,811.428,602.195,508.135,360.530,358.713,702.

225,120.2,544,275.2,113,509.710,270.114,811.428,602.195,508.135,360.530,358.713,702.

225,120.2,544,275.2,113,509.710,270.114,811.428,602.195,508.135,360.530,358.713,702.


11 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013

PPPPP


03/30/2011/08/1911/07/1908/20/1909/27/19

1,623,106.618,329.23,396.674,171.

1,090,131.

1,623,106.618,329.23,396.674,171.

1,090,131.

1,623,106.618,329.23,396.674,171.

1,090,131.

GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013HIG CAPITAL VJPM PEG SECONDARY IIJPM PEG SECONDARY II

PPPPPPPPPP


09/17/1908/26/1908/13/1905/09/1905/02/1908/08/1908/02/1906/03/1911/25/1907/25/19

1,536,137.839,981.

1,391,845.1,315,423.943,509.42,087.

1,529,414.114,258.373,138.664,265.

1,536,137.839,981.

1,391,845.1,315,423.943,509.42,087.

1,529,414.114,258.373,138.664,265.

1,536,137.839,981.

1,391,845.1,315,423.943,509.42,087.

1,529,414.114,258.373,138.664,265.


12 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

EIG ENERGY FUND XVIEIG ENERGY FUND XVIEIG ENERGY FUND XVIEIG ENERGY FUND XVICRESTVIEW III

PPPPP


09/30/1905/17/1903/06/2011/01/1904/18/19

54,356.618,750.66,673.3,785.34,402.

54,356.618,750.66,673.3,785.34,402.

54,356.618,750.66,673.3,785.34,402.

CRESTVIEW IIICRESTVIEW IIICRESTVIEW IIIMARINER IIFCHIG MID MARKET IIHIG MID MARKET IIACCEL XIISEQUOIA US GWTH VISEQUOIA CHINA GR IIISEQUOIA CHINA GR III

PPPPPPPPPP


09/20/1910/21/1912/30/1903/18/2003/09/2008/30/1907/19/1909/12/1909/19/1905/17/19

30,154.22,919.

11,118,709.335,220.898,105.235,100.262,816.2,545.

177,821.67,880.

30,154.22,919.

11,118,709.335,220.898,105.235,100.262,816.2,545.

177,821.67,880.

30,154.22,919.

11,118,709.335,220.898,105.235,100.262,816.2,545.

177,821.67,880.


13 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

SEQUOIA CHINA GR IIIBAYVIEWBAYVIEWBAYVIEWBAYVIEW

PPPPP


02/28/2001/15/2005/15/1911/15/1907/15/19

521,006.1,860,111.813,454.

1,571,816.1,260,960.

521,006.1,860,111.813,454.

1,571,816.1,260,960.

521,006.1,860,111.813,454.

1,571,816.1,260,960.

BAYVIEWBAYVIEWGAVEA VGAVEA VJPM PEG SECONDRY IIIJPM PEG SECONDRY IIIGSO CAP SOLUTION IIIGSO CAP SOLUTION IIIGSO CAP SOLUTION IIIGSO CAP SOLUTION III

PPPPPPPPPP


06/14/1908/15/1905/10/1911/18/1911/08/1906/05/1912/11/1906/10/1903/31/2001/30/20

1,261,807.2,835,111.3,511,994.5,681,091.316,427.34,315.31,576.7,879.7,499.

115,191.

1,261,807.2,835,111.3,511,994.5,681,091.316,427.34,315.31,576.7,879.7,499.

115,191.

1,261,807.2,835,111.3,511,994.5,681,091.316,427.34,315.31,576.7,879.7,499.

115,191.


14 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

GSO CAP SOLUTION IIIGSO CAP SOLUTION IIIORBIMED PI VIIORBIMED PI VIISEQUOIA US GRTH VIII

PPPPP


04/15/1908/23/1909/10/1901/30/2002/18/20

20,692.53,129.176,845.

6,288,604.230,226.

20,692.53,129.176,845.

6,288,604.230,226.

20,692.53,129.176,845.

6,288,604.230,226.

IDG CHINA VTR IVIDG CHINA VTR IVIDG CHINA VTR IVSEQUOIA CHINA GR IVWTI VLL VIIISEQUOIA US GRWTH VIISEQUOIA US GRWTH VIISEQUOIA US GRWTH VIISEQUOIA US GRWTH VIISEQUOIA US GRWTH VII

PPPPPPPPPP


09/11/1904/30/1912/10/1901/15/2011/11/1903/16/2003/09/2010/15/1911/11/1912/09/19

1,491,535.805,931.508,242.56,419.273,989.

1,662,252.1,756,286.535,328.4,602.

496,531.

1,491,535.805,931.508,242.56,419.273,989.

1,662,252.1,756,286.535,328.4,602.

496,531.

1,491,535.805,931.508,242.56,419.273,989.

1,662,252.1,756,286.535,328.4,602.

496,531.


15 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

SEQUOIA US GRWTH VIISEQUOIA GLB GRWTH IISEQUOIA GLB GRWTH IISEQUOIA GLB GRWTH IISEQUOIA GLB GRWTH II

PPPPP


03/05/2003/16/2003/05/2003/09/2012/09/19

1,935,892.875,116.

1,019,178.924,621.261,420.

1,935,892.875,116.

1,019,178.924,621.261,420.

1,935,892.875,116.

1,019,178.924,621.261,420.

SEQUOIA GLB GRWTH IISEQUOIA GLB GRWTH IIACCEL LEADERS FUNDACCEL GROWTH FUND IVACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH II

PPPPPPPPPP


10/15/1901/15/2001/10/2011/26/1912/06/1912/04/1912/06/1909/09/1908/05/1909/04/19

281,847.219,693.492,936.278,112.440,985.519,848.340,137.465,264.490,263.468,347.

281,847.219,693.492,936.278,112.440,985.519,848.340,137.465,264.490,263.468,347.

281,847.219,693.492,936.278,112.440,985.519,848.340,137.465,264.490,263.468,347.


16 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

ACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH IIACCEL GROWTH IIACCEL XI

PPPPP


05/03/1901/03/2003/23/2003/30/2010/07/19

644,366.439,738.

1,583,059.765,880.120,914.

644,366.439,738.

1,583,059.765,880.120,914.

644,366.439,738.

1,583,059.765,880.120,914.

SEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VSEQUOIA US GROWTH VEMERGENCE III

PPPPPPPPPP


02/26/2002/10/2002/28/2012/09/1901/27/2003/04/2003/05/2003/09/2003/16/2003/16/20

10,264.11,597.10,473.6,875.13,074.10,352.15,321.13,712.12,870.

29,980,004.

10,264.11,597.10,473.6,875.13,074.10,352.15,321.13,712.12,870.

29,980,004.

10,264.11,597.10,473.6,875.13,074.10,352.15,321.13,712.12,870.

29,980,004.


17 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

EMERGENCE IIIEMERGENCE IIIEMERGENCE IIIEMERGENCE IIIEMERGENCE III

PPPPP


11/18/1912/16/1901/06/2001/21/2003/05/20

1,475,770.2,630,342.9,066,584.3,428,433.34,609,214.

1,475,770.2,630,342.9,066,584.3,428,433.34,609,214.

1,475,770.2,630,342.9,066,584.3,428,433.34,609,214.

EMERGENCE IIIAH III PARALLELAH III PARALLELAH III PARALLELAH III PARALLELAH III PARALLELAH III PARALLELAH IIIAH IIIAH III

PPPPPPPPPP


02/04/2002/03/2002/03/2002/10/2002/10/2002/13/2002/07/2003/20/2010/07/1902/13/20

979,687.

173,738.277,394.

814,574.277,394.

1,565,934.575,949.485,810.

658.

277,394.

979,687.-658.

173,738.277,394.-277,394.814,574.277,394.

1,565,934.575,949.485,810.

979,687.-658.

173,738.277,394.-277,394.814,574.277,394.

1,565,934.575,949.485,810.


18 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

AH IIIAH IIIAH IIIAH IIISEQUOIA GLB GROWTH

PPPPP


02/07/2002/03/2012/09/1910/15/1910/10/19

308,902.466,050.836,805.

1,048,178.250,612.

308,902.466,050.836,805.

1,048,178.250,612.

308,902.466,050.836,805.

1,048,178.250,612.

SEQUOIA GLB GROWTHSEQUOIA US VTR XIVSEQUOIA US VTR XIVSEQUOIA US VTR XIVSEQUOIA US VTR XIVSEQUOIA US VTR XIVSEQUOIA US VTR XIVSEQUOIA CHINA VTR IVSEQUOIA CHINA VTR IVSEQUOIA CHINA VTR IV

PPPPPPPPPP


01/15/2008/09/1908/21/1908/29/1902/28/2012/17/1902/26/2005/15/1908/26/1901/15/20

423,859.584,561.591,909.532,662.457,721.224,584.222,529.187,173.220,947.350,879.

423,859.584,561.591,909.532,662.457,721.224,584.222,529.187,173.220,947.350,879.

423,859.584,561.591,909.532,662.457,721.224,584.222,529.187,173.220,947.350,879.


19 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

WTI VLL VIISILCHESTER INTLSILCHESTER INTLSILCHESTER INTLACCEL XII

PPPPP


11/11/1903/31/2001/31/2002/28/2004/05/19

304,339.26,939.11,997.21,736.

1,111,512.

35,510.12,500.24,955.

304,339.-8,571.-503.

-3,219.1,111,512.

304,339.-8,571.-503.

-3,219.1,111,512.

ACCEL GROWTH IIIACCEL GROWTH IIIAH IV PARALLELAH IV PARALLELAH IV PARALLELSEQUOIA CHINA VTR VISEQUOIA CHINA VTR VSEQUOIA CHINA VTR VSEQUOIA CHINA VTR VSTARWOOD XI

PPPPPPPPPP


12/17/1912/06/1906/20/1903/13/2003/17/2004/19/1912/12/1904/19/1904/22/1912/23/19

752,758.227,833.

2,084,384.959,928.

1,768,173.7,563.48,901.1,767.

151,480.96,310.

752,758.227,833.

2,084,384.959,928.

1,768,173.7,563.48,901.1,767.

151,480.96,310.

752,758.227,833.

2,084,384.959,928.

1,768,173.7,563.48,901.1,767.

151,480.96,310.


20 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

ARBORETUM IIIGENERL ATLANTIC 2013GENERL ATLANTIC 2013GENERL ATLANTIC 2013CRESTVIEW III

PPPPP


01/09/2001/30/2003/16/2003/30/2004/18/19

587,164.264,137.13,982.136,129.162,546.

587,164.264,137.13,982.136,129.162,546.

587,164.264,137.13,982.136,129.162,546.

CRESTVIEW IIICRESTVIEW IIICRESTVIEW IIICRESTVIEW IIICRESTVIEW IIIORBIMED ROYALTY IIWTI VLL VIIIMHR INST PARTNERS IVMHR INST PARTNERS IVEIG ENERGY XVII

PPPPPPPPPP


05/30/1907/19/1908/30/1909/20/1910/21/1906/26/1906/14/1907/24/1901/06/2006/19/19

91,088.191,502.151,723.133,585.101,529.

3,309,307.123,000.46,255.338,918.231,013.

91,088.191,502.151,723.133,585.101,529.

3,309,307.123,000.46,255.338,918.231,013.

91,088.191,502.151,723.133,585.101,529.

3,309,307.123,000.46,255.338,918.231,013.


21 22PAGE OF


92359104-01-19


(f) (g) (h) (e)

(l)

(j) (k) (i)

2 2

3

3





1a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Gross sales price

a

b

c

d

e

f

g

h

i

j

k

l

m

n

o





a

b

c

d

e

f

g

h

i

j

k

l

m

n

o




Part IV

i jpmo

EPIRIS IIGENERL ATLANTIC 2018GENERL ATLANTIC 2018GENERL ATLANTIC 2018MARATHON GLOBAL INTL

PPPPP


02/20/2006/26/1910/25/1911/14/19VARIOUS

6,675.795,128.179,601.12,794.

8,369,326.

6,675.795,128.179,601.12,794.

-8,369,326.

6,675.795,128.179,601.12,794.

-8,369,326.

K-1 ADJUSTMENTS, NET OF UBI AND RELATED AMOUNTS ABOVECAPITAL GAINS DIVIDENDS

277,295,041.

P VARIOUS VARIOUS

27,323,282.

-495,781,534.27,323,282.

-495,781,534.27,323,282.


N/A

22 22PAGE OF


92363104-01-19

3

Total from continuation sheets

Grants and Contributions Paid During the Year (Continuation)


RecipientFoundation

status ofrecipient



��


ALEGENT CREIGHTON HEALTH704 N. 3RD STREET

10,025.

NA PC EEMERGENCY AT CHIHEALTH PLAINVIEW

ALEGENT HEALTH-MEMORIAL HOSPITAL

ALEH NEGEV FOR REHABILITATION AND

254,208,211.

AMC MEDICAL RESEARCH BV

AMERICAN ASSOCIATES BEN-GURION

SCHUYLER

DEVELOPMENT

ALVIN AILEY DANCE FOUNDATION, INC.

MEIBERGDREEF 9

UNIVERSITY OF THE NEGEV, INC.

104 W 17TH STREET

MERHAVIM REGIONAL COUNCIL

THE JOAN WEILL CENTER FOR DANCE

AMSTERDAM, NETHERLANDS

1001 AVENUE OF THE AMERICAS, 19TH

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CHI HEALTH SCHUYLER

CONSTRUCTION OF A NEW

DEVELOPMENT OF AN

GENERAL OPERATING

EEMERGENCY PROJECT

REHABILITATION

GENERAL OPERATING

EPIGENETIC BIOMARKER

SUPPORT

HOSPITAL AT ALEH

12,276.

SUPPORT

THAT PREDICTS750,592.

407,240.

AMERICAN ASSOCIATION OF DIABETES


357,500.

AMERICAN DIABETES ASSOCIATION, INC.2451 CRYSTAL DRIVE, SUITE 900

EDUCATORS, INC

EDUCATORS, INC

AMERICAN CAMPING ASSOCIATION INC

ARLINGTON, VA 22202

NA

200 WEST MADISON ST.


5000 STATE ROAD 67 NORTH

PC 2019-2021 TYPE 1DIABETES CAMP

NA

NA

INITIATIVE

CHARITABLE TRUST 13-7184401THE LEONA M. AND HARRY B. HELMSLEY

NA

NC

NC

PC

10,000.

5,000.

AADE TECHNOLOGY

AADE TECHNOLOGY

INSTITUTE: DANA -

INSTITUTE: DANA -

ACA PROFESSIONAL

DIABETES ADVANCED

DIABETES ADVANCED

DEVELOPMENT 2019-2021

852,051.

343,754.

41,084.

PLAINVIEW, NE 68729

SCHUYLER, NE 68661

OFAKIM, ISRAEL NEGEV-NAHALAT ERAN

NEW YORK, NY 10019

TREATMENT SUCCESS

FLOOR NEW YORK, NY 10018

CHICAGO, IL 60606 NETWORK ACCESS

CHICAGO, IL 60606 NETWORK ACCESS

MARTINSVILLE, IN 46151


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



247,903.

NA PC MENTAL HEALTH PROVIDERDIABETES EDUCATION

AMERICAN DIABETES ASSOCIATION, INC.

AMERICAN HEART ASSOCIATION, INC.

2451 CRYSTAL DRIVE, SUITE 900



7272 GREENVILLE AVENUE

AMICI DI ADWA ONLUS

ARLINGTON, VA 22202



DALLAS, TX 75231

VIA GIACOMO MATTEOTTI, 8

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

PATRON SUPPORT OF THE

AHA POST-ACUTE STROKE

ASSOCIATION'S 79TH,

MISSION: LIFELINE

MISSION: LIFELINE -

CARE QUALITY

HOSPITAL FOR ADWA,

80TH, AND 81ST

STROKE SYSTEM OF CARE

75,000.


STANDARDIZATION

ETHIOPIA IN TIGRAY

400,000.

2,036,960.

ASIAN HEALTH CARE FOUNDATION

AUSTRALASIAN GASTRO INTESTINAL

574,012.

AUSTRALASIAN GASTRO INTESTINAL

AUSTRALASIAN GASTRO INTESTINALRESEARCH FOUNDATION LTD.LEVEL 2

6-3-661, SOMAJIGUDA

RESEARCH FOUNDATION LTD.

RESEARCH FOUNDATION LTD.

FITZROY, AUSTRALIA

NA

HYDERABAD, INDIA

LEVEL 2

LEVEL 2

NC THE ENIGMA STUDIES -EASTERN INFLAMMATORYBOWEL DISEASE GUT

NA

NA

NA

MICROBIOTA


PC

NC

NC

1,113,500.

3,660,190.

ACCESS TO CROHN'S

THE ENIGMA STUDIES -

THE ENIGMA STUDIES -

DIAGNOSTICS IN INDIA

EASTERN INFLAMMATORY


FOR PATIENTS LIVING IN

BOWEL DISEASE GUT

BOWEL DISEASE GUT

547,802.

340,860.

583,175.

ARLINGTON, VA 22202 PROGRAM

SESSIONS

DALLAS, TX 75231 IN NEBRASKA

DALLAS, TX 75231 IN NORTH DAKOTA

PROJECT

CENTO (FERRARA), ITALY REGION

POVERTY

FITZROY, AUSTRALIA MICROBIOTA

FITZROY, AUSTRALIA MICROBIOTA


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


AVERA HEALTH3900 W AVERA DR

2,785,331.

NA PC ECARE TELE-PSYCHIATRY24/7 CARE TEAM

BAPTIST MEDICAL CENTRE

BAR ILAN UNIVERSITY

AVERA HEALTH

BAPTIST MEDICAL CENTRE ROAD

MAX VE-ANNA WEBB ST.

BARZILAI MEDICAL CENTER


3900 W AVERA DR

NALERIGU, GHANA

RAMAT GAN, ISRAEL

HAHISTADROUT ST2

HAHISTADROUT ST2

NA

NA

NA

NA

NA

PC

PC

PC

GOV

GOV

CAPITAL SUPPORT:

EXPANDING AI RESEARCH

TELEHEALTH EDUCATION

BAPTIST MEDICAL CENTRE

AT BAR ILAN

BUILD-OUT OF NEW

REPAIRS TO ONCOLOGY

PROGRAM

FACILITY EXPANSION &

1,585,461.

UNIVERSITY'S COMPUTER

FORTIFIED SURGICAL

DEPARTMENT

1,893,800.

414,222.

BAUM HARMON MERCY HOSPITAL

61,677.

BEN-GURION UNIVERSITY OF THE NEGEV

BENNETT COUNTY HOSPITAL AND NURSINGHOME102 MAJOR ALLEN ST

255 N. WELCH AVENUE

BEIT URI

BEN-GURION BLVD. 1

MARTIN, SD 57551

NA

PRIMGHAR, IA 51245

ZUKIT 4

BEER SHEVA, ISRAEL

PC EPHARMACY ANDEEMERGENCY

NA

NA


NA

PC

PC

PC

1,732,985.

250,000.

BAUM HARMON MERCY

RANDOMIZED

HOSPITAL DIGITAL

ASSISTED LIVING

INTERVENTIONAL STUDY

RADIOLOGY IMAGING

BUILDING AND CLINIC

OF MINDFULNESS-BASED

272,213.

337,908.

282,660.

SIOUX FALLS, SD 57108


UPDATES

SCIENCE DEPT

ASHKELON, ISRAEL DEPARTMENT

ASHKELON, ISRAEL

PROJECT

AFULA, ISRAEL FOR 24/7 CARE

STRESS-REDUCTION


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


BIG HORN HOSPITAL ASSOCIATION17 N MILES AVE

285,225.

NA PC EEMERGENCY ANDEPHARMACY AT BIG HORN

BIOBRICKS FOUNDATION INCORPORATED

BILLINGS CLINIC FOUNDATION



955 MASSACHUSETTS AVENUE, STE 330

BIPARTISAN POLICY CENTER, INC.

2917 TENTH AVENUE NORTH



CAMBRIDGE, MA 02139

1225 I ST NW #1000

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

BIONET: ENABLING

BILLINGS CLINIC

MONTANA PSYCHIATRY

INTERNAL MEDICINE

RESEARCHERS TO

RURAL HEALTH CARE TASK

PSYCHIATRIC

RESIDENCY PROGRAM

26,400.

RESIDENCY SCHOLAR

RELIABLY SHARE

FORCE

310,400.

559,851.

247,486.

BOARD OF TRUSTEES OF THE LELAND

BOARD OF TRUSTEES OF THE LELANDSTANFORD JUNIOR UNIVERSITY443 VIA ORTEGA

BNAI ZION MEDICAL CENTER

BNAI ZION MEDICAL CENTER

STANFORD JUNIOR UNIVERSITY

STANFORD, CA 94305

NA

47 GOLOMB ST.

47 GOLOMB ST.

443 VIA ORTEGA

PC OPTIMIZING UPTAKE &SUSTAINED USE OFDEVICES IN PEOPLE WITH

NA

T1D


NA

NA

PC

GOV

GOV

8,800.

750,000.

LONGITUDINAL STUDY OF

CONSTRUCT A FORTIFIED

PURCHASE OF AN MRI

MYOELECTRIC GUTPRINT

EMERGENCY DEPT &

MACHINE FOR BNAI ZION

OF CROHN'S PATIENTS

500,000.

1,400,000.

304,323.

HARDIN, MT 59034 HOSPITAL

BILLINGS, MT 59102 STABILIZATION UNIT

BILLINGS, MT 59102

BILLINGS, MT 59102 SUPPORT PROJECT

BIOLOGICAL MATERIALS

WASHINGTON, DC 20005

HAIFA, ISRAEL UNDERGROUND HOSPITAL

HAIFA, ISRAEL MEDICAL CENTER

STANFORD, CA 94305


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



679,914.

NA PC OPTIMIZING UPTAKE &SUSTAINED USE OFDEVICES IN PEOPLE WITH











443 VIA ORTEGA

443 VIA ORTEGA

443 VIA ORTEGA

443 VIA ORTEGA

443 VIA ORTEGA

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

GENERAL OPERATING

EFFECTS OF AN

INVESTIGATING THE ROLE

TARGETING

EXPANSION & EVALUATION

SUPPORT FOR THE

INTERMITTENT REDUCED

OF THE HUMAN EXPOSOME

CAR-EXPRESSING

OF ECHO FOR PEOPLE

GRADUATE SCHOOL OF

CALORIE DIET ON

10,000.

IN CROHN'S DISEASE

REGULATORY T CELLS TO

WITH DIABETES ON IIT

159,542.

519,225.

10,000.

BRIGHAM AND WOMEN'S HOSPITAL

BRIGHAM AND WOMEN'S HOSPITAL75 FRANCIS STREET

BOSTON MEDICAL CENTER CORPORATION

BOSTON SYMPHONY ORCHESTRA, INC.

75 FRANCIS STREET

BOSTON, MA 02115

NA

ONE BOSTON MEDICAL PLACE

301 MASSACHUSETTS AVENUE

BOSTON, MA 02115

PC GENERAL OPERATINGSUPPORT

NA


NA

NA

PC

PC

PC

1,003,345.

2,563,672.

PASSIVE WIRELESS

STAGING CROHN'S

GENERAL OPERATING

MONITORING TO PREDICT

DISEASE USING MUCOSAL

SUPPORT

AND TRACK CROHN'S

217,750.

10,000.

2,690,856.

STANFORD, CA 94305 T1D

STANFORD, CA 94305 BUSINESS

STANFORD, CA 94305 CROHN'S DISEASE

STANFORD, CA 94305

STANFORD, CA 94305 PANCREATIC ISLETS

STANFORD, CA 94305

BOSTON, MA 02118 EXOSOMES

BOSTON, MA 02115

DISEASE


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


BURGESS HEALTH CENTER1600 DIAMOND STREET

340,876.

NA PC EEMERGENCY ANDEPHARMACY AT BURGESS

CAL POLY CORPORATION

BUTLER COUNTY HEALTH CARE CENTER


ONE GRAND AVENUE

CALLAWAY HOSPITAL DISTRICT

CAMBRIDGE MEMORIAL HOSPITAL INC.

372 S 9TH ST

372 S 9TH ST

SAN LUIS OBISPO, CA 93407

211 EAST KIMBALL ST.

1305 WEST HIGHWAY 6/34

NA

NA

NA

NA

NA

PC

GOV

GOV

GOV

PC

JUPYTER

EPHARMACY AT BUTLER

BUTLER COUNTY HEALTH

SUSTAINABILITY: WHITE

EEMERGENCY AT CALLAWAY

EEMERGENCY AT TRI

COUNTY HEALTH CARE

CARE CENTER RADIOLOGY

15,820.

PAPERS AND ENTERPRISE

DISTRICT HOSPITAL

VALLEY HEALTH SYSTEM

29,187.

143,041.

CARE-FOR-RARE FOUNDATION

460,489.

CARE-FOR-RARE FOUNDATION

CARILION MEDICAL CENTER1906 BELLEVIEW AVENUEROANOKE, VA 24014

CARE FOR THE HOMELESS, INC.

UNIVERSITT MNCHEN

UNIVERSITT MNCHEN

NA

30 EAST 33RD STREET, 5TH FLOOR

MUNICH, GERMANY

MUNICH, GERMANY

PC ESTABLISHING NEWPARADIGMS INPRE-CLINICAL CROHN'S

NA

NA

DISEASE (INSPIRE)


NA

PC

PC

PC

495,858.

36,465.

DEFINING AND

DEFINING AND

NEW YORK CITY

DEVELOPING THE

DEVELOPING THE

COLLABORATIVE FOR

THERAPEUTIC PIPELINE


200,000.

306,298.

306,298.

ONAWA, IA 51040 HEALTH CENTER

DAVID CITY, NE 68632 CENTER

DAVID CITY, NE 68632 EQUIPMENT PROJECT

DEPLOYMENTS

CALLAWAY, NE 68825

CAMBRIDGE, NE 69022

NEW YORK, NY 10016 HOMELESS HEALTHCARE

FOR VEO-IBD: MUNICH

FOR VEO-IBD: MUNICH


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


CATHOLIC RELIEF SERVICES-USCCB228 W. LEXINGTON ST.

835,103.

NA PC FOOD FOR ALL -ETHIOPIA 2.0

CATHOLIC RELIEF SERVICES-USCCB



228 W. LEXINGTON ST.





BALTIMORE, MD 21201



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

INTEGRATED WATER,

ADDRESSING

COMMUNITY RECOVERY AND

SANITATION, AND

RURAL EMERGENCY HEALTH

KOM-YILMA II: EXPANDED

MISSIONARIES OF

RESILIENCE IN EASTERN

650,540.

HYGIENE IMPROVEMENT

SERVICE AND TRANSPORT

WASH INITIATIVES IN

1,142,919.

3,695,355.

430,484.

CENTER FOR EXCELLENCE IN HEALTH CAREJOURNALISM10 NEFF HALL

CEDARS-SINAI MEDICAL CENTER



COLUMBIA, MO 65211

NA

8700 BEVERLY BLVD

8700 BEVERLY BLVD

8700 BEVERLY BLVD

PC TRAINING ANDDEVELOPMENT OF HEALTHCARE JOURNALISTS


NA

NA

NA

PC

PC

PC

1,151,419.

729,485.

GENE DISCOVERY TO

TARGETING

GENE DISCOVERY TO

CLINICAL UTILITY AND

MICROORGANISMS IN

CLINICAL UTILITY AND

55,633.

328,078.

54,368.

BALTIMORE, MD 21201

BALTIMORE, MD 21201 CHARITY CRITICAL NEEDS

BALTIMORE, MD 21201 ETHIOPIA

PROJECT

BALTIMORE, MD 21201 (REST) II

BALTIMORE, MD 21201 BURKINA FASO

LOS ANGELES, CA 90048 RELEVANCE TO ADULT IBD

LOS ANGELES, CA 90048 CREEPING FAT

LOS ANGELES, CA 90048 RELEVANCE TO ADULT IBD


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


CENTER FOR URBAN COMMUNITY SERVICES,INC.198 EAST 121ST STREET

200,000.

NA PC NEW YORK CITYCOLLABORATIVE FORHOMELESS HEALTHCARE

CENTRAL MONTANA MEDICAL FACILITIES,

CHANCELLOR MASTERS & SCHOLARS OF THE



CENTRAL COMMUNITY HOSPITAL

INC.

UNIVERSITY OF OXFORD



901 DAVIDSON STREET NW

408 WENDELL

UNIVERSITY OFFICES, WELLINGTON SQUARE



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EPHARMACY AT CENTRAL

INNATE AND ADAPTIVE

INNATE AND ADAPTIVE

PHARMACOLOGICAL


MONTANA MEDICAL CENTER

THERAPEUTIC TARGETS OF

THERAPEUTIC TARGETS OF

MODULATION TO ADDRESS

COMMUNITY HOSPITAL16,728.

VEO-IBD - OXFORD

VEO-IBD - OXFORD

GLUCAGON SECRETION IN

112,750.

27,649.

CHILDREN'S HOSPITAL CORPORATION

214,396.


CHILDREN'S HOSPITAL CORPORATIONATTN: RESEARCH FINANCE

ATTN: RESEARCH FINANCE



BOSTON, MA 02241-4413

NA

BOSTON, MA 02241-4413


BOSTON, MA 02241-4413

PC GLUCOSE-RESPONSIVEAPPROACHES TO INSULIN

NA

NA

AND GLUCAGON DELIVERY


NA

PC

PC

PC

112,750.

431,665.

DEFINING AND

DEFINING AND

DEVELOPING THE

GLUCOSE-RESPONSIVE

DEVELOPING THE


APPROACHES TO INSULIN


271,595.

214,396.

271,596.

NEW YORK, NY 10035

ELKADER, IA 52043

LEWISTOWN, MT 59457

OXFORD, UNITED KINGDOM STUDIES

OXFORD, UNITED KINGDOM STUDIES

OXFORD, UNITED KINGDOM T1D

FOR VEO-IBD: BOSTON

BOSTON, MA 02241-4413 AND GLUCAGON DELIVERY

FOR VEO-IBD: BOSTON


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


CHILDREN'S HOSPITAL LOS ANGELESSABAN RESEARCH INSTITUTE

568,884.

NA PC TEAM CLINIC: EXPANSIONOF A CARE MODEL FOR

CHILDREN'S HOSPITAL MEDICAL CENTER

CHILDREN'S HOSPITAL OF PHILADELPHIA

3333 BURNET AVENUE

2716 SOUTH STREET

CHILDREN'S HUNGER FUND

CHILDREN'S MERCY HOSPITAL


CINCINNATI, OH 45229

PHILADELPHIA, PA 19146-2305

13931 BALBOA BLVD

2401 GILLHAM ROAD

2401 GILLHAM ROAD

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

BIOMARKERS OF

CROHN'S DISEASE

INTESTINAL FIBROSIS IN

EPITHELIAL STEM CELL

MEDICAL AND ORPHAN

IMPROVING T1D CARE

IMPROVING T1D CARE

SMALL BOWEL CROHN'S

ATLAS: PEDIATRIC TO

23,463.

CARE INITIATIVE IN

WITH ADVANCED

WITH ADVANCED

528,092.

831,221.

CITY PARKS FOUNDATION

CLALIT HEALTH SERVICES

573,675.

CLALIT HEALTH SERVICES101 ARLOZOROV STREET

830 FIFTH AVENUE

101 ARLOZOROV STREET


TEL AVIV, ISRAEL

NA

NEW YORK, NY 10065

TEL AVIV, ISRAEL


PC BIO-MDT APPROACH TOPERSONALIZED TREATMENT

NA

NA

OF POUCHITIS


NA

PC

PC

PC

618,365.

528,093.

CATALYST: GROWING

EARLY CROHN'S DISEASE:

INTENSIVE PARK

UNDERSTANDING

ISRAELI IBD RESEARCH

ENGAGEMENT IN

PATHOGENESIS,

NUCLEUS (IIRN):

411,950.

213,125.

68,090.

LOS ANGELES, CA 90027 ADOLESCENTS WITH T1D

DISEASE

ADULT CONTINUUM

SYLMAR, CA 91342 ETHIOPIA

KANSAS CITY, MO 64108 PREDICTIVE ANALYTICS

KANSAS CITY, MO 64108 PREDICTIVE ANALYTICS

VULNERABLE COMMUNITIES

BEHAVIOR, RESPONSE

TEL AVIV, ISRAEL CONSORTIUM MANAGEMENT


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



475,893.

NA PC KIRYAT SHMONA MEDICALCLINIC


CLINICAL DATA INTERCHANGE STANDARDS




CLARINDA REGIONAL HEALTH CENTER

CONSORTIUM INC



TEL AVIV, ISRAEL

220 ESSIE DAVISON DRIVE

401 WEST 15TH STREET, SUITE 800

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV


CDISC STANDARDS

LINEAR ACCELERATOR FOR


UNDERSTANDING

EEMERGENCY AT CLARINDA

DEVELOPMENT PROJECT

SOROKA HOSPITAL

NUCLEUS (IIRN):

1,500,000.

PATHOGENESIS,

REGIONAL HEALTH CENTER

FOR CROHN'S DISEASE

116,635.

67,595.



1,210,000.


COLD SPRING HARBOR LABORATORY1 BUNGTOWN ROADCOLD SPRING HARBOR, NY 11724

CONSORTIUM INC

CONSORTIUM INC

CONSORTIUM INC

NA




PC TRAINING & EMPOWERINGTHE NEXT GENERATION OFBIOSCIENTISTS

NA

NA

NA

(TENXBIO)


PC

PC

PC

211,475.

336,031.

CDISC TRANSFORMATIONAL

CDISC STANDARDS

CDISC STANDARDS

CHANGE INITIATIVE

DEVELOPMENT PROJECT

DEVELOPMENT PROJECT

FOR TYPE 1 DIABETES

FOR TYPE 1 DIABETES

1,816,000.

252,756.

200,000.

TEL AVIV, ISRAEL

TEL AVIV, ISRAEL


BEHAVIOR, RESPONSE

CLARINDA, IA 51632

AUSTIN, TX 78701

AUSTIN, TX 78701

AUSTIN, TX 78701

AUSTIN, TX 78701


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


COOK COUNTY HOSPITAL DISTRICT515 5TH AVENUE WEST

19,017.

NA GOV EEMERGENCY AT NORTHSHORE HEALTH

COUNTY OF GARFIELD FOR THE GARFIELD

COUNCIL ON THE ENVIRONMENT, INC.


COUNTY HEALTH CENTER

COZAD HOSPITAL DISTRICT NO. 2


100 GOLD ST. SUITE 3300


332 LEAVITT AVENUE

300 EAST 12TH STREET


NA

NA

NA

NA

NA

GOV

PC

PC

GOV

GOV

GARFIELD COUNTY HEALTH

INTER-GENERATIONAL,

GENERAL OPERATING

CENTER RADIOLOGY

EPHARMACY AT COZAD

COZAD COMMUNITY

VIABLE GREENSPACE IN

SUPPORT

284,982.

EQUIPMENT PROJECT

COMMUNITY HOSPITAL

HOSPITAL RADIOLOGY

21,198.

15,000.

160,567.

CROHN'S AND COLITIS CANADA60 ST CLAIR AVE EAST, SUITE 600TORONTO, CANADA

CRITICAL PATH INSTITUTE

CROHN'S & COLITIS FOUNDATION, INC.

CROHN'S & COLITIS FOUNDATION, INC.

NA

1730 E. RIVER RD.

733 THIRD AVENUE, SUITE 510

733 THIRD AVENUE, SUITE 510

PC SPHERE-SEQUENCING TOSTUDY ABERRANTCELLULAR INTERACTIONSIN CROHN'S


NA

NA

NA

PC

PC

PC

112,500.

130,713.

T1D BIOMARKER

IBD PLEXUS ACADEMIC

IBD QORUS EXPANSION

CONSORTIUM -

EXPANSION

155,826.

963,015.

1,155,892.

GRAND MARAIS, MN 55604

NEW YORK, NY 10038 NYCHA COMMUNITIES

NEW YORK, NY 10038

JORDAN, MT 59337

COZAD, NE 69130

COZAD, NE 69130 EQUIPMENT PROJECT

TUCSON, AZ 85719 SUPPLEMENTATION

NEW YORK, NY 10017

NEW YORK, NY 10017


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


CROHN'S AND COLITIS CANADA60 ST CLAIR AVE EAST, SUITE 600TORONTO, CANADA

NA PC GENETIC,

399,436.

ENVIRONMENTAL,MICROBIAL (GEM)PROJECT - THE IMPACT

CULBERTSON FROID BAINVILLE HEALTH

DARTMOUTH- HITCHCOCK CLINIC

CARE CORPORATION

CURA FOUNDATION

DALLAS COUNTY HOSPITAL

ONE MEDICAL CENTER DRIVE

DAVIS COUNTY HOSPITAL

818 2ND AVE E

1180 AVENUE OF THE AMERICAS, FLOOR 8

610 10TH STREET

LEBANON, NH 03756

509 N MADISON

NA

NA

NA

NA

NA

PC

PC

PC

GOV

GOV

CT SCANNER AT

CAPACITY BUILDING FOR

ROOSEVELT MEDICAL

FIFTH INTERNATIONAL

EEMERGENCY AND

VIRTUAL IBD

EEMERGENCY AT DAVIS

CENTER

VATICAN CONFERENCE

500,000.

EPHARMACY AT DALLAS

TELEMEDICINE NETWORK

COUNTY HOSPITAL

201,135.

350,000.

DE LA SALLE SOLIDARIET INTERNAZIONALE

138,000.

DIABETES NSW

DOUGLAS COUNTY MEMORIAL HOSPITAL708 8TH STREETARMOUR, SD 57313

ONLUS

DELAWARE COUNTY MEMORIAL HOSPITAL

26 ARUNDEL ST

NA

VIA AUREALIA, 476

709 W MAIN ST

SYDNEY, AUSTRALIA

PC DOUGLAS COUNTYMEMORIAL HOSPITALRADIOLOGY EQUIPMENT

NA

NA

PROJECT


NA

PC

PC

PC

47,720.

12,554.

ESTABLISHING A ROBUST

ENHANCE DSNW'S

MEDICAL EDUCATION

EEMERGENCY AND

CAPACITY TO EXPAND THE

CENTER - ETHIOPIA

EPHARMACY

EVIDENCE BASE ON

1,975,934.

362,513.

596,300.

PHASE

CULBERTSON, MT 59218

NEW YORK, NY 10036

PERRY, IA 50220 COUNTY HOSPITAL

PROGRAM

BLOOMFIELD, IA 52537

ROME, ITALY

MANCHESTER, IA 52057

DIABETES


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


DREAMED DIABETES LTD.3 SHIMSHON ST

360,672.

NA NC MD-LOGIC PUMP GUIDE4U- ADVISORY SYSTEM TO

DURRELL WILDLIFE CONSERVATION TRUST

ELY-BLOOMENSON COMMUNITY HOSPITAL

END FUND, INC.

ENDOCRINE SOCIETY

LES AUGRES MANOR, TRINITY

ELLSWORTH MUNICIPAL HOSPITAL

328 W. CONAN ST.

2 PARK AVENUE, 18TH FLOOR

2055 L STREET, NW

JERSEY, UNITED KINGDOM

920 SOUTH OAK STREET

ELY, MN 55731

NEW YORK, NY 10016


NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

DEVELOPMENT &

ELY-BLOOMENSON

NEGLECTED TROPICAL

ENDO 2019-2021 T1D

SUSTAINABILITY OF

EPHARMACY AT HANSEN

COMMUNITY HOSPITAL

DISEASE & WASH,

SCIENTIFIC SESSIONS

CONSERVATION ZONES IN

FAMILY HOSPITAL

93,960.

RADIOLOGY EQUIPMENT

HEALTH, & EDUCATION IN

AND SCIENTIFIC

3,363,531.

65,392.

ENGINEERING MINISTRIES INTERNATIONAL

2,550,000.

EZRATH NASHIM SARAH HERZOG MEMORIALHOSPITAL92 GIVAT SHAUL ST.

ENDOCRINE SOCIETY

USA

ENVIRONMENTAL GRANTMAKERS ASSOCIATION

JERUSALEM, ISRAEL

NA

2055 L STREET, NW

130 EAST KIOWA

475 RIVERSIDE DR.

PC SUPPORT FOR THEBUILD-OUT OF THE NEWCOMPREHENSIVE

NA

REHABILITATION CENTER


NA

NA

PC

PC

PC

595,455.

40,000.

EMI GLOBAL LEADERSHIP

ENDOCRINE FELLOWS

INITIATIVE

GENERAL OPERATING

SERIES: T1D CARE AND

SUPPORT

175,214.

209,700.

22,300.

PETAH TIKVA, ISRAEL IMPROVE CARE OF T1D

MADAGASCAR

IOWA FALLS, IA 50126

PROJECT

ANGOLA

ABSTRACT AWARDS

WASHINGTON, DC 20036 MANAGEMENT (2018-2020)

COLORADO SPRINGS, CO 80903

NEW YORK, NY 10115


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


FALL RIVER HEALTH SERVICES1201 HIGHWAY 71 S

13,697.

NA PC EPHARMACY AT FALLRIVER HEALTH SERVICES

FIRST AFFILIATED HOSPITAL OF SUN

FOR INSPIRATION AND RECOGNITION OF

FALL RIVER HEALTH SERVICES

YAT-SEN UNIVERSITY

FLOYD VALLEY HOSPITAL

SCIENCE AND TECHNOLOGY

FORSCHERGRUPPE DIABETES E.V.

1201 HIGHWAY 71 S

58 ZHONGSHAN II ROAD

714 LINCOLN STREET NE

200 BEDFORD STREET

HELMHOLTZ ZENTRUM MNCHEN,

NA

NA

NA

NA

NA

GOV

PC

PC

GOV

PC

INDUSTRIALIZATION

FIRST SENIOR MENTOR

EEMERGENCY AT FALL

RELATED ENVIRONMENTAL

EEMERGENCY AT FLOYD

PROGRAM

FR1DA-PLUS COHORT

RIVER HEALTH SERVICES

CHANGES & MICROBIOME

111,664.

VALLEY HEALTHCARE

STUDY

200,000.

91,003.

288,301.

FOUNDATION FOR THE DEFENSE OF

FREEMAN REGIONAL HEALTH SERVICES510 EAST 8TH STFREEMAN, SD 57029

FOUNDATION CENTER

FOUNDATION CENTER

DEMOCRACIES INC

NA

32 OLD SLIP, 24TH FLOOR

32 OLD SLIP, 24TH FLOOR

1800 M ST. NW

PC FREEMAN REGIONALHEALTH SERVICESDIGITAL RADIOLOGY

NA

EQUIPMENT PROJECT.


NA

NA

PC

PC

PC

107,519.

415,038.

2019 NATIONAL SECURITY

GENERAL OPERATING

GENERAL OPERATING

FELLOWS TRIP TO ISRAEL

SUPPORT

SUPPORT

16,001.

12,750.

179,000.

HOT SPRINGS, SD 57747


GUANGZHOU, CHINA ALTERATIONS

LE MARS, IA 51031

MANCHESTER, NH 03101

NEUHERBERG, GERMANY

NEW YORK, NY 10005

NEW YORK, NY 10005



92363104-01-19

3




RecipientFoundation

status ofrecipient



��


FRIENDS OF CRAWFORD PARK, INC.7 RYE RIDGE PLAZA

5,000.

NA GOV GENERAL OPERATINGSUPPORT

FRIENDS OF ISRAEL DISABLED VETERANS

GEORGIA TECH RESEARCH CORPORATION

INC BEIT HALOCHEM

FRIENDS OF THE ISRAEL DEFENSE FORCES


505 10TH STREET, NW

GEOSCIENCE AUSTRALIA

1133 BROADWAY, SUITE 232

60 EAST 42 STREET

60 EAST 42 STREET

ATLANTA, GA 30332-0420

101 JERRABOMBERRA AVE

NA

NA

NA

NA

NA

PC

SO-II

PC

PC

GOV


USE OF SINGLE-CELL

BEIT HALOCHEM REHAB

IMPACT! SCHOLARSHIP

IMPACT! SCHOLARSHIP

RNA-SEQ TO IDENTIFY

DIGITAL EARTH AFRICA:

SPORTS AND REC CENTER

PROGRAM

500,000.

PROGRAM

NOVEL CELL TYPES IN CD

PHASE 2 (OPERATIONAL

654,246.

268,000.

833,267.

GRAND CANYON UNIVERSITY3300 WEST CAMELBACK ROAD

GHANA RURAL INTEGRATED DEVELOPMENT

GLOBAL SOLIDARITY FUND

GORDON MEMORIAL HOSPITAL DISTRICT

PHOENIX, AZ 85017

NA

7774 10 SIDEROAD

425 LEXINGTON AVE.

300 E 8TH ST

PC DEVELOPMENT OF ACONTINUOUSINSULIN-GLUCOSE SENSOR


NA

NA

NA

PC

PC

GOV

266,000.

2,500,000.

PROVIDING QUALITY

CONSORTIUM TO MAXIMIZE

EEMERGENCY AT GORDON

HEALTH CARE AT LEYAATA

SERVICES FOR REFUGEES,

MEMORIAL HOSPITAL

1,637,095.

1,000,000.

121,905.

RYE BROOK, NY 10573

NEW YORK, NY 10010-8134

NEW YORK, NY 10165

NEW YORK, NY 10165

PATIENTS

SYMONSTON, AUSTRALIA BUILD)

MILTON, CANADA HOSPITAL

NEW YORK, NY 10017 MIGRANTS & IDPS

GORDON, NE 69343


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


GRANITE FALLS MUNICIPAL HOSPITAL ANDMANOR345 10TH AVE.

20,160.

NA GOV EPHARMACY AT GRANITEFALLS HEALTH

GRANTMAKERS FOR EFFECTIVE

GUTTENBERG MUNICIPAL HOSPITAL

ORGANIZATIONS

GRANTMAKERS IN HEALTH


200 MAIN ST

HADASSAH MEDICAL ORGANIZATION

1310 L. STREET NW

1100 CONNECTICUT AVENUE NW


GUTTENBERG, IA 52052

P.O.B. 12000

NA

NA

NA

NA

NA

PC

GOV

PC

PC

PC

GENERAL OPERATING

EEMERGENCY AND

SUPPORT


GENERAL OPERATING

EPHARMACY AT

CREATING AND EQUIPPING

EFFECTIVE PHILANTHROPY

18,920.

SUPPORT

GUTTENBERG MUNICIPAL

PEDIATRIC BONE MARROW

188,547.

150,000.

19,981.

HARLAN COUNTY HEALTH SYSTEM717 NORTH BROWN


HAMILTON COUNTY PUBLIC HOSPITAL

HANCOCK COUNTY HEALTH SYSTEM

ALMA, NE 68920-0836

NA

P.O.B. 12000

2350 HOSPITAL DRIVE

532 1ST STREET N.W.

PC EPHARMACY AT HARLANCOUNTY HEALTH SYSTEM


NA

NA

NA

PC

GOV

PC

20,535.

1,246,000.

CREATING AND EQUIPPING

EEMERGENCY AT VAN

EEMERGENCY AT HANCOCK

PEDIATRIC BONE MARROW

DIEST MEDICAL CENTER

COUNTY HEALTH SYSTEM

881,500.

37,996.

33,504.

GRANITE FALLS, MN 56241


WASHINGTON, DC 20036 FUND


HOSPITAL

JERUSALEM, ISRAEL TRANSPLANTATION UNIT

JERUSALEM, ISRAEL TRANSPLANTATION UNIT

WEBSTER CITY, IA 50595

BRITT, IA 50423


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


HEALTH ADVOCACY SUMMIT, INC.1962 DOCKSIDE DRIVE

60,016.

NA PC SUPPORT FOR THE HEALTHADVOCACY SUMMIT AND

HEALTH FINANCE INSTITUTE

HEBREW UNIVERSITY OF JERUSALEM

HELMHOLTZ (GMBH)

1690 NORTH QUINN STREET

HEALTH RESEARCH ALLIANCE, INC.

HEALTH RESEARCH ALLIANCE, INC.

OFFICE OF THE PRESIDENT

HELMHOLTZ ZENTRUM MNCHEN

ARLINGTON, VA 22209

65 TW ALEXANDER DRIVE

65 TW ALEXANDER DRIVE

JERUSALEM, ISRAEL

NEUHERBERG, GERMANY

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CATALYZE FINANCE &

METHYLATION PATTERNS

IDENTIFICATION OF

PARTNERS TO ADDRESS

GENERAL OPERATING

GENERAL OPERATING

OF CELL-FREE DNA AS A

INFANTS WITH HIGH RISK

GLOBAL BURDEN OF

SUPPORT

768,168.

SUPPORT

NOVEL BIOMARKER IN

OF T1D - PRIMARY

491,902.

22,150.

408,210.

HELMHOLTZ (GMBH)

HERLEV OG GENTOFTE HOSPITALHERLEV AND GENTOFTE HOSPITAL

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)


HERLEV, DENMARK

NA



NEUHERBERG, GERMANY

GOV TARGETING GIP/GLP-2RECEPTORS TO PREVENT

NA

HYPOGLYCEMIA IN T1D


NA

NA

PC

PC

PC

24,650.

3,439,051.

IDENTIFICATION OF

THE GPPAD-03 STUDY:

THE GPPAD-03 STUDY:


THE PRIMARY ORAL

THE PRIMARY ORAL

OF T1D - PRIMARY

2,813,885.

1,822,133.

2,857,583.

GREENWOOD, ID 46143 CCYAN

CHRONIC DISEASE

RESEARCH TRIANGLE PARK, NC 27709

RESEARCH TRIANGLE PARK, NC 27709

CROHN'S

PREVENTION

NEUHERBERG, GERMANY INSULIN TRIAL


PREVENTION


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


HILLEL YAFFE MEDICAL CENTERHA-SHALOM ST.HADERA, ISRAEL

1,500,000.

NA PC BUY 2 ADVANCED IMAGINGDEVICES (SPECT-CT) FORTHE NUCLEAR MEDICINE

ICAHN SCHOOL OF MEDICINE AT MOUNT




SINAI

SINAI

SINAI

SINAI

INDIANA UNIVERSITY (AMPATH PROJECT)

1 GUSTAVE L. LEVY PL




702 ROTARY CIRCLE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

INTEGRATIVE NETWORK

SAFETY AND

MODULATING EARLY LIFE

INTEGRATIVE NETWORK

APPROACHES FOR VEO-IBD

TOLERABILITY OF ORAL

MICROBIOME THROUGH


AMPATH MODEL

TARGET GENE

BFAHF-2 IN PEDIATRIC

110,000.

DIETARY INTERVENTION

TARGET GENE

REPLICATION IN GHANA

110,000.

100,593.

INDIANA UNIVERSITY

INDIANA UNIVERSITY

476,096.

INSTITUT D'INVESTIGACIONES BIOMEDICASAUGUST PI I SUNYERROSSELL 149

OFFICE OF RESEARCH ADMINISTRATION


INDIANA UNIVERSITY

BARCELONA, SPAIN

NA

DETROIT, MI 48278-0867



GOV EARLY DETECTION OFPERIANAL FISTULIZINGDISEASE

NA

NA


NA

PC

PC

PC

437,773.

3,226,399.

IMPROVING FAMILY

IMPROVING FAMILY

MANAGEMENT AND

MANAGEMENT AND

GLUCOSE-RESPONSIVE

GLYCEMIC CONTROL IN

GLYCEMIC CONTROL IN

INSULIN ANALOGS

250,000.

400,000.

676,181.

INST.

NEW YORK, NY 10029 IDENTIFICATION

NEW YORK, NY 10029 CROHN'S DISEASE

NEW YORK, NY 10029 IN CROHN'S


INDIANAPOLIS, ID 46202

YOUTH WITH T1D

YOUTH WITH T1D



92363104-01-19

3




RecipientFoundation

status ofrecipient



��


INSTITUT NATIONALE DE LA SANTE ET DELA RECHERCHE MEDICALETOUR LES MERCURIALES - 40 RUE JEAN

197,527.

NA GOV BENIGN ISLETAUTOIMMUNITY TO T1D:CD8+ T-CELL BIOMARKERS

INTERNATIONAL WATER MANAGEMENT

JACOBSON MEMORIAL HOSPITAL CARE

INSULIN FOR LIFE USA, INC.

INTERNATIONAL DEVELOPMENT ENTERPRISES

INSTITUTE

IOWA DEPARTMENT OF NATURAL RESOURCES

CENTER

5745 SW 75TH STREET #116

1031 33RD STREET STE. 270

127 SUNIL MAWATHA

502 E. 9TH ST.

601 EAST ST. N.

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

WATER SECURE AFRICA

JACOBSON MEMORIAL

STRENGTHENING

CLOSING THE GAP ON

INITIATIVE: OPEN DATA

BACKBONE STATE PARK

HOSPITAL CARE CENTER

ORGANIZATIONAL

IMPROVED SANITATION IN

193,050.

CUBE EXTENSION

BUILDING RESTORATION

RADIOLOGY EQUIPMENT

650,000.

781,623.

JAEB CENTER FOR HEALTH RESEARCH


544,787.


JAEB CENTER FOR HEALTH RESEARCHFOUNDATION, INC.15310 AMBERLY DRIVE, SUITE 350

FOUNDATION, INC.

FOUNDATION, INC.

FOUNDATION, INC.

TAMPA, FL 33647

NA

15310 AMBERLY DRIVE, SUITE 350



PC PILOT STUDY TO ASSESSTHE EFFECT OF REMOTEINITIATION OF CGM IN

NA

NA

NA

DIABETES


PC

PC

PC

2,057,093.

219,291.

CGM MONITORING OF

CONTINUOUS GLUCOSE

CGM INTERVENTION IN

MATERNAL DYSGLYCEMIA

MONITORS FOR

TEENS AND YOUNG ADULTS

NON-DIABETICS AGE

WITH TYPE 1 DIABETES

1,099,023.

168,279.

71,228.

JAURES BAGNOLET, FRANCE OF PROGRESSION

GAINESVILLE, FL 32608 CAPACITY

DENVER, CO 80210 NORTHERN GHANA

BATTARAMULLA, SRI LANKA

DES MOINES, IA 50319

ELGIN, ND 58533 PROJECT

TAMPA, FL 33647

TAMPA, FL 33647

TAMPA, FL 33647


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



178,318.

NA PC PILOT STUDY TO ASSESSTHE EFFECT OF REMOTEINITIATION OF CGM IN





JDRF AUSTRALIA

FOUNDATION, INC.

FOUNDATION, INC.

FOUNDATION, INC.

FOUNDATION, INC.

80-84 CHANDOS STREET, ST LEONARDS,





2065, NSW, AUSTRALIA SYDNEY,

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CGM INTERVENTION IN

EXERCISE WITH TYPE 1

T1D EXCHANGE

CGM INTERVENTION IN

ENDIA FOLLOW UP


DIABETES INITIATIVE:


2020-2022

WITH TYPE 1 DIABETES

PILOT PHASE

215,000.

WITH TYPE 1 DIABETES500,000.

238,957.

JDRF AUSTRALIA

JDRF AUSTRALIA

497,200.

JDRF INTERNATIONAL26 BROADWAY, 14TH FLOOR



JDRF INTERNATIONAL

NEW YORK, NY 10004

NA

2065, NSW, AUSTRALIA SYDNEY,

2065 SYDNEY, AUSTRALIA

26 BROADWAY, 14TH FLOOR

PC AUTOIMMUNITY SCREENINGFOR KIDS (ASK):

NA

NA

IMPLEMENTATION PHASE


NA

PC

PC

PC

3,122,789.

1,655,217.

ENDIA SCIENTIFIC

REDUCING PANCREATIC

DIRECTIONS 2018-2021

BETA CELLS USING

JDRF PEAK PROGRAM

IMMUNOTHERAPY IN

E-LEARNING

669,318.

130,195.

68,578.

TAMPA, FL 33647 DIABETES

TAMPA, FL 33647

TAMPA, FL 33647

TAMPA, FL 33647

TAMPA, FL 33647

AUSTRALIA

AUSTRALIA

CHILDREN WITH T1D

NEW YORK, NY 10004


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


JDRF INTERNATIONAL26 BROADWAY, 14TH FLOOR

25,000.

NA PC ORTHOGONALLY REDUNDANTGLUCOSE SENSOR TO

JDRF INTERNATIONAL

JDRF INTERNATIONAL


JDRF INTERNATIONAL

JDRF INTERNATIONAL

JDRF INTERNATIONAL


NEW YORK, NY 10004




NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ADDITIONAL SIGNALS TO

ADDITIONAL SIGNALS FOR

IMPROVE GLUCOSE

CLINICAL TRIAL OF CGM

HELMSLEY/JDRF

HCP T1D EDUCATION

GLUCOSE CONTROL

CONTROL SURROUNDING

49,500.

IN OLDER ADULTS WITH

CO-FUNDED WORKSHOPS147,743.

164,621.

JENNIE M. MELHAM MEMORIAL MEDICAL

236,110.

JOHNS HOPKINS UNIVERSITY NA PC

JEWISH INSTITUTE FOR NATIONAL

A MULTIDISCIPLINARY3400 NORTH CHARLES STREETBALTIMORE, MD 21218

JDRF T1D FUND, LLC

CENTER, INC.

SECURITY OF AMERICA

99 HIGH STREET

145 MEMORIAL DRIVE

1101 14TH STREET, NW

BIOENGINEERINGAPPROACH TOFISTULA-IN-ANO IN

NA

NA

CROHN'S


NA

PC

PC

PC

396,226.

150,000.

EPHARMACY AT JENNIE M

JINSA 2020 GENERALS

JDRF T1D FUND PHASE II

MELHAM MEMORIAL

AND ADMIRALS TRIP TO

MEDICAL CENTER, INC.

ISRAEL

2,000,000.

192,342.

254,392.

NEW YORK, NY 10004 IMPROVE CARE OF T1D

NEW YORK, NY 10004

EXERCISE

NEW YORK, NY 10004 TYPE 1 DIABETES

NEW YORK, NY 10004

NEW YORK, NY 10004

BOSTON, MA 02110

BROKEN BOW, NE 68822



92363104-01-19

3




RecipientFoundation

status ofrecipient



��


JOSLIN DIABETES CENTER, INC.ONE JOSLIN PLACE

35,348.

NA PC PERL CGM STUDY

JUVENILE DIABETES RESEARCH FOUNDATION

KATHOLIEKE UNIVERSITEIT LEUVEN

KING'S COLLEGE LONDON

CANADA

WAAISTRAAT 6 BOX 5105



150 STAMFORD STREET

235 YORKLAND BLVD., SUITE 600

LEUVEN, BELGIUM



LONDON, UNITED KINGDOM

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ACCESS TO CONTINUOUS

PREDICTIVE SEROLOGICAL

EVALUATE THE

GLUCOSE MONITORS FOR

BIOMARKER SIGNATURES

INNODIA - CONTINUED

AN ENTEROCHROMAFFIN

BIOLOGICAL, SOCIAL AND

ALL CANADIANS

FOR RESPONSE TO

34,166.

SUPPORT

CELL AND MACROPHAGE

ECONOMIC IMPACT OF

1,191,602.

277,093.


403,438.


KING'S COLLEGE LONDON150 STAMFORD STREETLONDON, UNITED KINGDOM


150 STAMFORD STREET

150 STAMFORD STREET

NA

150 STAMFORD STREET



PC TARGETING BETA CELLSBY GENERATING HIGHAFFINITY T CELL

NA

NA

RECEPTORS


NA

PC

PC

PC

1,220,848.

198,792.

IDENTIFYING THE ROLE

T CELL RECEPTOR

UNDERSTANDING

OF FOOD ADDITIVE

SEQUENCING IN T1D -

EXTREMELY EARLY-ONSET

EMULSIFIERS IN CROHN'S

BIOMARKER & TECHNOLOGY

282,635.

329,883.

110,769.

BOSTON, MA 02215

TORONTO, CANADA

ANTI-TNFS

LEUVEN, BELGIUM

LEUVEN, BELGIUM ATLAS OF THE HUMAN GUT

HYPOGLYCEMIA

LONDON, UNITED KINGDOM TYPE 1 DIABETES

DISEASE

DEVELOPMENT


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


KING'S COLLEGE LONDON150 STAMFORD STREET

92,101.

NA PC UNDERSTANDINGEXTREMELY EARLY-ONSET

KMR ADVANCEMENT OF MEDICAL CENTERS



KITTSON MEMORIAL HOSPITAL ASSOCIATION

LTD.

LTD.

KNOXVILLE COMMUNITY HOSPITAL, INC.

150 STAMFORD STREET

1010 SOUTH BIRCH AVENUE

8 HA'ALIYAH ST.

8 HA'ALIYAH ST.

1002 SOUTH LINCOLN

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ESTABLISHMENT OF THE


MULTIPEPT1DE

EEMERGENCY AT KITTSON

HEALTH DISCOVERY TOWER


EPHARMACY AT KNOXVILLE

PROOF-OF-CONCEPT

HEALTHCARE

370,168.

HOSPITAL & CLINICS

1,976,868.

104,275.

LIBERTY COUNTY HOSPITAL AND NURSING

569,094.

LUNDS UNIVERSITETPARADISGATAN 2

HOME INC

LISBON AREA HEALTH SERVICES

LOOMIS INSTITUTE

LUND, SWEDEN

NA

315 WEST MADISON

905 MAIN STREET

4 BATCHELDER ROAD

PC VALIDATION OFPCR-BASED ISLET

NA

AUTOANTIBODY DETECTION


NA

NA

PC

PC

PC

3,594,100.

21,056.

LIBERTY MEDICAL CENTERRADIOLOGY EQUIPMENT

CHI LISBON HEALTH

GENERAL OPERATING

PROJECT

PORTABLE DIGITAL X-RAY

SUPPORT

363,000.

143,041.

10,000.

LONDON, UNITED KINGDOM TYPE 1 DIABETES

LONDON, UNITED KINGDOM STUDY: STAGE I

HALLOCK, MN 56728

HAIFA, ISRAEL

HAIFA, ISRAEL

KNOXVILLE, IA 50138

CHESTER, MT 59522

LISBON, ND 58054 EQUIPMENT PROJECT

WINDSOR, CT 06095


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


LUTHERAN CHARITY ASSOCIATION, INC.2422 20TH STREET SW

13,500.

NA PC JRMC CANCER CENTER

MACCABI HEALTHCARE SERVICES

MASSACHUSETTS GENERAL HOSPITAL

27 HAMERED ST

MADISON HEALTHCARE SERVICES

MANNING REGIONAL HEALTHCARE CENTER

MARY C. WHEELER SCHOOL, INC.

55 FRUIT STREET

TEL AVIV, ISRAEL

900 2ND AVENUE

1550 6TH STREET

216 HOPE STREET

BOSTON, MA 02114-2696

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EQUIPMENT FOR

TETHERED CAPSULE

ADDITIONAL OPERATING

MADISON HEALTHCARE

EEMERGENCY AT MANNING

GENERAL OPERATING

ENDOMICROSCOPY

ROOMS AT ASSUTA ASHDOD

SERVICES RADIOLOGY

3,000,000.

REGIONAL HEALTHCARE

SUPPORT

VISUALIZATION OF THE

10,000.

300,990.


MASSACHUSETTS INSTITUTE OF TECHNOLOGY

182,017.

MAYO CLINIC

MAYO CLINIC200 FIRST STREET SW

55 FRUIT STREET

77 MASSACHUSETTS AVE

200 FIRST STREET SW

ROCHESTER, MN 55905

NA

BOSTON, MA 02114-2696

CAMBRIDGE, MA 02139

ROCHESTER, MN 55905

PC STENOSIS THERAPY ANDANTI-FIBROTIC RESEARCH

NA

NA

NA

CONSORTIUM


PC

PC

PC

29,424.

1,009,098.

STUDYING THE IMPACT OF

AN INGESTIBLE

OFF-SITE REMOTE

RAPID ACTING ANALOG

MICROBIO-ELECTRONIC

CONTROL ROBOTIC

DIFFERENCE ON GLUCOSE

DEVICE TO DIAGNOSE AND

PERCUTANEOUS CORONARY

365,470.

802,000.

1,680,385.

JAMESTOWN, ND 58401

HOSPITAL

MADISON, MN 56256 EQUIPMENT PROJECT

MANNING, IA 51455 CENTER

PROVIDENCE, RI 02906

CROHN'S BOWEL WALL

CONTROL

MONITOR CROHN'S

INTERVENTIONS


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


MAYO CLINIC200 FIRST STREET SWROCHESTER, MN 55905

115,900.

NA PC 2019-2021 MILITARYSCIENCES MEDICALTRAINING/SUPPORT

MEDIZINISCHE HOCHSCHULE HANNOVER

MEMORIAL HOSPITAL OF CARBON COUNTY

MAYO CLINIC

MEDICINES FOR HUMANITY, INC.

CARL NEUBERG STREET 1

MEEKER MEMORIAL HOSPITAL

2221 W. ELM STREET

200 FIRST STREET SW

800 HINGHAM STREET

HANNOVER, GERMANY

612 S SIBLEY AVE

RAWLINS, WY 82301

NA

NA

NA

NA

NA

PC

GOV

PC

PC

GOV

CREATING T1D-SPECIFIC

MEMORIAL HOSPITAL OF

INFLAMMATORY BOWEL

THE MAI M'BELEKI

CHIMERIC ANTIGEN

EEMERGENCY AT MEEKER

CARBON COUNTY

DISEASE SHARE NETWORK

PROJECT IN RURAL

219,999.

RECEPTORS FOR

MEMORIAL HOSPITAL

RADIOLOGY EQUIPMENT

123,771.

701,555.

1,010,150.

MONTANA DEPARTMENT OF PUBLIC HEALTH

MOZILLA FOUNDATION331 E EVELYN AVE

MERCY HEALTH SERVICES IOWA CORP

MERCY MEDICAL CENTER NEW HAMPTON

AND HUMAN SERVICES

MOUNTAIN VIEW, CA 94041

NA

1111 3RD ST SW

308 NORTH MAPLE AVENUE

PO BOX 202951

PC BUILDING OPENBIOMEDICINE

NA


NA

NA

GOV

PC

PC

117,039.

881,757.

MONTANA FIRST

EEMERGENCY AT MERCY

EEMERGENCY AT MERCYONE

RESPONDER AED PROJECT

MEDICAL CENTER

NEW HAMPTON MEDICAL

28,535.

117,686.

5,559,106.

PROJECT

ROCHESTER, MN 55905 RESEARCH PROJECTS

ROCKLAND, MA 02370 ZAMBIA

REGULATORY T-CELLS

LITCHFIELD, MN 55355

PROJECT

DYERSVILLE, IA 52040 DYERSVILLE

NEW HAMPTON, IA 50659 CENTER

HELENA, MT 59620


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


NATIONAL ALLIANCE FOR CAREGIVING1730 RHODE ISLAND AVE. NWWASHINGTON, DC 20036

102,966.

NA PC GUIDEBOOK FORCAREGIVERS OF CHILDREN& ADOLESCENTS WITH

NATIONAL PARK FOUNDATION



1110 VERMONT AVE, NW



NATURAL AREAS CONSERVANCY, INC.





1234 FIFTH AVENUE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

LITTLE BIGHORN

LITTLE BIGHORN

BADLANDS NATIONAL PARK

BATTLEFIELD NATIONAL


BATTLEFIELD NATIONAL

FORMALIZING A NEW YORK

CEDAR PASS VISITOR

MONUMENT VISITOR

1,075,000.

CEDAR PASS VISITOR

MONUMENT VISITOR

CITY TRAIL SYSTEM

200,000.

1,150,000.

NCD ALLIANCE

16,667.

NEW VENTURE FUND1201 CONNECTICUT AVE NW, SUITE 300

NATURE CONSERVANCY

31-33 AVENUE GIUSEPPE MOTTA

NCD ALLIANCE


NA

4245 NORTH FAIRFAX DRIVE, SUITE 100

GENEVA, SWITZERLAND


PC OPEN RESEARCH FUNDERSGROUP

NA


NA

NA

PC

PC

PC

375,000.

750,000.

PUTTING PEOPLE WITH

FUTURE FOREST NEW YORK

NCDS FIRST: DRIVING

GENERAL OPERATING

CITY PHASE II

ADVOCACY, CHANGE,

SUPPORT

750,000.

1,015,450.

42,500.

CROHN'S DISEASE

WASHINGTON, DC 20005 CENTER

CENTER


CENTER

NEW YORK, NY 10029

ARLINGTON, VA 22203

IMPROVING CARE

GENEVA, SWITZERLAND


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



1,465,166.

NA PC TYPE 1 DIABETES CAMPSPROJECT (2019-2021)

NEW YORK CITY BALLET, INC.

NEW YORK UNIVERSITY

NEW YORK-PRESBYTERIAN FUND INC

NEWCASTLE UNIVERSITY

NEWCASTLE UNIVERSITY

DAVID H. KOCH THEATER

550 1ST AVE

850 THIRD AVENUE

NEWCASTLE UPON TYNE

NEWCASTLE UPON TYNE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

GENERAL OPERATING

RESEARCH FOR

SUPPORT FOR THE BERRIE

GPPAD UK EXPANSION:

GPPAD UK EXPANSION:

SUPPORT

TELEPSYCHIATRY PILOT

15,000.

CENTER FOR DIABETES

NEWCASTLE

NEWCASTLE

43,789.

44,427.

NEWS DEEPLY, INC.

458,468.

NORTH DAKOTA STATE UNIVERSITY1301 12TH AVENUE N

115 5TH AVENUE

NORTH BIG HORN HOSPITAL DISTRICT

NORTH DAKOTA DEPARTMENT OF HEALTH

FARGO, ND 58102

NA

NEW YORK, NY 10003

1115 LANE 12

600 E BOULEVARD AVENUE

PC AMERICAN INDIAN PUBLICHEALTH INSTITUTE AND

NA

SUSTAINABILITY PROJECT


NA

NA

PC

PC

GOV

200,000.

142,314.

A STRATEGIC ROADMAPFOR COMMUNITY CREATION

EPHARMACY AT NORTH BIG

NORTH DAKOTA LAW

OF 'CROHN'S DISEASE

HORN HOSPITAL DISTRICT

ENFORCEMENT AED

79,775.

18,363.

4,000,000.


NEW YORK, NY 10023

NEW YORK, NY 10016 IN SHELTERS

NEW YORK, NY 10022

NEWCASTLE, UNITED KINGDOM

NEWCASTLE, UNITED KINGDOM

DEEPLY'

LOVELL, WY 82431

BISMARCK, ND 58505-0200 PROJECT


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


NORTHEAST MONTANA HEALTH SERVICES,INC.211 H ST W

25,000.

NA PC EEMERGENCY ANDEPHARMACY AT POPLARCOMMUNITY HOSPITAL

NORTHEAST MONTANA HEALTH SERVICES,

PARTNERS IN HEALTH A NONPROFIT

INC.

OAKES COMMUNITY HOSPITAL

OAKLAND MERCY HOSPITAL

OSMOND GENERAL HOSPITAL, INC.

CORPORATION

315 KNAPP STREET

1200 N 7TH STREET

601 E 2ND ST.

402 N MAPLE ST

800 BOYLSTON STREET

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EEMERGENCY AND

UNIVERSAL ACCESS TO

EPHARMACY AT TRINITY

OAKES COMMUNITY

EEMERGENCY AT OAKLAND

OSMOND GENERAL

TYPE 1 DIABETES CARE

HOSPITAL

HOSPITAL RADIOLOGY

32,850.

MERCY HOSPITAL

HOSPITAL RADIOLOGY310,436.

302,730.



39,250.

PHILANTHROPY NEW YORK, INC.320 EAST 43RD STREET

CORPORATION

CORPORATION

PAWNEE COUNTY MEMORIAL HOSPITAL

NEW YORK, NY 10017

NA

800 BOYLSTON STREET

800 BOYLSTON STREET

600 I STREET


NA

NA


NA

PC

PC

GOV

11,079.

1,406,278.

UNIVERSAL ACCESS TO

VOICES OF NCDI POVERTY

TYPE 1 DIABETES CARE

PROJECT & LANCET

EEMERGENCY AT PAWNEE

COMMISSION

COUNTY MEMORIAL

2,047,597.

191,328.

101,440.

POPLAR, MT 59255

WOLF POINT, MT 59201

OAKES, ND 58474 EQUIPMENT PROJECT

OAKLAND, NE 68045

OSMOND, NE 68765 EQUIPMENT PROJECT

BOSTON, MA 02219

BOSTON, MA 02219

BOSTON, MA 02219 PUBLICATION/LAUNCH

PAWNEE CITY, NE 68420 HOSPITAL


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


PHILIP HEALTH SERVICES, INC.503 W. PINE STREET

129,531.

NA PC

PRESIDENT AND FELLOWS OF HARVARD

IMPLEMENTATION OFAVERA EEMERGENCY AT


PRAIRIE RIDGE HOSPITAL AND HEALTH


COLLEGE

COLLEGE

SERVICES

PREP FOR PREP

COLLEGE

25 SHATTUCK STREET

25 SHATTUCK STREET

1411 HIGHWAY 79 E

328 WEST 71ST STREET

25 SHATTUCK STREET

BOSTON, MA 02115

BOSTON, MA 02115

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CREATING

CREATING

EEMERGENCY AT PRAIRIE

DEVELOPMENT MDI-BGM

MICRONEEDLE-BASED

MICRONEEDLE-BASED

RIDGE HOSPITAL

GENERAL OPERATING

DECISION SUPPORT

SENSOR TO ENHANCE

SENSOR TO ENHANCE

SUPPORT

16,453.

SYSTEM

AUTOMATED INSULIN

AUTOMATED INSULIN

492,037.

25,000.

500,000.

PUBLIC HEALTH SOLUTIONS40 WORTH STREET, 5TH FLOOR

PROJECT NYAME NSA, LTD.

PROJECT RENEWAL, INC.

PROVIDENCE MEDICAL CENTER

NEW YORK, NY 10013

NA

33 WILLETS LANE

200 VARICK STREET, SUITE 900

1200 PROVIDENCE ROAD

PC NEW YORK CITYCOLLABORATIVE FORHOMELESS HEALTHCARE


NA

NA

NA

PC

PC

PC

597,342.

492,037.

SUPPORTING VULNERABLE

NEW YORK CITY

EEMERGENCY AT

CHILDREN IN EASTERN

COLLABORATIVE FOR

PROVIDENCE MEDICAL

230,600.

200,000.

131,485.

PHILIP, SD 57567 PHILIP HEALTH SERVICES

ELBOW LAKE, MN 56531

NEW YORK, NY 10023

BOSTON, MA 02115

DELIVERY

DELIVERY

MANHASSET, NY 11030 GHANA


WAYNE, NE 68787 CENTER


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


PUBLIC HEALTH SOLUTIONS40 WORTH STREET, 5TH FLOOR

3,385,000.

NA PC NEW YORK CITYCOLLABORATIVE FOR

RAMBAM HEALTH CORPORATION


REGENTS OF THE UNIVERSITY OF


HA'ALIA HASNIA 8


HA'ALIA HASNIA 8

CALIFORNIA, SANTA BARBARA

MINNESOTA

HAIFA, ISRAEL

HA'ALIA HASNIA 8

HAIFA, ISRAEL

ENGINEERING SCIENCE BUILDING

401 EAST RIVER ROAD

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

PREDICTING AND

PREDICTING AND

NOVEL PATCH PUMP

REDEFINING THE FUTURE

OPTIMIZING DRUG

POINT OF CARE ASSAY

OPTIMIZING DRUG

MECHANISM

OF EMERGENCY MEDICINE

THERAPY IN CROHN'S

FOR SERUM NEUTRALIZING

225,790.

THERAPY IN CROHN'S

270,000.

348,070.

REGIONAL HEALTH SERVICES OF HOWARD

20,500.

ROCK COUNTY COMMUNITY HOSPITAL102 E SOUTH STREET

COUNTY

RINGGOLD COUNTY HOSPITAL

ROBARTS CLINICAL TRIALS, INC.

BASSETT, NE 68714

NA

235 8TH AVE WEST

504 N. CLEVELAND ST.

100 DUNDAS STREET

GOV EPHARMACY AT ROCKCOUNTY HOSPITAL

NA


NA

NA

GOV

GOV

NC

345,425.

2,539,549.

EPHARMACY AT REGIONALHEALTH SERVICES OF

EEMERGENCY AT RINGGOLD

STENOSIS THERAPY AND

HOWARD COUNTY

COUNTY HOSPITAL

ANTI-FIBROTIC RESEARCH

24,804.

14,954.

753,533.


DISEASE

HAIFA, ISRAEL ANTI-IFX ANTIBODIES

DISEASE

SANTA BARBARA, CA 93117

MINNEAPOLIS, MN 55455

CRESCO, IA 52136

MOUNT AYR, IA 50854-2201

LONDON, CANADA (STAR) CONSORTIUM


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


ROSEBUD COMMUNITY HOSPITAL, INC.383 NORTH 17TH AVENUE

197,452.

NA PC EPHARMACY AND ADM ATROSEBUD HEALTH CARE

SAGE BIONETWORKS

SAGE BIONETWORKS

SAGE BIONETWORKS

ROUNDABOUT THEATRE COMPANY, INC.

ROUNDUP MEMORIAL HOSPITAL ASSOCIATION

2901 THIRD AVE

2901 THIRD AVE

2901 THIRD AVE

231 W 39TH STREET, 1200

1202 3RD STREET WEST

SEATTLE, WA 98121-3014



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EXTENDING IMPACT OF

EXTENDING IMPACT OF

IMPROVING SCIENTIFIC

GENERAL OPERATING

EPHARMACY AT ROUNDUP

VEOIBD CONSORTIUM

VEOIBD CONSORTIUM

INSIGHTS THROUGH

SUPPORT

MEMORIAL HEALTHCARE

10,000.

THROUGH RESOURCE

THROUGH RESOURCE

COMMUNITY-BASED

66,720.

22,104.

SAINT LOUIS UNIVERSITY

SALVATION ARMY WORLD SERVICE OFFICE

252,750.

SANFORD CHAMBERLAIN MEDICAL CENTER300 SOUTH BRYON BOULEVARD

221 NORTH GRAND BOULEVARD

615 SLATERS LANE


CHAMBERLAIN, SD 57325

NA

SAINT LOUIS, MO 63103-2006

ALEXANDRIA, VA 22314

615 SLATERS LANE

PC SANFORD CHAMBERLAINRADIOLOGY EQUIPMENT

NA

NA

PROJECT


NA

PC

PC

PC

66,720.

888,278.

NOVEL TARGET TO FIGHT

ELECTRICAL

ALPHA CELL DYSFUNCTION

INFRASTRUCTURE TO

IMPROVE PRIMARY HEALTH

& STOP HYPOGLYCEMIA IN

PROMOTE HEALTH

CARE SERVICES IN

296,855.

48,118.

204,850.

FORSYTH, MT 59327 CENTER

NEW YORK, NY 10018

ROUNDUP, MT 59072

SHARING

SHARING

RESEARCH

T1D

DELIVERY SYSTEMS

ALEXANDRIA, VA 22314 CHIKANKATA, ZAMBIA


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


SAPIR ACADEMIC COLLEGED.N. HOF ASHKELONREGIONAL COUNCIL SHAAR HANEGEV,

1,026,836.

NA PC MECHINA COLLEGEPREPARATORY COMPLEX -RENOVATION &

SAPIR ACADEMIC COLLEGE


SEATTLE CHILDREN'S HOSPITAL

SHAARE ZEDEK MEDICAL CENTER


D.N. HOF ASHKELON

D.N. HOF ASHKELON

PO BOX 5731, M/S: S-200

12 SHMUEL BAYIT STREET


REGIONAL COUNCIL SHAAR HANEGEV,



JERUSALEM, ISRAEL

JERUSALEM, ISRAEL

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC


MECHINA COLLEGE

DEVELOPMENT OF

POPULATION-BASED

RCT OF TASTY & HEALTHY

AUDITORIUM

PREPARATORY COMPLEX -

ANTIGEN-SPECIFIC ETREG

ANALYSES OF IBD USING

DIETARY APPROACH FOR

RENOVATION &

561,509.

THERAPY IN T1D - STAGE

ADMINISTRATIVE

REMISSION IN CROHN'S

214,337.

271,429.


200,000.

SHATTERPROOF A NONPROFIT CORP101 MERRITT 7 CORPORATE PARK



SHATTERPROOF A NONPROFIT CORP

NORWALK, CT 06851

NA


JERUSALEM, ISRAEL

101 MERRITT 7 CORPORATE PARK


NA


NA

NA

PC

PC

PC

1,476,286.

468,140.

POPULATION-BASED

EQUIPMENT PURCHASES

ANALYSES OF IBD USING

GENERAL OPERATING

FOR THE NEW

ADMINISTRATIVE

SUPPORT

2,708,895.

214,338.

200,000.

ISRAEL CONSTRUCTION

ISRAEL

ISRAEL CONSTRUCTION

3 STUDIES

DATABASE

DISEASE

JERUSALEM, ISRAEL RADIOTHERAPY CENTER

DATABASE

NORWALK, CT 06851


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


SIMULATION IN MOTION MONTANA, INC.C/O MONTANA MEDICAL ASSOCIATIONHELENA, MT 59601

253,173.

NA PC CAPACITY BUILDINGTOWARD A SUSTAINABLESIMULATION IN MOTION

SOCIETY FOR THE PRESERVATION OF NEW

SOS CHILDREN'S VILLAGES-USA, INC.

SOUTH DAKOTA DIVISION OF PARKS AND

SOCIAL SCIENCE RESEARCH COUNCIL

ENGLAND ANTIQUITIES


1620 I STREET, NW, SUITE 900

RECREATION

ONE PIERREPONT PLAZA, 15TH FLOOR

141 CAMBRIDGE STREET



523 E. CAPITOL AVE

NA

NA

NA

NA

NA

PC

PC

GOV

PC

PC

GENERAL OPERATING

EDUCATION &

CUSTER STATE PARK

DATA2GO.NYC: HEALTH

SUPPORT

EDUCARE 2.0:

EMPOWERMENT IN DEBRE

LEGION LAKE FIRE

70,000.

EDUCATION &

MARKOS & WOLDIYA,

REHABILITATION PROJECT

2,415,431.

10,000.

SOUTH SHORE CONSERVATORY OF MUSIC,

7,500.

ST. ANDREW'S HOSPITAL

ST. FRANCIS HOUSE OF SIOUX FALLS1301 E. AUSTIN STREET

SOUTH LINCOLN HOSPITAL DISTRICT

INC.

316 OHMER


NA

711 ONYX ST

135 WEBSTER STREET

BOTTINEAU, ND 58318

PC OPERATING SUPPORT

NA

NA


NA

PC

PC

GOV

739,741.

481,250.

GENERAL OPERATING

ST. ANDREW'S HEALTH

RADIOLOGY IMPROVEMENT

SUPPORT

CENTER RADIOLOGY

PROJECT

DIGITAL REPLACEMENT

140,713.

35,000.

282,213.

MONTANA

BROOKLYN, NY 11201

BOSTON, MA 02114

WASHINGTON, DC 20006 EMPOWERMENT

ETHIOPIA

PIERRE, SD 57501

KEMMERER, WY 83101

HANOVER, MA 02339

PROJECT


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


ST. JAMES HEALTHCARE500 ELDORADO BLVD., STE 4300

1,481,046.

NA PC INTERVENTIONALCARDIOLOGY AND IMAGING

STATE OF SOUTH DAKOTA

STICHTING HEALTH ACTION INTERNATIONAL


600 E CAPITOL AVENUE

OVERTOOM 60/II

OVERTOOM 60/II

STICHTING PHARMACCESS INTERNATIONAL


PIERRE, SD 57501



AHTC, TOWER C4, PAASHEUVELWEG 25


NA

NA

NA

NA

NA

GOV

PC

PC

PC

PC

SOUTH DAKOTA FIRST

SOLVING PROBLEMS OF

SOLVING PROBLEMS OF

RESPONDER AUTOMATED

INSULIN SOURCES AND

INSULIN SOURCES AND

INVESTING IN QUALITY

IMPROVING MEDICINE

EXTERNAL DEFIBRILLATOR

SUPPLY (ACCISS) STUDY,

3,198,341.

SUPPLY (ACCISS) STUDY,

HEALTHCARE THROUGH

QUALITY THROUGH

327,052.

1,119,872.

T1D EXCHANGE SUPPORTING FOUNDATION,

2,596,770.

T1D EXCHANGE, INC11 AVENUE DE LAFAYETTE

INC.

T1D EXCHANGE, INC

T1D EXCHANGE, INC

BOSTON, MA 02111

NA

11 AVENUE DE LAFAYETTE



PC T1D EXCHANGE COREOPERATING GRANT

NA


NA

NA

SO-I

PC

PC

133,000.

686,875.

ADVANCING AUTOMATEDINSULIN DELIVERY

T1D EXCHANGE CORE

T1D EXCHANGE CORE

SYSTEMS

OPERATING GRANT

OPERATING GRANT

130,705.

2,596,768.

2,596,768.

BROOMFIELD, CO 80021 CAPACITY IMPROVEMENT

PROJECT

PHASE II

PHASE II

AMSTERDAM, NETHERLANDS SAFECARE

AMSTERDAM, NETHERLANDS DIGITAL PROCUREMENT

BOSTON, MA 02111

BOSTON, MA 02111

BOSTON, MA 02111


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


TEAR AUSTRALIA14 SOLWOOD LANE

158,814.

NA PC THE RESET COMMUNITIESPROJECT IN RURAL

THE ASPEN INSTITUTE, INC.

THE ASPEN INSTITUTE, INC.

THE BARUCH PADEH MEDICAL CENTER,


TECHNISCHE UNIVERSITAET MUENCHEN

ONE DUPONT CIRCLE NW

ONE DUPONT CIRCLE NW

PORIYA

PORIYA

ARCISSTRAE 21




THE BARUCH PADEH MEDICAL CENTER,PORIYA

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

COLLABORATION WITH

HELMSLEY - ASPEN

CONSTRUCTION OF THE

COMPUTERIZED

FMT FOR MAINTENANCE OF

ASPEN INSTITUTE'S

INSTITUTE'S ASPEN

12-BED INTENSIVE CARE

TOMOGRAPHY (CT)

REMISSION IN PEDIATRIC

ASPEN IDEAS: HEALTH

178,970.

IDEAS COLLABORATION:

AND RESPIRATION UNIT

SCANNER FOR THE

99,377.

175,000.

THE BROAD INSTITUTE, INC.

1,500,791.

THE BROAD INSTITUTE, INC.415 MAIN STREET

415 MAIN STREET



CAMBRIDGE, MA 02142

NA

CAMBRIDGE, MA 02142

415 MAIN STREET

415 MAIN STREET

PC NOVEL THERAPEUTICAPPROACHES FOR CROHN'S

NA

DISEASE


NA

NA

PC

PC

PC

175,000.

1,600,000.

HUMAN COLON AND SMALLINTESTINE CELL ATLAS

NOVEL THERAPEUTIC

PLANNING AND EXECUTING

IN HEALTH AND CROHN'S

APPROACHES FOR CROHN'S

THE GUT ROADMAP

375,000.

1,149,704.

343,698.

BLACKBURN, AUSTRALIA ZAMBIA

MUNICH, GERMANY CROHN'S DISEASE

FESTIVAL 2020

HEALTH FESTIVAL

PORIYA TIBERIAS, ISRAEL

TIBERIAS, ISRAEL PROTECTED CT INSTITUTE

DISEASE

CAMBRIDGE, MA 02142 DISEASE

CAMBRIDGE, MA 02142


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


THE CENTER FOR EFFECTIVEPHILANTHROPY, INC.675 MASSACHUSETTS AVENUE

41,500.

NA PC GENERAL OPERATINGSUPPORT

THE CHINESE UNIVERSITY OF HONG KONG


THE CLEVELAND CLINIC FOUNDATION

PI CH'IU BUILDING

PI CH'IU BUILDING

9500 EUCLID AVENUE

THE CLEVELAND CLINIC FOUNDATION

THE COMMUNICATIONS NETWORK

SHATIN, NEW TERRITORIES, HONG KONG


CLEVELAND, OH 44195

9500 EUCLID AVENUE

777 6TH STREET NW

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

MATERNAL TRANSFER OF

ENIGMA STUDIES -

BIOMARKER OF INNATE

BACTERIOME, FUNGOME,


IMMUNITY PERTURBATION


GENERAL OPERATING

VIROME, & METABOLOME

BOWEL DISEASE GUT

531,671.

SUB-CLASSIFIES CROHN'S


SUPPORT

232,610.

619,514.

281,540.

THE HOSPITAL FOR SICK CHILDREN

THE HOSPITAL FOR SICK CHILDREN555 UNIVERSITY AVETORONTO, CANADA

THE DIATRIBE FOUNDATION

THE HOLE IN THE WALL GANG FUND, INC.

555 UNIVERSITY AVE

NA

804 HAIGHT ST

555 LONG WHARF DRIVE

TORONTO, CANADA

PC DEFINING ANDDEVELOPING THETHERAPEUTIC PIPELINE

NA

FOR VEO-IBD: TORONTO


NA

NA

PC

PC

PC

83,554.

12,000.

DEFINING AND

DIATRIBE HCP PLANNING

GENERAL OPERATING

DEVELOPING THE

PROJECT

SUPPORT


96,500.

25,000.

281,540.

CAMBRIDGE, MA 02139

IN CROHNS

MICROBIOTA

DISEASE

CLEVELAND, OH 44195 CONSORTIUM


SAN FRANCISCO, CA 94117

NEW HAVEN, CT 06511

FOR VEO-IBD: TORONTO


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


THE LEGATUM INSTITUTE FOUNDATION11 CHARLES STREETLONDON, UNITED KINGDOM

356,418.

NA NC UNITED STATESPROSPERITY INDEX -PUBLIC HEALTH

THE MAX STERN ACADEMIC COLLEGE OF


THE MAYORS FUND TO ADVANCE NEW YORK


THE MILKEN INSTITUTE

EMEK YEZREEL LTD. (CC)


CITY

CITY

1250 FOURTH STREET

YEZREEL VALLEY

YEZREEL VALLEY



SANTA MONICA, CA 90401

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

SCHOLARSHIP AND AID

AUGMENT EQUIPMENT AND

A CONCEPTUAL PLAN FOR

CONNECTIONS TO CARE

STRATEGY ROADMAP FOR

FOR ETHIOPIAN-ISRAELIS

SYSTEMS AT YVC'S

NYC NEIGHBORHOOD

COLLABORATIVE POOLED

ADOPTING A UNIVERSAL

SEEKING NURSING

NURSING SCHOOL

200,000.

GREENWAYS

FUND

PEDIATRIC T1D

500,000.

216,787.

THE ONE LOVE FOUNDATION IN HONOR OF


256,908.


THE REGENTS OF THE UNIVERSITY OFCALIFORNIA, LOS ANGELESUCLA OFFICE OF CONTRACTS AND GRANTS

YEARDLEY LOVE, INC.

YEARDLEY LOVE, INC.

YEARDLEY LOVE, INC.

LOS ANGELES, CA 90095-1406

NA

44 PONDFIELD ROAD SUITE 12



PC GLUCOSE RESPONSIVEGLUCAGON - GLUCOSESENSING NANOGELS

NA

NA

NA


PC

PC

PC

450,000.

300,000.

MARKETING AND

CAPACITY BUILDING

CAPACITY BUILDING

EDUCATIONAL CONTENT

PROJECT SUPPORT

PROJECT SUPPORT

EXPANSION1,000,000.

500,000.

93,500.

INDICATORS

YEZREEL VALLEY, ISRAEL DEGREES

YEZREEL VALLEY, ISRAEL SIMULATION CENTER

NEW YORK, NY 10007

NEW YORK, NY 10007

SCREENING

BRONXVILLE, NY 10708




92363104-01-19

3




RecipientFoundation

status ofrecipient



��


THE REGENTS OF THE UNIVERSITY OFCALIFORNIA, SAN DIEGO9500 GILMAN DRIVE - MAIL CODE 0934

575,441.

NA PC PERSONALIZING CROHN'SDISEASE THERAPEUTICSTHROUGH PHASE 0 HUMAN

THE REGENTS OF THE UNIVERSITY OF





CALIFORNIA, SAN DIEGO

CALIFORNIA, SAN FRANCISCO




9500 GILMAN DRIVE - MAIL CODE 0934

3333 CALIFORNIA STREET, SUITE 315,




NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

3D MEDICAL IMAGING

VALIDATING A CLASS OF

RITUXIMAB FOLLOWED BY

ENGINEERING TREG CELLS

IDENTIFICATION AND

PILOT TO IMPROVE

DRUGS THAT MAY PROTECT

ABATACEPT FOR

TO TREAT TYPE 1

ANALYSIS OF EXTREME

CROHN'S SURGICAL

BETA CELLS IN T1D

295,887.

PREVENTION OR REVERSAL

DIABETES

FORMS OF TYPE 1

221,050.

164,315.



160,239.


THE REGENTS OF THE UNIVERSITY OFCOLORADO, DENVERANSCHUTZ MEDICAL CAMPUS, BUILDING 500


COLORADO, DENVER

COLORADO, DENVER

AURORA, CO 80045

NA


ANSCHUTZ MEDICAL CAMPUS, BUILDING 500


PC DEVELOPMENT OF ACONTINUOUSINSULIN-GLUCOSE SENSOR

NA

NA

NA


PC

PC

PC

345,727.

442,500.


CONTINUOUS GLUCOSE :

CULTURALLY SENSITIVE


WHAT FAMILY DOCS AND

GROUP CLINIC MODEL FOR

BETA CELLS IN T1D

EDUCATORS NEED TO KNOW

LATINO PATIENTS W/

272,500.

259,717.

280,324.

LA JOLLA, CA 92093 TRIALS

LA JOLLA, CA 92093 OUTCOMES

BOX 0962 SAN FRANCISCO, CA 94143

BOX 0962 SAN FRANCISCO, CA 94143 OF T1D


BOX 0962 SAN FRANCISCO, CA 94143 DIABETES


AURORA, CO 80045

AURORA, CO 80045 DIABETES


92363104-01-19

3




RecipientFoundation

status ofrecipient



��



373,884.

NA PC SINGLE PERSISTENTISLET AUTOANTIBODYPHENOTYPE: CUSTOMIZED

THE SHEBA FUND FOR HEALTH SERVICES




THE TEL AVIV JAFFA ACADEMIC COLLEGE

AND RESEARCH (R.A.)

AND RESEARCH (R.A.)

AND RESEARCH (R.A.)

AND RESEARCH (R.A.)

RABENU YERUHAM ST., P.O.B 8401

TEL-HASHOMER

TEL-HASHOMER

TEL-HASHOMER

TEL-HASHOMER

TEL AVIV YAFFO, ISRAEL 6818211

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

COMPREHENSIVE

INTESTINAL RESPONSE TO

"MSR ON WHEELS" TO

COMPREHENSIVE

SCHOLARSHIPS FOR

INDIVIDUALIZED

MICROBIAL SIGNALS IN

SERVE NORTHERN

INDIVIDUALIZED

ULTRA-ORTHODOX

PROACTIVE THERAPY OF

CROHN'S IN RURAL/URBAN

316,106.

ISRAEL'S HEALTH CARE


(HAREDI) MEN PURSUING

412,695.

80,718.

THE TRUSTEES OF COLUMBIA UNIVERSITY

761,652.

THE TRUSTEES OF COLUMBIA UNIVERSITY

THE TRUSTEES OF COLUMBIA UNIVERSITYIN THE CITY OF NEW YORK615 WEST 131ST STREET

THE TRUSTEES OF BOSTON UNIVERSITY

IN THE CITY OF NEW YORK

IN THE CITY OF NEW YORK

NEW YORK, NY 10027-3922

NA

881 COMMONWEALTH AVENUE



PC NOVEL SPATIALLYRESOLVED GENOMICPROFILING OF CROHN'S

NA

NA

DISEASE TISSUE


NA

PC

PC

PC

246,242.

371,641.

POVERTY TRACKER:

THE ROLE OF

USE OF AUTOMATED

HEALTHCARE NEEDS & USE

GAMMA-DELTA T CELLS IN

INSULIN DELIVERY

OF LOW-INCOME NEW

HUMAN EARLY LIFE

400,000.

116,046.

221,417.

AURORA, CO 80045 RISK ANALYSIS

RAMAT GAN, ISRAEL CROHN'S DISEASE

RAMAT GAN, ISRAEL AREAS

RAMAT GAN, ISRAEL SYSTEM


NURSING DEGREES

BOSTON, MA 02215 SYSTEM IN PRIMARY CARE

NEW YORK, NY 10027-3922 YORKERS

NEW YORK, NY 10027-3922 IMMUNITY


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


THE UNITED NATIONS INSTITUTE FORTRAINING AND RESEARCHUNITED NATIONS INSTITUTE FOR TRAINING

2,000,000.

NA PC ACCELERATING ACCESS:TREATMENT FOR NCDS INLOW /MIDDLE-INCOME

THE UNIVERSITY OF BRITISH COLUMBIA

THE UNIVERSITY OF CHICAGO

THE UNIVERSITY OF EDINBURGH

OFFICE OF RESEARCH SERVICES

5801 SOUTH ELLIS AVENUE



BHF CENTRE FOR CARDIOCASCULAR SCIENCES

VANCOUVER, CANADA

CHICAGO, IL 60637



EDINBURGH, UNITED KINGDOM

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ENGINEERING

IMMUNO

DISCERN ALPHA CELL

ANTIGEN-SPECIFIC

PHARMACOGENOMICS TO

A CELL ATLAS OF THE

THE CONNECTOME OF THE

DYSFUNCTION AND

REGULATORY T CELLS FOR

PREDICT RESPONSE TO

275,000.

ILEAL COLONIC CROHN'S

HUMAN ENTERIC SYSTEM

CORRECTING GLUCAGON

324,243.

411,939.



449,021.

THE WEIZMANN INSTITUTE OF SCIENCE

THE WEIZMANN INSTITUTE OF SCIENCE234 HERZEL STREHOVOT, ISRAEL



234 HERZEL ST

NA



REHOVOT, ISRAEL

PC PERSONALIZEDNUTRITIONAL,MICROBIOME AND HOST

NA

NA

NA

PATTERNS IN CROHN'S


PC

PC

PC

993,812.

145,716.

GCA - HUMAN GUT CELL

DISCERN ALPHA CELL

DECIPHERING FACTORS

ATLAS - NORMAL

DYSFUNCTION AND

DRIVING INCREASED

INTESTINE AND CROHN'S

CORRECTING GLUCAGON

INCIDENCE OF CROHN'S

830,534.

145,716.

136,550.

AND RESEARCH GENEVA, SWITZERLAND COUNTRIES.

USE IN T1D

BIOLOGICS IN CROHN'S

CHICAGO, IL 60637 DISEASE

CHICAGO, IL 60637 IN HEALTH

SECRETION IN T1D

DISEASE

SECRETION IN T1D

IN CHINA


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


THE WEIZMANN INSTITUTE OF SCIENCE234 HERZEL ST

159,804.

NA PC THE WEIZMANN QUANTUMNANO-PHYSICS

TRINITY HEALTH FOR THE TRINITY


TIDEPOOL PROJECT

TIOGA MEDICAL CENTER

TRICKLE UP PROGRAM, INC.

KENMARE HOSPITAL

234 HERZEL ST

555 BRYANT ST #429

810 N WELO ST

104 WEST 27TH STREET, 12TH FLOOR

317 1ST AVE NW

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

RADIOLOGY DIGITAL

THE WEIZMANN QUANTUM

EXPANDING THE

EEMERGENCY AT TIOGA

GENERAL OPERATING

UPGRADE

NANO-PHYSICS

AVAILABILITY OF THE

159,804.

MEDICAL CENTER

SUPPORT25,000.

999,600.

TRUSTEES OF THE UNIVERSITY OFPENNSYLVANIA

UNIVERSITE CATHOLIQUE DE LOUVAIN

46,634.

UNIVERSITY OF BIRMINGHAM

UNIVERSITY OF CAMBRIDGETHE OLD SCHOOLS

OFFICE OF RESEARCH SERVICES,

PLACE DE L'UNIVERSITE 1

INSTITUTE OF IMMUNOLOGY AND

CAMBRIDGE, UNITED KINGDOM

NA


LOUVAIN-LA-NEUVE, BELGIUM

IMMUNOTHERAPY BIRMINGHAM, UNITED

PC

NA

GPPAD UK EXPANSION:CAMBRIDGE

NA

NA


PC

PC

PC

15,322.

DURABLE ISLET311,828.

TRANSPLANT BY

DIRECT AND INDIRECT

ANTIGEN SPECIFIC

ADMINISTRATING

CAUSES FOR THE

IMMUNOTHERAPY IN TYPE

ENGINEERED T

IMPAIRED GLUCAGON

1 DIABETES

540,365.

300,557.

219,105.

REHOVOT, ISRAEL INITIATIVE


PALO ALTO, CA 94301 LOOP AID SYSTEM

TIOGA, ND 58852

NEW YORK, NY 10001

KENMARE, ND 58746-0697

REGULATORY CELLS

SECRETION IN T1D

KINGDOM


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF CAMBRIDGETHE OLD SCHOOLS

200,135.

NA PC GPPAD UK EXPANSION:CAMBRIDGE

UNIVERSITY OF FLORIDA

UNIVERSITY OF DUNDEE



219 GRINTER HALL

NETHERGATE


219 GRINTER HALL

219 GRINTER HALL

GAINESVILLE, FL 32611-5500

DUNDEE, UNITED KINGDOM

219 GRINTER HALL



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

HUMAN ATLAS OF

HYPO-RESOLVE -

T CELL RECEPTOR

HUMAN ATLAS OF THE

NEONATAL DEVELOPMENT

UNDERSTANDING ORGAN

HUMAN ATLAS NEONATAL

SEQUENCING IN T1D -


AND EARLY

CONSEQUENCES OF

DEVELOPMENTAL EARLY

147,070.

BIOMARKER & TECHNOLOGY

AND EARLY LIFE

LIFE-IMMUNITY

544,023.

1,028,551.

UNIVERSITY OF MELBOURNE

374,382.

UNIVERSITY OF MIAMI

UNIVERSITY OF MIAMI1320 SOUTH DIXIE HIGHWAY, SUITE 650

UNIVERSITY OF IOWA

LEVEL 4, ALAN GILBERT BUILDING

1320 SOUTH DIXIE HIGHWAY

CORAL GABLES, FL 33146

NA

DIVISION OF SPONSORED PROGRAMS

CARLTON, AUSTRALIA


PC THE GEORGE S.EISENBARTH NPOD AWARD

NA

NA

FOR TEAM SCIENCE


NA

PC

PC

GOV

296,789.

640,416.

DEVELOPMENT AND

A HOLISTIC DIET

RUPRI HEALTH PANEL

EVALUATION OF A

INTERVENTION FOR

SUPPORT

CONTINUOUS KETONE

PEOPLE WITH CROHN'S

183,128.

239,341.

449,367.


HYPOGLYCEMIA

GAINESVILLE, FL 32611-5500 LIFE PANCREAS/IMMUNITY

DEVELOPMENT

PANCREAS

(HANDEL-I)

IOWA CITY, IA 52442

SENSOR

DISEASE


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF MIAMI1320 SOUTH DIXIE HIGHWAY, SUITE 650CORAL GABLES, FL 33146

250,000.

NA PC DEVELOP A NEW METHODOF STUDYING ALPHA CELLFUNCTION IN PANCREATIC

UNIVERSITY OF NORTH CAROLINA AT

UNIVERSITY OF SOUTHERN CALIFORNIA

UNIVERSITY OF UTAH

CHAPEL HILL

UNIVERSITY OF NOTRE DAME DU LAC

SPONSORED PROJECTS ACCOUNTING

UNIVERSITY OF TEXAS SYSTEM

201 S. PRESIDENTS CIRCLE

104 AIRPORT DRIVE, SUITE 2200, CB 1350

317 MAIN BUILDING

LOS ANGELES, CA 90074-2095

1616 GUADALUPE STREET

SALT LAKE CITY, UT 84112

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

ANTI-TNF COMBINATION

SPECIALIZED TECHNOLOGY

ANTI-PHAGE ANTIBODIES:

CLINICAL TRIAL IN

GLUCOSE RESPONSIVE

EDUCATION FOR PATIENT

RESEARCH COORDINATION

CROHN'S DISEASE

PEDIATRIC CROHN'S

GLUCAGON - GLUCOSE

177,430.

& PROVIDER - TOOLS FOR

NETWORK FOR SYSTEMIC

DIAGNOSIS AND

257,476.

257,940.

UNIVERSITY OF VIRGINIA LAW SCHOOL

123,566.

UNIVERSITY OF WASHINGTON

UNIVERSITY OF WASHINGTON4333 BROOKLYN AVE NE, BOX 359472SEATTLE, WA 98195-9472

FOUNDATION


4333 BROOKLYN AVE NE, BOX 359472

NA

580 MASSIE ROAD



GOV SKIN PATHOLOGY INPEOPLE WITH T1D:IMPACT OF INSULIN

NA

NA

INFUSION VIA PUMP


NA

PC

GOV

GOV

243,292.

493,243.

GENERAL OPERATING

SKIN PATHOLOGY IN

SUPPORT

COMPUTATIONAL DESIGN

PEOPLE WITH T1D:

OF GLUCOSE RESPONSIVE

IMPACT OF INSULIN

50,000.

88,774.

200,000.

SLICE

CHAPEL HILL, NC 27599-1350 DISEASE

NOTRE DAME, IN 46556 STABILIZED MATERIALS

CGM

AUSTIN, TX 78701 CHANGE

TREATMENT RESPONSE

CHARLOTTESVILLE, VA 22903

SEATTLE, WA 98195-9472 CYCLIC PEPTIDES

INFUSION VIA PUMP


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF ZURICHINSTITUTE OF MOLECULAR CANCER RESEARCHZURICH, SWITZERLAND

844,420.

NA PC SPHERE-SEQUENCING TOSTUDY ABERRANTCELLULAR INTERACTIONS

VANDERBILT UNIVERSITY MEDICAL CENTER

UNIVESITAIR MEDISCH CENTRUM UTRECHT


UPPSALA UNIVERSITET

VAN BUREN COUNTY HOSPITAL


HEIDELBERGLAAN 100

HEIDELBERGLAAN 100

BOX 256

304 FRANKLIN STREET

NASHVILLE, TN 37203

NA

NA

NA

NA

NA

PC

PC

PC

GOV

GOV

COMBINATORIAL SINGLE

EPITHELIAL BASED

EPITHELIAL BASED

ALPHA-CELL SIGNALING

EEMERGENCY AT VAN

CELL STRATEGIES FOR

DIAGNOSTICS FOR

DIAGNOSTICS FOR

82,500.

FOR GLUCAGON SECRETION

BUREN COUNTY HOSPITAL

CROHN'S DISEASE GUT

138,238.

82,500.

VANDERBILT UNIVERSITY

299,082.

VIVLI, INC.14 STORY STREET, SUITE 406


2201 WEST END AVE

VILLAGES OF HOPE: AFRICA SOCIETY

CAMBRIDGE, MA 02138

NA


NASHVILLE, TN 37235

2450 MILLTOWER COURT

PC VIVLI GLOBAL PLATFORMFOR OPEN REPRODUCIBLE

NA

CLINICAL RESEARCH


NA

NA

PC

PC

PC

249,929.

1,018,318.

UNDERSTANDING CALCIUM

DEVELOPING AN ISLET

SIGNALING IN ALPHA

HOLISTIC CARE FOR

MODEL THAT MIMICS T1D

CELLS AND HOW THEY

VULNERABLE CHILDREN OF

250,000.

220,000.

218,855.

IN CROHN'S

UTRECHT, NETHERLANDS VEO-IBD


UPPSALA, SWEDEN

KEOSAUQUA, IA 52565

CELL ATLAS

NASHVILLE, TN 37203

WORK IN T1D

MISSISSAUGA, CANADA ZAMBIA


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


WASHINGTON UNIVERSITY660 S EUCLID AVE.ST LOUIS, MO 63110

250,000.

NA PC MANIPULATING ALPHACELL SIGNALING TORESTORE NORMAL

WEBSTER COUNTY COMMUNITY HOSPITAL

WEILL MEDICAL COLLEGE OF CORNELL

WATERAID AMERICA, INC.

WATERAID AMERICA, INC.

FOUNDATION

UNIVERSITY

WEST PARK HOSPITAL DISTRICT

233 BROADWAY, STE 2705

233 BROADWAY, STE 2705

621 N FRANKLIN STREET

1300 YORK AVENUE

707 SHERIDAN AVENUE

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

EPHARMACY AT WEBSTER

TARGETING THE

IMPROVING WASH IN

WASH IN SCHOOLS IN

COUNTY COMMUNITY

MYCOBIOME IN CROHN'S

CODY CARDIOLOGY CENTER

SCHOOLS AND HEALTHCARE

CENTER-EAST REGION

1,538,252.

HOSPITAL

DISEASE

CATHETERIZATION

574,404.

1,713,703.

28,500.

WNET FOR THE WLIW-21 PUBLIC

WORLD AFFAIRS COUNCIL OF NORTHERNCALIFORNIA312 SUTTER STREET

WHEATLAND MEMORIAL HEALTHCARE

WILDLIFE CONSERVATION SOCIETY

BROADCASTING


NA

530 3RD ST NW

2300 SOUTHERN BOULEVARD

825 EIGHTH AVENUE


NA


NA

NA

PC

PC

PC

19,000.

4,326.

GENERAL OPERATING

EEMERGENCY AT

GENERAL OPERATING

SUPPORT

WHEATLAND MEMORIAL

SUPPORT

20,411.

10,000.

5,000.

GLUCAGON SECRETORY

NEW YORK, NY 10007 FACILITIES

NEW YORK, NY 10007

RED CLOUD, NE 68970

NEW YORK, NY 10065-4805

CODY, WY 82414 LABORATORY PROJECT

HARLOWTON, MT 59036 HEALTHCARE

BRONX, NY 10460

NEW YORK, NY 10019-7435


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


WYOMING STATE PARKS AND CULTURALRESOURCES2301 CENTRAL AVENUE

200,000.

NA GOV GUERNSEY FOOTBRIDGEREPLACEMENT & BRIMMERPOINT TRAIL

WYOMING STATE PARKS AND CULTURAL

YALE UNIVERSITY

YITZHAK SHAMIR MEDICAL CENTER

RESOURCES

YALE UNIVERSITY

OFFICE OF SPONSORED PROJECTS

YALE UNIVERSITY

ZERIFIN

2301 CENTRAL AVENUE

2 WHITNEY AVENUE

NEW HAVEN, CT 06520-8327


BE'ER YA'AKOV, ISRAEL

NA

NA

NA

NA

NA

GOV

PC

GOV

PC

PC

MEDICINE LODGE STATE

BLOOD GLUCOSE

EXPANSION AND

ARCHAEOLOGICAL

GENERAL OPERATING

VARIABILITY & INSULIN

THERAPEUTIC TARGETS AT

RENOVATION OF

CULTURAL & OUTDOOR

SUPPORT

600,000.

ACTION DURING

THE HOST MICROBIOTA

GYNECOLOGICAL AND

324,198.

10,000.

YITZHAK SHAMIR MEDICAL CENTER

YOUNG MEN'S CHRISTIAN ASSOCIATION

42,900.

YOUTH DEVELOPMENT ORGANIZATION INC15 UNION STREET #563

ZERIFIN

RETIREMENT FUND

YOUTH DEVELOPMENT ORGANIZATION INC

LAWRENCE, MA 01840

NA

BE'ER YA'AKOV, ISRAEL

120 BROADWAY

15 UNION STREET #563

PC CAPACITY BUILDINGPROJECT SUPPORT

NA

NA


NA

GOV

PC

PC

70,048.

1,750,000.

EXPANSION AND

GENERAL OPERATING

RENOVATION OF

SUPPORT

EDUCATION AND

GYNECOLOGICAL AND

CHARACTER DEVELOPMENT

1,750,000.

10,000.

185,484.

CHEYENNE, WY 82002 CONSTRUCTION

CHEYENNE, WY 82002 EDUCATION

NEW HAVEN, CT 06510

MENSTRUAL CYCLE

NEW HAVEN, CT 06520-8327 INTERFACE FOR FIBROSIS

OBSTETRICS EMERGENCY

OBSTETRICS

NEW YORK, NY 10271

LAWRENCE, MA 01840 FOR LOCAL YOUTH


92363104-01-19

3




RecipientFoundation

status ofrecipient



��


ZEFAT ACADEMIC COLLEGE11 JERUSALEM STREET, POB 160ZEFAT, ISRAEL

1,103,914.

NA PC EQUIPPING THE MEDICALSIMULATION & TRAININGCENTER IN NORTHERN

ZIV MEDICAL CENTERRAMBAM ST.ZEFAT, ISRAEL

NA PC REINFORCE CRUCIALSITES DURINGEMERGENCIES: ORS,

2,396,876.


ISRAEL

BLOOD BANK & PHARMACY


92363504-01-19

3


Grants and Contributions Approved for Future Payment (Continuation)


RecipientFoundation

status ofrecipient



��


ADVENTIST HEALTH SYSTEM/SUNBELT, INC.601 E ROLLINS STORLANDO, FL 32803

1,000,000.

NA PC DETERMINING WHETHERGPR119 AGONISTS MIGHTPREVENT HYPOGLYCEMIA



329,659,976.


DEVELOPMENT

DEVELOPMENT

AMC MEDICAL RESEARCH BV

EDUCATORS, INC

AMERICAN CAMPING ASSOCIATION INC



MEIBERGDREEF 9


5000 STATE ROAD 67 NORTH

NA

NA

NA

NA

NA

PC

PC

NC

PC

PC



AADE TECHNOLOGY

REHABILITATION

REHABILITATION

DEVELOPMENT AND

INSTITUTE - DIABETES

ACA PROFESSIONAL

HOSPITAL

HOSPITAL

638,318.

VALIDATION OF AN

ADVANCED NETWORK

DEVELOPMENT 2019-2021

816,544.

746,031.

300,000.

AMERICAN DIABETES ASSOCIATION, INC.2451 CRYSTAL DRIVE, SUITE 900ARLINGTON, VA 22202




NA




PC FOCUS ON FELLOWS,DIABETES IS PRIMARY,PROFESSIONALMEMBERSHIP PROJECTS


NA

NA

NA

PC

PC

PC

580,202.

43,275.


2019-2021 T1D CAMP


AMERICAN DIABETES

INITIATIVE

AMERICAN DIABETES

75,000.

357,500.

75,000.

IN T1D

OFAKIM, ISRAEL

OFAKIM, ISRAEL

AMSTERDAM, NETHERLANDS EPIGENETIC BIOMARKER

CHICAGO, IL 60606 ACCESS

MARTINSVILLE, IN 46151

ARLINGTON, VA 22202 ASSOCIATION'S SESSIONS

ARLINGTON, VA 22202

ARLINGTON, VA 22202 ASSOCIATION'S


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


AMERICAN DIABETES ASSOCIATION, INC.2451 CRYSTAL DRIVE, SUITE 900ARLINGTON, VA 22202

300,000.

NA PC FOCUS ON FELLOWS,DIABETES IS PRIMARY,PROFESSIONAL



AMICI DI ADWA ONLUS

APHP, ST ANTOINE HOSPITAL


ARLINGTON, VA 22202


VIA GIACOMO MATTEOTTI, 8

184 RUE DU FAUBOURG SAINT-ANTOINE


NA

NA

NA

NA

NA

PC

PC

PC

GOV

GOV

FOCUS ON FELLOWS,DIABETES IS PRIMARY,

MISSION: LIFELINE

HOSPITAL FOR ADWA,

FECAL MICROBIOTA

FECAL MICROBIOTA

PROFESSIONAL


300,000.

ETHIOPIA IN TIGRAY

TRANSPLANTATION IN

TRANSPLANTATION IN

948,928.

2,053,475.

210,551.

ASIAN HEALTH CARE FOUNDATION

ASIAN HEALTH CARE FOUNDATION6-3-661, SOMAJIGUDAHYDERABAD, INDIA


ARIEL UNIVERSITY

6-3-661, SOMAJIGUDA

NA


POB 3

HYDERABAD, INDIA

PC IMPROVING ACCESS TODIAGNOSTICS FORCROHN'S DISEASE

NA

PATIENTS


NA

NA

PC

GOV

PC

2,026,060.

367,129.

ACCESS TO CROHN'S

FECAL MICROBIOTA

THE ARIEL UNIVERSITY

DIAGNOSTICS IN INDIA

TRANSPLANTATION IN

REGIONAL MEDICAL

FOR PATIENTS LIVING IN

421,681.

1,497,915.

210,221.

MEMBERSHIP PROJECTS

MEMBERSHIP PROJECTS

DALLAS, TX 75231 IN NEBRASKA

CENTO (FERRARA), ITALY REGION

PARIS, FRANCE CROHN'S DISEASE



ARIEL, ISRAEL CENTER BUILDING

POVERTY


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


AVERA HEALTH3900 W AVERA DR

1,354,776.

NA PC TELEHEALTH EDUCATIONPROGRAM

AVERA MCKENNAN FOR THE AVERA MERRILL

AVERA MERRILL PIONEER HOSPITAL

AVERA HEALTH

AVERA HEALTH

PIONEER HOSPITAL

1100 S 10TH AVE

BAR ILAN UNIVERSITY

3900 W AVERA DR

3900 W AVERA DR

1100 S 10TH AVE

ROCK RAPIDS, IA 51246

MAX VE-ANNA WEBB ST.

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EEMERGENCY AND

EEMERGENCY AND

ECARE TELE-PSYCHIATRY

TELEHEALTH EDUCATION

EPHARMACY AT AVERA

EPHARMACY AT AVERA

AI RESEARCH AT BIU'S

24/7 CARE TEAM

PROGRAM

1,252,083.

MERRILL PIONEER

MERRILL PIONEER

COMPUTER SCIENCE

19,959.

1,346,286.

33,956.

BEARTOOTH BILLINGS CLINIC2525 N BROADWAY




RED LODGE, MT 59068

NA

HAHISTADROUT ST2

HAHISTADROUT ST2

HAHISTADROUT ST2

PC EEMERGENCY ATBEARTOOTH BILLINGSCLINIC


NA

NA

NA

GOV

GOV

GOV

49,893.

1,836,200.

COVID-19 PANDEMIC

BUILD-OUT OF NEW

BUILD-OUT OF NEW

RESPONSE

FORTIFIED SURGICAL

FORTIFIED SURGICAL

250,000.

1,586,700.

1,519,500.




ROCK RAPIDS, IA 51246 HOSPITAL

HOSPITAL

RAMAT GAN, ISRAEL DEPARTMENT

ASHKELON, ISRAEL




92363504-01-19

3




RecipientFoundation

status ofrecipient



��


BEN-GURION UNIVERSITY OF THE NEGEVBEN-GURION BLVD. 1

154,960.

NA PC RANDOMIZEDINTERVENTIONAL STUDY

BENNETT COUNTY HOSPITAL AND NURSINGHOME

BIG HORN HOSPITAL ASSOCIATION

BIG HORN HOSPITAL ASSOCIATION



102 MAJOR ALLEN ST

17 N MILES AVE

17 N MILES AVE


1225 I ST NW #1000

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EPHARMACY ANDEEMERGENCY

EEMERGENCY AND

EEMERGENCY AND

MONTANA PSYCHIATRY


EPHARMACY

24,673.

EPHARMACY A

RESIDENCY PROGRAM

FORCE

898,186.

62,366.


2,593,624.






STANFORD, CA 94305

NA

1225 I ST NW #1000

443 VIA ORTEGA

443 VIA ORTEGA

PC EXPANSION & EVALUATIONOF ECHO FOR PEOPLEWITH T1D

NA

NA


NA

PC

PC

PC

24,948.

350,800.

TARGETING

EFFECTS OF AN


CAR-EXPRESSING


FORCE

REGULATORY T CELLS TO

CALORIE DIET ON

149,200.

90,459.

334,722.

BEER SHEVA, ISRAEL OF STRESS-REDUCTION

MARTIN, SD 57551

HARDIN, MT 59034

HARDIN, MT 59034

BILLINGS, MT 59102



STANFORD, CA 94305 PANCREATIC ISLETS

STANFORD, CA 94305 CROHN'S DISEASE


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


BOSTON MEDICAL CENTER CORPORATIONONE BOSTON MEDICAL PLACE

82,998.

NA PC STAGING CROHNS DISEASEUSING MUCOSAL EXOSOMES

BRIGHAM AND WOMEN'S HOSPITAL

BOSTON MEDICAL CENTER CORPORATION

75 FRANCIS STREET

BURGESS HEALTH CENTER

BURGESS HEALTH CENTER


ONE BOSTON MEDICAL PLACE

BOSTON, MA 02115

1600 DIAMOND STREET

1600 DIAMOND STREET

372 S 9TH ST

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

PASSIVE WIRELESS

STAGING CROHNS DISEASE

MONITORING TO PREDICT

EEMERGENCY AND

EEMERGENCY AND

EPHARMACY AT BUTLER

USING MUCOSAL EXOSOMES

AND TRACK CROHN'S

51,814.

EPHARMACY AT BURGESS

EPHARMACY AT BURGESS

COUNTY HEALTH CARE

33,587.

1,305,411.

333,298.

CARE-FOR-RARE FOUNDATIONKINDERSPITAL KLINIKUMMUNICH, GERMANY

CALLAWAY HOSPITAL DISTRICT

CAMBRIDGE MEMORIAL HOSPITAL INC.

CARE FOR THE HOMELESS, INC.

NA

211 EAST KIMBALL ST.

1305 WEST HIGHWAY 6/34

30 EAST 33RD STREET, 5TH FLOOR

PC DEFINING ANDDEVELOPING THETHERAPEUTIC PIPELINEFOR VEO-IBD


NA

NA

NA

GOV

PC

PC

71,508.

6,328.

EEMERGENCY AT CALLAWAY

EEMERGENCY AT TRI

NEW YORK CITY

DISTRICT HOSPITAL

VALLEY HEALTH SYSTEM

COLLABORATIVE FOR

11,675.

14,587.

200,000.

BOSTON, MA 02118

BOSTON, MA 02118

DISEASE



DAVID CITY, NE 68632 CENTER

CALLAWAY, NE 68825

CAMBRIDGE, NE 69022



92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CARE-FOR-RARE FOUNDATIONKINDERSPITAL KLINIKUMMUNICH, GERMANY

333,298.

NA PC DEFINING ANDDEVELOPING THETHERAPEUTIC PIPELINE

CARILION MEDICAL CENTER




1906 BELLEVIEW AVENUE





ROANOKE, VA 24014

ROANOKE, VA 24014

ROANOKE, VA 24014

ROANOKE, VA 24014


NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ESTABLISHING NEW

ESTABLISHING NEW

ESTABLISHING NEW

ESTABLISHING NEW

PARADIGMS IN

PARADIGMS IN

PARADIGMS IN

PARADIGMS IN

FOOD FOR ALL -

PRE-CLINICAL CROHNS

PRE-CLINICAL CROHNS

186,752.

PRE-CLINICAL CROHNS

PRE-CLINICAL CROHNS

ETHIOPIA 2.0

207,652.

202,108.

54,368.


CEDARS-SINAI MEDICAL CENTER8700 BEVERLY BLVDLOS ANGELES, CA 90048



8700 BEVERLY BLVD

NA



LOS ANGELES, CA 90048

PC IBD-GENE DISCOVERY TOUTILITY AND RELEVANCEOF THE FINDINGS TO

NA

ADULT


NA

NA

PC

PC

PC

181,208.

835,103.

THE DIAGNOSTIC AND

ADDRESSING

COMMUNITY RECOVERY AND

THERAPEUTIC POTENTIAL

MISSIONARIES OF

RESILIENCE IN EASTERN

OF TARGETING CREEPING

669,615.

2,752,636.

400,218.

FOR VEO-IBD

DISEASE

DISEASE

DISEASE (INSPIRE)

DISEASE (INSPIRE)

BALTIMORE, MD 21201

BALTIMORE, MD 21201 CHARITY CRITICAL NEEDS

BALTIMORE, MD 21201 ETHIOPIA

FAT


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CEDARS-SINAI MEDICAL CENTER8700 BEVERLY BLVD

393,039.

NA PC THE DIAGNOSTIC ANDTHERAPEUTIC POTENTIAL

CENTER FOR EXCELLENCE IN HEALTH CARE





JOURNALISM

JOURNALISM

JOURNALISM

8700 BEVERLY BLVD

8700 BEVERLY BLVD

10 NEFF HALL

10 NEFF HALL

10 NEFF HALL

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

TRAINING AND

TRAINING AND

TRAINING AND

VEO-IBD-GENE DISCOVERY

THE DIAGNOSTIC AND

DEVELOPMENT OF HEALTH



TO CLINICAL UTILITY

THERAPEUTIC POTENTIAL

55,631.

CARE JOURNALISTS AND



150,000.

375,747.

CENTER FOR URBAN COMMUNITY SERVICES,

110,000.

CENTRAL MONTANA MEDICAL FACILITIES,

CHANCELLOR MASTERS & SCHOLARS OF THEUNIVERSITY OF OXFORDUNIVERSITY OFFICES, WELLINGTON SQUARE

INC.

CENTRAL COMMUNITY HOSPITAL

INC.

OXFORD, UNITED KINGDOM

NA

198 EAST 121ST STREET

901 DAVIDSON STREET NW

408 WENDELL

PC INNATE AND ADAPTIVETHERAPEUTIC TARGETS OFVEO-IBD - OXFORD

NA

NA

STUDIES


NA

PC

PC

PC

250,000.

350,000.

NEW YORK CITY


COLLABORATIVE FOR


MONTANA MEDICAL CENTER

HOMELESS HEALTHCARE

COMMUNITY HOSPITAL

200,000.

6,692.

11,060.

LOS ANGELES, CA 90048 IN CREEPING FAT

LOS ANGELES, CA 90048 AND RELEVANCE

LOS ANGELES, CA 90048 CREEPING FAT

COLUMBIA, MO 65211 HEALTH REPORTING



NEW YORK, NY 10035

ELKADER, IA 52043

LEWISTOWN, MT 59457


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CHILDREN'S HOSPITAL CORPORATIONATTN: RESEARCH FINANCE

661,179.

NA PC GLUCOSE-RESPONSIVEAPPROACHES TO INSULIN



CHILDREN'S HOSPITAL LOS ANGELES




SABAN RESEARCH INSTITUTE


BOSTON, MA 02241-4413


BOSTON, MA 02241-4413

LOS ANGELES, CA 90027

3333 BURNET AVENUE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

DEFINING AND

DEFINING AND

EXPANSION OF AN

DEVELOPING THE

GLUCOSE-RESPONSIVE

DEVELOPING THE

MULTI-DISCIPLINARY

PRECISION CROHN'S


APPROACHES TO INSULIN

270,512.


CARE MODEL FOR YOUTH

DISEASE MANAGEMENT

446,031.

661,178.



426,038.


CHILDREN'S HOSPITAL OF PHILADELPHIA2716 SOUTH STREETPHILADELPHIA, PA 19146-2305

3333 BURNET AVENUE

3333 BURNET AVENUE

3333 BURNET AVENUE

NA




PC CROHNS DISEASEEPITHELIAL STEM CELLATLAS: PEDIATRIC TO

NA

NA

NA

ADULT CONTINUUM


PC

PC

PC

270,512.

391,672.

BIOMARKERS OF

PRECISION CROHN'S

BIOMARKERS OF


DISEASE MANAGEMENT


SMALL BOWEL CROHN'S

UTILIZING PREDICTIVE

SMALL BOWEL CROHN'S

520,795.

391,671.

504,212.


FOR VEO-IBD


FOR VEO-IBD

WITH T1D


DISEASE

PANELS

DISEASE


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CHILDREN'S HOSPITAL OF PHILADELPHIA2716 SOUTH STREETPHILADELPHIA, PA 19146-2305

424,937.

NA PC CROHNS DISEASEEPITHELIAL STEM CELLATLAS: PEDIATRIC TO



2716 SOUTH STREET

2716 SOUTH STREET






2401 GILLHAM ROAD

2401 GILLHAM ROAD

2401 GILLHAM ROAD

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CROHNS DISEASE

CROHNS DISEASE



TYPE 1 DIABETES RAPID



ATLAS: PEDIATRIC TO

ATLAS: PEDIATRIC TO

281,734.

LEARNING LAB

LEARNING LAB

LEARNING LAB

1,387,611.

272,676.

479,444.

CITY PARKS FOUNDATION830 FIFTH AVENUENEW YORK, NY 10065




NA

2401 GILLHAM ROAD

2401 GILLHAM ROAD

2401 GILLHAM ROAD

PC CATALYST: GROWINGINTENSIVE PARKENGAGEMENT INVULNERABLE COMMUNITIES


NA

NA

NA

PC

PC

PC

1,425,523.

1,387,612.




LEARNING LAB

LEARNING LAB

LEARNING LAB

1,499,623.

1,499,624.

1,500,000.

ADULT CONTINUUM

ADULT CONTINUUM

ADULT CONTINUUM

KANSAS CITY, MO 64108







92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CITY PARKS FOUNDATION830 FIFTH AVENUENEW YORK, NY 10065

491,131.

NA PC CATALYST: GROWINGINTENSIVE PARKENGAGEMENT IN









TEL AVIV, ISRAEL



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CLINICAL TRIAL TO

COVID-19 PANDEMIC

EMEK MEDICAL CENTER -

EVALUATE A NOVEL

BIOMARKER-BASED


RESPONSE

NEW OPERATING SUITES

5,000,000.

MDI-BGM DECISION

MULTIDISCIPLINARY TEAM

UNDERSTANDING THE

573,675.

659,275.


1,405,714.





TEL AVIV, ISRAEL

NA


TEL AVIV, ISRAEL


PC KIRYAT SHMONA MEDICALCLINIC

NA


NA

NA

PC

PC

PC

235,050.

213,125.

PEDIATRIC


REHABILITATION

BIOMARKER-BASED TEAM

NUCLEUS (IIRN):

DEPARTMENT AND

APPROACH TO

68,090.

3,131,101.

582,660.

VULNERABLE COMMUNITIES

TEL AVIV, ISRAEL

TEL AVIV, ISRAEL

SUPPORT SYSTEM

TEL AVIV, ISRAEL TO MICROBIAL-TARGETED

TEL AVIV, ISRAEL PATHOGENESIS


HYDROTHERAPY POOLS

TEL AVIV, ISRAEL PERSONALIZED MICROBIAL


92363504-01-19

3




RecipientFoundation

status ofrecipient



��



2,058,214.

NA PC YOSEFTAL HOSPITALADDITION










TEL AVIV, ISRAEL

TEL AVIV, ISRAEL

TEL AVIV, ISRAEL


NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

BIOMARKER-BASED TEAM

CLINICAL TRIAL TO

CLINICAL TRIAL TO

EMEK MEDICAL CENTER -

APPROACH TO

EVALUATE A NOVEL

EVALUATE A NOVEL

KIRYAT SHMONA MEDICAL

NEW OPERATING SUITES

PERSONALIZED

374,087.

MDI-BGM DECISION

MDI-BGM DECISION

CLINIC

818,272.

582,660.


514,830.


CLALIT HEALTH SERVICES101 ARLOZOROV STREETTEL AVIV, ISRAEL




NA


TEL AVIV, ISRAEL

TEL AVIV, ISRAEL

PC PEDIATRICREHABILITATIONDEPARTMENT AND

NA

NA

HYDROTHERAPY POOLS


NA

PC

PC

PC

818,272.

1,318,393.

CLINICAL TRIAL TO

CLINICAL TRIAL TO

YOSEFTAL HOSPITAL

EVALUATE A NOVEL

EVALUATE A NOVEL

ADDITION

MDI-BGM DECISION

MDI-BGM DECISION

3,847,500.

587,949.

587,950.

TEL AVIV, ISRAEL

TEL AVIV, ISRAEL

MICROBIAL-TARGETED

SUPPORT SYSTEM

SUPPORT SYSTEM

TEL AVIV, ISRAEL

TEL AVIV, ISRAEL

SUPPORT SYSTEM

SUPPORT SYSTEM


92363504-01-19

3




RecipientFoundation

status ofrecipient



��



1,094,286.

NA PC YOSEFTAL HOSPITALADDITION



COLUMBIA UNIVERSITY



CONSORTIUM INC

CONSORTIUM INC






NEW YORK, NY 10027-3922

NA

NA

NA

NA

NA

PC

PC

PC

GOV

GOV

CDISC STANDARDS

CDISC STANDARDS

THE ROLE OF



DEVELOPMENT PROJECT

DEVELOPMENT PROJECT

GAMMA-DELTA T CELLS IN



40,614.

FOR T1D

FOR CROHN'S DISEASE

HUMAN EARLY LIFE

395,077.

16,247.

COLUMBIA UNIVERSITY

COLUMBIA UNIVERSITY

267,204.

CONSORCI INSTITUT D'INVESTIGACIONES

CONSORCI INSTITUT D'INVESTIGACIONESBIOMEDICASROSSELL 149



BIOMEDICAS

BARCELONA, SPAIN

NA

NEW YORK, NY 10027-3922

NEW YORK, NY 10027-3922

ROSSELL 149

GOV EARLY DETECTION OFPERIANAL FISTULIZINGDISEASE

NA

NA

NA


PC

PC

GOV

343,353.

106,706.

POVERTY TRACKER

POVERTY TRACKER

EARLY DETECTION OF

SURVEY: HEALTHCARE

SURVEY: HEALTHCARE

PERIANAL FISTULIZING

NEEDS & USE OF

NEEDS & USE OF

DISEASE

110,040.

81,367.

262,204.

TEL AVIV, ISRAEL

CLARINDA, IA 51632

CLARINDA, IA 51632

AUSTIN, TX 78701

AUSTIN, TX 78701

IMMUNITY

LOW-INCOME NEW YORKERS

LOW-INCOME NEW YORKERS

BARCELONA, SPAIN


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


CONSORCI INSTITUT D'INVESTIGACIONESBIOMEDICASROSSELL 149

270,828.

NA GOV EARLY DETECTION OFPERIANAL FISTULIZINGDISEASE

CONSORCI INSTITUT D'INVESTIGACIONESBIOMEDICAS




CRITICAL PATH INSTITUTE

ROSSELL 149




1730 E. RIVER RD.

NA

NA

NA

NA

NA

GOV

PC

PC

GOV

PC

EARLY DETECTION OFPERIANAL FISTULIZING

INTER-GENERATIONAL,

INTER-GENERATIONAL,

EPHARMACY AT COZAD

T1D BIOMARKER

DISEASE


261,948.


COMMUNITY HOSPITAL

CONSORTIUM -

8,480.

257,703.


74,334.


DE LA SALLE SOLIDARIET INTERNAZIONALEONLUSVIA AUREALIA, 476

DALLAS COUNTY HOSPITAL



ROME, ITALY

NA

610 10TH STREET

LEBANON, NH 03756

LEBANON, NH 03756

PC ESTABLISHING A ROBUSTMEDICAL EDUCATIONCENTER - ETHIOPIA

NA

NA


NA

PC

PC

GOV

116,600.

160,500.



EEMERGENCY AND

VIRTUAL IBD

VIRTUAL IBD

EPHARMACY AT DALLAS



19,089.

195,140.

197,461.

BARCELONA, SPAIN

BARCELONA, SPAIN



COZAD, NE 69130

TUCSON, AZ 85719 SUPPLEMENTATION

PERRY, IA 50220 COUNTY HOSPITAL

PROGRAM

PROGRAM


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


DELAWARE COUNTY MEMORIAL HOSPITAL709 W MAIN ST

72,983.

NA PC EEMERGENCY ANDEPHARMACY

DELAWARE COUNTY MEMORIAL HOSPITAL

DIABETES NSW



END FUND, INC.

709 W MAIN ST

26 ARUNDEL ST



2 PARK AVENUE, 18TH FLOOR

NA

NA

NA

NA

NA

PC

PC

GOV

GOV

PC

EEMERGENCY AND

STRENGTHENING THE

EPHARMACY AT HANSEN

EPHARMACY AT HANSEN

ADDRESSING TRACHOMA

EPHARMACY

CAPACITY TO EXPAND THE

29,195.

FAMILY HOSPITAL

FAMILY HOSPITAL

SURGERY GAPS IN

8,493.

602,266.

ENDOCRINE SOCIETY

EZRATH NASHIM SARAH HERZOG MEMORIAL

17,325.

FALL RIVER HEALTH SERVICES1201 HIGHWAY 71 S

2055 L STREET, NW

HOSPITAL

FALL RIVER HEALTH SERVICES


NA


92 GIVAT SHAUL ST.

1201 HIGHWAY 71 S

PC EEMERGENCY AT FALLRIVER HEALTH SERVICES

NA

NA


NA

PC

PC

PC

21,233.

1,812,084.

ENDO T1D SCIENTIFIC

SUPPORT FOR THE

SESSIONS AND

BUILD-OUT OF THE NEW

EEMERGENCY AT FALL

SCIENTIFIC ABSTRACT

REHABILITATION CENTER

RIVER HEALTH SERVICES

40,000.

950,000.

43,309.



SYDNEY, AUSTRALIA EVIDENCE BASE



NEW YORK, NY 10016 ETHIOPIA

AWARDS

JERUSALEM, ISRAEL



92363504-01-19

3




RecipientFoundation

status ofrecipient



��


FLORESTA USA INCORPORATED4747 MORENA BLVD. STE 100

175,400.

NA PC EQUIPPING RURALFAMILIES IN THE AMHARA










60 EAST 42 STREET

NA

NA

NA

NA

NA

GOV

GOV

PC

PC

PC

EEMERGENCY AT FLOYD

EEMERGENCY AT FLOYD

FR1DA-PLUS COHORT

FR1DA-PLUS COHORT

IMPACT! SCHOLARSHIP

VALLEY HEALTHCARE

VALLEY HEALTHCARE

37,092.

STUDY

STUDY

PROGRAM

467,844.

14,837.

1,000,000.

GLOBAL SOLIDARITY FUND425 LEXINGTON AVE.NEW YORK, NY 10017

GALILEE MEDICAL CENTER


GEOSCIENCE AUSTRALIA

NA



101 JERRABOMBERRA AVE

PC CONSORTIUM TO MAXIMIZESERVICES FOR REFUGEES,MIGRANTS & IDPS -ETHIOPIA


NA

NA

NA

PC

PC

GOV

437,691.

268,000.

RENOVATION OF TWO

RENOVATION OF TWO

DIGITAL EARTH AFRICA:

FLOORS OF THE INTERNAL

FLOORS OF THE INTERNAL

PHASE 2 (OPERATIONAL

2,200,000.

2,200,000.

2,500,000.

SAN DIEGO, CA 92117 REGION OF ETHIOPIA

LE MARS, IA 51031

LE MARS, IA 51031

NEUHERBERG, GERMANY

NEUHERBERG, GERMANY

NEW YORK, NY 10165

NAHARYIA, ISRAEL MEDICINE BUILDING

NAHARYIA, ISRAEL MEDICINE BUILDING

SYMONSTON, AUSTRALIA BUILD)


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


GORDON MEMORIAL HOSPITAL DISTRICT300 E 8TH ST

38,111.

NA GOV EEMERGENCY AT GORDONMEMORIAL HOSPITAL

GRANITE FALLS MUNICIPAL HOSPITAL AND

GORDON MEMORIAL HOSPITAL DISTRICT

GRAND CANYON UNIVERSITY

GRAND CANYON UNIVERSITY

MANOR


300 E 8TH ST

3300 WEST CAMELBACK ROAD

3300 WEST CAMELBACK ROAD

345 10TH AVE.


NA

NA

NA

NA

NA

GOV

GOV

PC

PC

PC

EPHARMACY AT GRANITE

EEMERGENCY AT GORDON

DEVELOPMENT OF A

DEVELOPMENT OF A

FALLS HEALTH


MEMORIAL HOSPITAL

CONTINUOUS

14,384.

CONTINUOUS

EFFECTIVE PHILANTHROPY

8,064.

697,611.


15,199.


HAMILTON COUNTY PUBLIC HOSPITAL2350 HOSPITAL DRIVE

200 MAIN ST


YAAKOV KALMAN MANN ROAD

WEBSTER CITY, IA 50595

NA


200 MAIN ST

JERUSALEM, ISRAEL

GOV EEMERGENCY AT VANDIEST MEDICAL CENTER

NA

NA


NA

GOV

PC

GOV

743,149.

150,000.

EEMERGENCY AND

EQUIP A NEW WARD TO

EPHARMACY AT

EEMERGENCY AND

TREAT VENTILATED &

GUTTENBERG MUNICIPAL

EPHARMACY

NON-VENTILATED

67,301.

26,922.

1,000,000.

GORDON, NE 69343

GORDON, NE 69343

PHOENIX, AZ 85017 INSULIN-GLUCOSE SENSOR

PHOENIX, AZ 85017 INSULIN-GLUCOSE SENSOR

GRANITE FALLS, MN 56241

WASHINGTON, DC 20036 FUND

HOSPITAL


COVID-19 PATIENTS


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


HARLAN COUNTY HEALTH SYSTEM717 NORTH BROWN

9,737.

NA GOV EPHARMACY AT HARLANCOUNTY HEALTH SYSTEM





HELEN KELLER INTERNATIONAL





ONE DAG HAMMARSKJOLD PLAZA

ARLINGTON, VA 22209

ARLINGTON, VA 22209

JERUSALEM, ISRAEL

JERUSALEM, ISRAEL

NEW YORK, NY 10017

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CATALYZE FINANCE &

CATALYZE FINANCE &



IMPROVE HEALTH,

PARTNERS TO ADDRESS

PARTNERS TO ADDRESS



NUTRITION AND

GLOBAL BURDEN OF

GLOBAL BURDEN OF

761,650.

NOVEL BIOMARKER IN

NOVEL BIOMARKER IN

LIVELIHOODS IN SISSILI

249,301.

1,633,848.

3,607,426.

HELMHOLTZ (GMBH)HELMHOLTZ ZENTRUM MNCHEN

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)

NEUHERBERG, GERMANY

NA




PC THE GPPAD-03 STUDY:THE PRIMARY ORALINSULIN TRIAL


NA

NA

NA

PC

PC

PC

271,601.

1,398,422.

THE GPPAD-03 STUDY:

IDENTIFICATION OF

FR1DA ORAL INSULIN

THE PRIMARY ORAL


INTERVENTION TRIAL

3,331,965.

3,439,051.

166,791.

ALMA, NE 68920-0836

CHRONIC DISEASE

CHRONIC DISEASE

CROHNS

CROHNS

PROVINCE


NEUHERBERG, GERMANY OF T1D FOR PREVENTION

NEUHERBERG, GERMANY AMENDMENT


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


HELMHOLTZ (GMBH)HELMHOLTZ ZENTRUM MNCHENNEUHERBERG, GERMANY

4,110,767.

NA PC IDENTIFICATION OFINFANTS WITH HIGH RISKOF T1D FOR PRIMARY

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)


HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)


NEUHERBERG, GERMANY




NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

IDENTIFICATION OF

THE GPPAD-03 STUDY:

INFANTS WITH RISK OF

FR1DA ORAL INSULIN

THE GPPAD-03 STUDY:

FR1DA ORAL INSULIN

THE PRIMARY ORAL

T1D FOR PRIMARY

3,607,425.

INTERVENTION TRIAL

THE PRIMARY ORAL

INTERVENTION TRIAL

2,916,082.

4,110,767.

1,949,907.


HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)

HELMHOLTZ (GMBH)

NEUHERBERG, GERMANY

NA




PC THE GPPAD-03 STUDY:THE PRIMARY ORALINSULIN TRIAL


NA

NA

NA

PC

PC

PC

361,753.

361,752.

THE GPPAD-03 STUDY:

THE GPPAD-03 STUDY:

THE GPPAD-03 STUDY:

THE PRIMARY ORAL

THE PRIMARY ORAL

THE PRIMARY ORAL

3,216,082.

2,834,555.

2,634,554.

PREVENTION


PREVENTION








92363504-01-19

3




RecipientFoundation

status ofrecipient



��



1,949,907.

NA PC THE GPPAD-03 STUDY:THE PRIMARY ORAL



HERLEV OG GENTOFTE HOSPITAL

HERLEV OG GENTOFTE HOSPITAL

IBD PASSPORT

SINAI

SINAI

HERLEV AND GENTOFTE HOSPITAL

HERLEV AND GENTOFTE HOSPITAL

48 CAMBERLY HOUSE



NA

NA

NA

NA

NA

PC

PC

GOV

GOV

PC

STUDY TO EVALUATE

THE MELODY TRIAL

TARGETING GIP/GLP-2

TARGETING GIP/GLP-2

IBD-PASSPORT

SAFETY AND

RECEPTORS TO PREVENT

RECEPTORS TO PREVENT

461,670.

TOLERABILITY OF ORAL214,842.

402,594.



110,000.


ICAHN SCHOOL OF MEDICINE AT MOUNTSINAI1 GUSTAVE L. LEVY PL

SINAI

SINAI

SINAI

NEW YORK, NY 10029

NA




PC INTEGRATIVE NETWORKAPPROACHES FOR IBDTARGET GENE

NA

NA

NA

IDENTIFICATION


PC

PC

PC

201,695.

383,087.

INTEGRATIVE NETWORK

STUDY TO EVALUATE

MODULATING EARLY LIFE


SAFETY AND

MICROBIOME THROUGH

TARGET GENE

TOLERABILITY FOR


110,000.

214,842.

462,745.


HERLEV, DENMARK HYPOGLYCEMIA IN T1D

HERLEV, DENMARK HYPOGLYCEMIA IN T1D


NEW YORK, NY 10029 BFAHF-2

NEW YORK, NY 10029


NEW YORK, NY 10029 CROHN'S DISEASE

NEW YORK, NY 10029


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


ICAHN SCHOOL OF MEDICINE AT MOUNTSINAI1 GUSTAVE L. LEVY PL

267,814.

NA PC STUDY TO EVALUATESAFETY ANDTOLERABILITY OF ORAL





SINAI

SINAI

SINAI

SINAI

INDIANA UNIVERSITY (AMPATH PROJECT)





702 ROTARY CIRCLE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

MODULATING EARLY

STUDY TO EVALUATE

MODULATING MICROBIOME

MODULATING MICROBIOME

MICROBIOME WITH

SAFETY AND

THROUGH DIETARY

THROUGH DIETARY

AMPATH MODEL


TOLERABILITY OF ORAL

492,812.

INTERVENTION IN

INTERVENTION IN

REPLICATION IN GHANA

409,388.

267,814.

INSTITUT NATIONALE DE LA SANTE ET DE

62,068.

INTEGRATED BIOBANK OF LUXEMBOURG("IBBL")1 RUE LOUIS RECH

INDIANA UNIVERSITY

MEDICALE

INSULIN FOR LIFE USA, INC.

DUDELANGE, LUXEMBOURG

NA


TOUR LES MERCURIALES - 40 RUE JEAN

5745 SW 75TH STREET #116

PC BIOBANKING FOR THEPRIMARY ORAL INSULINTRIAL

NA


NA

NA

GOV

PC

PC

479,190.

3,474,440.

FROM BENIGN ISLET

IMPROVING MANAGEMENT

AUTOIMMUNITY TO T1D

STRENGTHENING

AND GLYCEMIC CONTROL

ORGANIZATIONAL

672,728.

345,840.

193,050.

NEW YORK, NY 10029 BFAHF-2 IN CROHN'S

NEW YORK, NY 10029 IN CROHN'S

NEW YORK, NY 10029 BFAHF-2

NEW YORK, NY 10029 CROHN'S

NEW YORK, NY 10029 CROHN'S

INDIANAPOLIS, ID 46202

DETROIT, MI 48278-0867 IN YOUTH WITH T1D

JAURES BAGNOLET, FRANCE

GAINESVILLE, FL 32608 CAPACITY


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


INTEGRATED BIOBANK OF LUXEMBOURG("IBBL")1 RUE LOUIS RECH

68,877.

NA PC BIOBANKING FOR THEPRIMARY ORAL INSULINTRIAL

INTEGRATED BIOBANK OF LUXEMBOURG



INTERNATIONAL WATER MANAGEMENT

("IBBL")

("IBBL")

("IBBL")LUXEMBOURG

INTERNATIONAL DEVELOPMENT ENTERPRISES

INSTITUTE

1 RUE LOUIS RECH

1 RUE LOUIS RECH

1 RUE LOUIS RECH

1031 33RD STREET STE. 270

127 SUNIL MAWATHA

NA

NA

NA

NA

NA

PC

PC

GOV

PC

PC

BIOBANKING FOR THE

BIOBANKING FOR THE

BIOBANKING FOR THE

WATER SECURE AFRICA

PRIMARY ORAL INSULIN



CLOSING THE GAP ON

INITIATIVE: OPEN DATA

TRIAL

TRIAL

75,686.

TRIAL

IMPROVED SANITATION IN

CUBE EXTENSION

183,193.

133,956.

878,930.


IOWA DEPARTMENT OF PUBLIC HEALTH



TAMPA, FL 33647

NA

321 EAST 12TH

321 EAST 12TH

321 EAST 12TH

PC CGM MONITORING OFMATERNAL DYSGLYCEMIA


NA

NA

NA

GOV

GOV

GOV

55,259.

942,226.

IOWA FIRST RESPONDER



AED INITIATIVE

AED INITIATIVE

AED INITIATIVE

9,660,579.

271,086.

184,892.





DENVER, CO 80210 NORTHERN GHANA

BATTARAMULLA, SRI LANKA





92363504-01-19

3




RecipientFoundation

status ofrecipient



��



159,838.

NA PC EXERCISE IN DIABETESINITIATIVE: LARGEADULT STUDY

JDRF AUSTRALIA

JDRF AUSTRALIA

JDRF AUSTRALIA

JDRF AUSTRALIA

JDRF INTERNATIONAL

80-84 CHANDOS STREET, ST LEONARDS



80-84 CHANDOS STREET


NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ENDIA SCIENTIFIC

ENDIA FOLLOW UP

ENDIA FOLLOW UP

THE DREAM-NANO STUDY

CLINICAL TRIAL OF CGM

DIRECTIONS 2018-2021

2020-2022

287,210.

2020-2022

IN OLDER ADULTS WITH

365,926.

1,345,269.

JDRF INTERNATIONAL

28,400.

JENNIE M. MELHAM MEMORIAL MEDICALCENTER, INC.145 MEMORIAL DRIVE


JDRF INTERNATIONAL

JDRF INTERNATIONAL


NA

NEW YORK, NY 10004



PC EPHARMACY AT JENNIE MMELHAM MEMORIALMEDICAL CENTER, INC.

NA


NA

NA

PC

PC

PC

1,233,601.

121,778.

ADDITIONAL SIGNALS TOIMPROVE GLUCOSE

DEVELOPMENT OF NOVEL

DEVELOPMENT OF NOVEL

CONTROL SURROUNDING

INSULIN INFUSION SET

INSULIN INFUSION SET

167,907.

149,008.

432,631.

TAMPA, FL 33647

SYDNEY, AUSTRALIA

SYDNEY, AUSTRALIA

SYDNEY, AUSTRALIA

SYDNEY, AUSTRALIA

NEW YORK, NY 10004 T1D

EXERCISE

NEW YORK, NY 10004

NEW YORK, NY 10004


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


JENNIE M. MELHAM MEMORIAL MEDICALCENTER, INC.145 MEMORIAL DRIVE

11,360.

NA PC EPHARMACY

JOHNS HOPKINS UNIVERSITY



3400 NORTH CHARLES STREET





BALTIMORE, MD 21218

BALTIMORE, MD 21218



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

A MULTIDISCIPLINARY

A MULTIDISCIPLINARY

A MULTIDISCIPLINARY

APPROACH TO

BIOENGINEERING

INNODIA HARVEST

AN ENTEROCHROMAFFIN

BIOENGINEERING

FISTULA-IN-ANO IN

236,110.

APPROACH IN CROHN'S

CELL AND MACROPHAGE

497,878.

239,373.


481,994.

KATHOLIEKE UNIVERSITEIT LEUVENWAAISTRAAT 6 BOX 5105




LEUVEN, BELGIUM

NA

LEUVEN, BELGIUM



PC INNODIA HARVEST

NA


NA

NA

PC

PC

PC

239,373.

497,699.

IDENTIFICATION ANDVALIDATION OF A

INNODIA - CONTINUED

AN ENTEROCHROMAFFIN

PREDICTIVE SEROLOGICAL

SUPPORT

CELL AND MACROPHAGE

435,842.

1,467,112.

497,699.


BALTIMORE, MD 21218 APPROACH

CROHN'S PATIENTS

PATIENTS

LEUVEN, BELGIUM


BIOMARKER

LEUVEN, BELGIUM



92363504-01-19

3




RecipientFoundation

status ofrecipient



��


KATHOLIEKE UNIVERSITEIT LEUVENWAAISTRAAT 6 BOX 5105

405,930.

NA PC AN ENTEROCHROMAFFINCELL AND MACROPHAGE




150 STAMFORD STREET


150 STAMFORD STREET




150 STAMFORD STREET


150 STAMFORD STREET

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EVALUATION OF

TARGETING BETA CELLS

AN ENTEROCHROMAFFIN

BIOLOGICAL, SOCIAL AND

IDENTIFYING THE ROLE

BY GENERATING HIGH

T CELL RECEPTOR

CELL AND MACROPHAGE

ECONOMIC IMPACT OF

405,930.

OF FOOD ADDITIVE

AFFINITY T CELL

SEQUENCING IN T1D

92,994.

177,354.


317,168.

KING'S COLLEGE LONDON150 STAMFORD STREET

150 STAMFORD STREET




NA


150 STAMFORD STREET

150 STAMFORD STREET

PC IDENTIFYING THE ROLEOF FOOD ADDITIVE

NA



NA

NA

PC

PC

PC

294,699.

316,515.

IDENTIFYING THE ROLEOF FOOD ADDITIVE

UNDERSTANDING

EVALUATION OF


EXTREMELY EARLY-ONSET

BIOLOGICAL AND SOCIAL

383,164.

124,739.

177,354.



HYPOGLYCEMIA

LONDON, UNITED KINGDOM EMULSIFIERS IN CROHN'S

RECEPTORS


DISEASE

LONDON, UNITED KINGDOM T1D

LONDON, UNITED KINGDOM IMPACT OF HYPOGLYCEMIA


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


KING'S COLLEGE LONDON150 STAMFORD STREETLONDON, UNITED KINGDOM

755,981.

NA PC EVALUATE THEBIOLOGICAL, SOCIAL ANDECONOMIC IMPACT OF

KLINIKUM DER





LUDWIG-MAXIMILIANS-UNIVERSITT MNCHEN

LTD.

LTD.



CAMPUS GROHADERN

8 HA'ALIYAH ST.

8 HA'ALIYAH ST.

NA

NA

NA

NA

NA

GOV

PC

PC

PC

PC

FECAL MICROBIOTA





TRANSPLANTATION FOR



HEALTHCARE

HEALTHCARE

29,321.

TREATMENT OF CROHN'S

4,019,770.

11,729.

11,771.

MANNING REGIONAL HEALTHCARE CENTER1550 6TH STREET

KNOXVILLE COMMUNITY HOSPITAL, INC.

LUNDS UNIVERSITET

LUTHERAN CHARITY ASSOCIATION, INC.

MANNING, IA 51455

NA

1002 SOUTH LINCOLN

PARADISGATAN 2

2422 20TH STREET SW

GOV EEMERGENCY AT MANNINGREGIONAL HEALTHCARECENTER


NA

NA

NA

PC

PC

PC

416,756.

2,950,750.

EPHARMACY AT KNOXVILLE

VALIDATION OF

JRMC CANCER CENTER

HOSPITAL & CLINICS

PCR-BASED ISLET

8,423.

377,744.

13,500.

HYPOGLYCEMIA

HALLOCK, MN 56728

HALLOCK, MN 56728

MUNICH, GERMANY DISEASE

HAIFA, ISRAEL

HAIFA, ISRAEL

KNOXVILLE, IA 50138

LUND, SWEDEN AUTOANTIBODY DETECTION

JAMESTOWN, ND 58401


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


MASSACHUSETTS GENERAL HOSPITAL55 FRUIT STREET

254,915.

NA PC UNDERSTANDING THEIMPACT OF RAPID ACTING


MASSACHUSETTS INSTITUTE OF TECHNOLOGY

MAYO CLINIC

55 FRUIT STREET



77 MASSACHUSETTS AVE

200 FIRST STREET SW

BOSTON, MA 02114-2696

55 FRUIT STREET

55 FRUIT STREET

CAMBRIDGE, MA 02139

ROCHESTER, MN 55905

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

TETHERED CAPSULE

IMPLANTABLE DEPOTS AND

MILITARY SCIENCES

ENDOMICROSCOPY FOR

DEVELOPMENT OF FAST

DEVELOPMENT OF FAST

FIBERS FOR DETECTION

MEDICAL

VISUALIZATION OF

ON/OFF INSULIN

794,394.

ON/OFF INSULIN

AND TREATMENT OF

TRAINING/SUPPORT

462,050.

313,795.

MAYO CLINIC

124,891.

MAYO CLINIC200 FIRST STREET SWROCHESTER, MN 55905

200 FIRST STREET SW

MAYO CLINIC

MAYO CLINIC

NA

ROCHESTER, MN 55905

200 FIRST STREET SW

200 FIRST STREET SW

PC MILITARY SCIENCESMEDICALTRAINING/SUPPORT

NA

PROJECT


NA

NA

PC

PC

PC

70,916.

243,059.

FEASIBILITY OF REMOTECONTROL ROBOTIC



PERCUTANEOUS



542,433.

254,489.

103,827.

BOSTON, MA 02114-2696 GLUCOSE

CROHN'S BOWEL

BOSTON, MA 02114-2696 RECEPTOR ACTIVATORS

BOSTON, MA 02114-2696 RECEPTOR ACTIVATORS

CROHN'S

PROJECT

INTERVENTIONS

ROCHESTER, MN 55905 CONSORTIUM

ROCHESTER, MN 55905 CONSORTIUM


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


MEDIZINISCHE HOCHSCHULE HANNOVERCARL NEUBERG STREET 1

89,605.

NA PC CREATING T1D-SPECIFICANTIGEN RECEPTORS FOR






AND HUMAN SERVICES

612 S SIBLEY AVE

612 S SIBLEY AVE



PO BOX 202951

NA

NA

NA

NA

NA

GOV

GOV

GOV

PC

PC

MONTANA FIRST






MEMORIAL HOSPITAL

MEMORIAL HOSPITAL

43,633.

NEW HAMPTON MEDICAL

NEW HAMPTON MEDICAL15,178.

18,524.


1,400,000.

NATIONAL PARK FOUNDATION1110 VERMONT AVE, NWWASHINGTON, DC 20005

AND HUMAN SERVICES

NATIONAL ACADEMY OF SCIENCES


NA

PO BOX 202951

500 5TH STREET NW


PC LITTLE BIGHORNBATTLEFIELD NATIONALMONUMENT VISITOR

NA

CENTER


NA

NA

GOV

PC

PC

39,103.

219,190.

MONTANA FIRSTRESPONDER AED PROJECT

STRENGTHENING MINORITY


SERVING INSTITUTIONS

CEDAR PASS VISITOR

191,663.

150,000.

1,100,000.

HANNOVER, GERMANY REGULATORY T-CELLS





HELENA, MT 59620

HELENA, MT 59620




92363504-01-19

3




RecipientFoundation

status ofrecipient



��


NATIONAL PARK FOUNDATION1110 VERMONT AVE, NWWASHINGTON, DC 20005

1,750,000.

NA PC LITTLE BIGHORNBATTLEFIELD NATIONALMONUMENT VISITOR




NATURE CONSERVANCY

NATURE CONSERVANCY


1234 FIFTH AVENUE

1234 FIFTH AVENUE



NA

NA

NA

NA

NA

PC

PC

PC

PC

PC






CEDAR PASS VISITOR

CITY TRAIL SYSTEM

750,000.

CITY TRAIL SYSTEM

CITY PHASE II

CITY PHASE II

500,000.

500,000.

NCD ALLIANCE

1,015,450.

NCD ALLIANCE31-33 AVENUE GIUSEPPE MOTTAGENEVA, SWITZERLAND

NCD ALLIANCE


NCD ALLIANCE

NA


GENEVA, SWITZERLAND


PC PUTTING PEOPLE WITHNCDS FIRST: DRIVINGADVOCACY, CHANGE,

NA

IMPROVING CARE


NA

NA

PC

PC

PC

500,000.

500,000.

PUTTING PEOPLE WITH

GENERAL OPERATING

NCDS FIRST: DRIVING

GENERAL OPERATING

SUPPORT

ADVOCACY, CHANGE,

SUPPORT

42,500.

1,055,700.

42,500.

CENTER


NEW YORK, NY 10029

NEW YORK, NY 10029

ARLINGTON, VA 22203

ARLINGTON, VA 22203

GENEVA, SWITZERLAND

IMPROVING CARE

GENEVA, SWITZERLAND


92363504-01-19

3




RecipientFoundation

status ofrecipient



��



1,375,225.

NA PC T1D CAMPS PROJECT(2019-2021)

NEW YORK UNIVERSITY

NEW YORK UNIVERSITY

NEW YORK COMMUNITY TRUST



550 1ST AVE

550 1ST AVE

909 THIRD AVENUE

909 THIRD AVENUE

909 THIRD AVENUE

NEW YORK, NY 10016

NEW YORK, NY 10016

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

IDENTIFYING

IDENTIFYING

NEW YORK CITY FUND FOR



ENVIRONMENTAL

ENVIRONMENTAL

YOUTH AND FAMILY

YOUTH AND FAMILY

500,000.

YOUTH AND FAMILY

CONTRIBUTORS TO

CONTRIBUTORS TO

969,747.

200,000.

7,346.

NORTH BIG HORN HOSPITAL DISTRICT1115 LANE 12

NEW YORK UNIVERSITY



LOVELL, WY 82431

NA

550 1ST AVE

850 THIRD AVENUE

850 THIRD AVENUE

GOV EPHARMACY AT NORTH BIGHORN HOSPITAL DISTRICT


NA

NA

NA

PC

PC

PC

200,000.

772,565.

EVALUATION OF PILOT

IMPROVING CARE FOR

IMPROVING CARE FOR

ENDOCRINOLOGY TELEECHO

UNDERSERVED CHILDREN

UNDERSERVED CHILDREN

30,912.

200,000.

200,000.


NEW YORK, NY 10022 HOMELESSNESS



CROHN'S DISEASE

CROHN'S DISEASE

NEW YORK, NY 10016 CLINIC IN NEW MEXICO

NEW YORK, NY 10022 WITH T1D

NEW YORK, NY 10022 WITH T1D


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


NORTH DAKOTA DEPARTMENT OF HEALTH600 E BOULEVARD AVENUE

153,789.

NA GOV NORTH DAKOTA LAWENFORCEMENT AED

PALO ALTO VETERANS INSTITUTE FOR




NORTH DAKOTA DEPARTMENT OF HEALTH

RESEARCH

RESEARCH

RESEARCH

RESEARCH

600 E BOULEVARD AVENUE

3801 MIRANDA AVENUE

3801 MIRANDA AVENUE

3801 MIRANDA AVENUE

3801 MIRANDA AVENUE

NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV

CELL ATLAS OF

CELL ATLAS OF

CELL ATLAS OF

CELL ATLAS OF

NORTH DAKOTA LAW

INTESTINAL LYMPHOID

INTESTINAL LYMPHOID

INTESTINAL LYMPHOID

INTESTINAL LYMPHOID

ENFORCEMENT AED

TISSUES AND CROHN'S

173,689.

TISSUES IN CROHN'S

TISSUES IN CROHN'S

TISSUES AND CHANGES IN

499,175.

1,000,000.


PARKER INSTITUTE FOR CANCER

2,950,411.

PARKER INSTITUTE FOR CANCER

PARTNERS IN HEALTH A NONPROFITCORPORATION800 BOYLSTON STREET

RESEARCH

IMMUNOTHERAPY

IMMUNOTHERAPY

BOSTON, MA 02219

NA

3801 MIRANDA AVENUE

1 LETTERMAN DRIVE

1 LETTERMAN DRIVE

PC UNIVERSAL ACCESS TOT1D CARE

NA

NA

NA


PC

PC

PC

500,825.

500,825.

CELL ATLAS OF

UNDERSTANDING

UNDERSTANDING

INTESTINAL LYMPHOID

AUTOIMMUNE DIABETES

AUTOIMMUNE DIABETES

TISSUES IN CROHN'S

FOLLOWING

FOLLOWING

499,175.

1,106,748.

1,108,140.



PALO ALTO, CA 94304-0038 DISEASE



PALO ALTO, CA 94304-0038 CROHN'S

PALO ALTO, CA 94304-0038

SAN FRANCISCO, CA 94129 IMMUNOTHERAPIES.

SAN FRANCISCO, CA 94129 IMMUNOTHERAPIES


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


PAWNEE COUNTY MEMORIAL HOSPITAL600 I STREET

29,679.

NA GOV EEMERGENCY AT PAWNEECOUNTY MEMORIAL



PAWNEE COUNTY MEMORIAL HOSPITAL

PHILIP HEALTH SERVICES, INC.

PHILIP HEALTH SERVICES, INC.

COLLEGE

COLLEGE

600 I STREET

503 W. PINE STREET

503 W. PINE STREET

25 SHATTUCK STREET

25 SHATTUCK STREET

NA

NA

NA

NA

NA

PC

PC

GOV

PC

PC

DEVELOPMENT OF

DEVELOPMENT OF

EEMERGENCY AT PAWNEE

IMPLEMENTATION OF

IMPLEMENTATION OF

MICRONEEDLE-BASED

MICRONEEDLE SENSOR FOR

COUNTY MEMORIAL

AVERA EEMERGENCY AT

11,936.

AVERA EEMERGENCY AT

SENSOR FOR INSULIN

AUTOMATED INSULIN

505,556.

29,491.



200,000.

PROJECT RENEWAL, INC.200 VARICK STREET, SUITE 900

COLLEGE

COLLEGE

PROJECT NYAME NSA, LTD.

NEW YORK, NY 10014

NA

25 SHATTUCK STREET

25 SHATTUCK STREET

33 WILLETS LANE

PC NEW YORK CITYCOLLABORATIVE FOR

NA

NA

HOMELESS HEALTHCARE


NA

PC

PC

PC

12,317.

505,557.

DEVELOPMENT MDI-BGM

DEVELOPMENT MDI-BGM

DECISION SUPPORT

DECISION SUPPORT

SUPPORTING VULNERABLE

SYSTEM

SYSTEM

CHILDREN IN EASTERN

422,795.

218,708.

152,810.





BOSTON, MA 02115 DELIVERY

BOSTON, MA 02115 DELIVERY

BOSTON, MA 02115

BOSTON, MA 02115

MANHASSET, NY 11030 GHANA


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


PROVIDENCE MEDICAL CENTER1200 PROVIDENCE ROAD

41,340.

NA PC EEMERGENCY ATPROVIDENCE MEDICAL


PROVIDENCE MEDICAL CENTER

PUBLIC HEALTH SOLUTIONS

RAMAT HANEGEV

HA'ALIA HASNIA 8


1200 PROVIDENCE ROAD

40 WORTH STREET, 5TH FLOOR

RAMAT HANEGEV

HAIFA, ISRAEL

HA'ALIA HASNIA 8

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

PREDICTING AND

EEMERGENCY AT

NEW YORK CITY

RAMAT HANEGEV REGIONAL

OPTIMIZING DRUG

POINT OF CARE ASSAY

PROVIDENCE MEDICAL

COLLABORATIVE FOR

16,407.

COUNCIL MEDICAL CENTER

THERAPY IN CROHN'S


208,850.

1,015,000.

180,000.

REGENTS OF THE UNIVERSITY OFCALIFORNIA, SANTA BARBARAENGINEERING SCIENCE BUILDING




SANTA BARBARA, CA 93117

NA

HA'ALIA HASNIA 8

HA'ALIA HASNIA 8

HA'ALIA HASNIA 8

PC NOVEL PATCH PUMPMECHANISM


NA

NA

NA

PC

PC

PC

1,620,172.

133,355.

POINT OF CARE ASSAY

POINT OF CARE ASSAY

COVID 19 PANDEMIC



RESPONSE

120,355.

78,850.

1,000,000.




RAMAT HANEGEV, ISRAEL

DISEASE




HAIFA, ISRAEL


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


REGENTS OF THE UNIVERSITY OFMINNESOTA401 EAST RIVER ROAD

5,851,298.

NA PC REDEFINING THE FUTUREOF EMERGENCY MEDICINE


REGIONAL HEALTH SERVICES OF HOWARD

MINNESOTA

COUNTY



ROCK COUNTY COMMUNITY HOSPITAL

401 EAST RIVER ROAD

235 8TH AVE WEST

100 DUNDAS STREET

100 DUNDAS STREET

102 E SOUTH STREET

NA

NA

NA

NA

NA

PC

GOV

NC

NC

GOV

REDEFINING THE FUTURE

EPHARMACY AT REGIONAL

OF EMERGENCY MEDICINE

HEALTH SERVICES OF



EPHARMACY AT ROCK

HOWARD COUNTY

5,148,153.



COUNTY HOSPITAL

374,911.

9,922.

155,671.

RUTGERS, THE STATE UNIVERSITY OF NEWJERSEY110 BERGEN STREET

ROSEBUD COMMUNITY HOSPITAL, INC.

ROSEBUD COMMUNITY HOSPITAL, INC.

ROUNDUP MEMORIAL HOSPITAL ASSOCIATION

NEWARK, NJ 07103

NA

383 NORTH 17TH AVENUE

383 NORTH 17TH AVENUE

1202 3RD STREET WEST

PC WHITE BLOOD CELLS FORTREATMENT OF CROHN'SDISEASE


NA

NA

NA

PC

PC

PC

621,628.

8,200.

EPHARMACY AND ADM

EPHARMACY AND ADM

EPHARMACY AT ROUNDUPMEMORIAL HEALTHCARE

28,152.

11,262.

8,842.



CRESCO, IA 52136



BASSETT, NE 68714

FORSYTH, MT 59327

FORSYTH, MT 59327

ROUNDUP, MT 59072


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


RUTGERS, THE STATE UNIVERSITY OF NEWJERSEY110 BERGEN STREET

162,601.

NA PC TARGETING OFLYMPHOCYTE FUNCTION FOR TREATMENT OF

SAGE BIONETWORKS

SAGE BIONETWORKS

SAGE BIONETWORKS

2901 THIRD AVE

2901 THIRD AVE

2901 THIRD AVE








NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EXTENDING IMPACT OF

EXTENDING IMPACT OF

IMPROVING SCIENTIFIC

VEOIBD CONSORTIUM

VEOIBD CONSORTIUM

INSIGHTS THROUGH

A NOVEL TARGET TO

A NOVEL TARGET TO

THROUGH RESOURCE

THROUGH RESOURCE

66,720.

COMMUNITY-BASED

COUNTERACT

COUNTERACT ALPHA CELL

341,798.

66,720.

1,487,551.


SEATTLE CHILDREN'S HOSPITALPO BOX 5731, M/S: S-200SEATTLE, WA 98145-5005


SANFORD RESEARCH

D.N. HOF ASHKELON

NA

615 SLATERS LANE

2301 EAST 60TH ST N


PC DEVELOPMENT OFANTIGEN-SPECIFIC ETREGTHERAPY IN T1D - STAGE

NA

3 STUDIES


NA

NA

PC

PC

PC

974,878.

260,774.

MECHINA COLLEGE

IMPROVE PRIMARY HEALTH

SANFORD PLEDGE: PHASES

PREPARATORY COMPLEX -

CARE SERVICES IN

1 AND 2

RENOVATION &

183,266.

491,115.

2,908,773.

NEWARK, NJ 07103 CROHN'S DISEASE

SHARING

SHARING

RESEARCH

SAINT LOUIS, MO 63103-2006 HYPOGLYCEMIA IN T1D

SAINT LOUIS, MO 63103-2006 DYSFUNCTION

ALEXANDRIA, VA 22314 CHIKANKATA, ZAMBIA

SIOUX FALLS, SD 57104-0569

ISRAEL CONSTRUCTION


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


SEATTLE CHILDREN'S HOSPITALPO BOX 5731, M/S: S-200SEATTLE, WA 98145-5005

1,224,949.

NA PC DEVELOPMENT OFANTIGEN-SPECIFIC ETREGTHERAPY IN T1D - STAGE











JERUSALEM, ISRAEL

JERUSALEM, ISRAEL

JERUSALEM, ISRAEL

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

EXCLUDING

RCT EXCLUDING

RCT EXCLUDING

THE

EQUIPMENT PURCHASES

PRO-INFLAMMATORY

PRO-INFLAMMATORY

PRO-INFLAMMATORY

EPIDEMIOLOGICAL-IIRN

FOR THE NEW

214,337.

NUTRIENTS FOR CROHN'S



415,669.

791,105.


200,000.

SHATTERPROOF A NONPROFIT CORP

SHATTERPROOF A NONPROFIT CORP101 MERRITT 7 CORPORATE PARKNORWALK, CT 06851



101 MERRITT 7 CORPORATE PARK

NA

JERUSALEM, ISRAEL


NORWALK, CT 06851

PC PROVIDING FAMILIESWITH CRITICAL SUPPORTON PREVENTION AND

NA

NA

RECOVERY


NA

PC

PC

PC

513,193.

666,492.

RCT EXCLUDING

PROVIDING FAMILIES

PRO-INFLAMMATORY

COVID-19 EMERGENCY

WITH SUPPORT ON


MEDICAL RESPONSE

PREVENTION AND

527,468.

1,000,000.

200,000.

3 STUDIES

JERUSALEM, ISRAEL PROJECT

JERUSALEM, ISRAEL RADIOTHERAPY CENTER

REMISSION

REMISSION

REMISSION

REMISSION

JERUSALEM, ISRAEL PROGRAM

RECOVERY


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


SIMULATION IN MOTION MONTANA, INC.C/O MONTANA MEDICAL ASSOCIATIONHELENA, MT 59601

253,173.

NA PC CAPACITY BUILDINGTOWARD A SUSTAINABLESIMULATION IN MOTION

SIMULATION IN MOTION MONTANA, INC.





C/O MONTANA MEDICAL ASSOCIATION





HELENA, MT 59601

HELENA, MT 59601

HELENA, MT 59601

HELENA, MT 59601

HELENA, MT 59601

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CAPACITY BUILDING

CAPACITY BUILDING

CAPACITY BUILDING

CAPACITY BUILDING

CAPACITY BUILDING

TOWARD A SUSTAINABLE





SIMULATION IN MOTION


253,173.




612,500.

253,174.

240,625.


SOUTH DAKOTA DIVISION OF PARKS ANDRECREATION523 E. CAPITOL AVE

SIOUX COUNCIL, BOY SCOUTS OF AMERICA

SOCIAL SCIENCE RESEARCH COUNCIL


PIERRE, SD 57501

NA

800 N WEST AVENUE

ONE PIERREPONT PLAZA, 15TH FLOOR


GOV CUSTER STATE PARKLEGION LAKE FIREREHABILITATION PROJECT

NA


NA

NA

PC

PC

PC

150,000.

200,000.

EDUCATION &

WETLAND\NATURE STUDY

DATA2GO.NYC: HEALTH

EMPOWERMENT IN DEBRE

AREA DEVELOPMENT

MARKOS & WOLDIYA,

75,000.

70,000.

1,292,968.

MONTANA

MONTANA

MONTANA

MONTANA

MONTANA

MONTANA


BROOKLYN, NY 11201

ETHIOPIA


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


STANFORD UNIVERSITY443 VIA ORTEGA

2,533,369.

NA PC EXPANSION & EVALUATIONOF ECHO FOR PEOPLE

STANFORD UNIVERSITY

STANFORD UNIVERSITY

STATE OF SOUTH DAKOTA UNIFIED

STANFORD UNIVERSITY

443 VIA ORTEGA

STANFORD UNIVERSITY

443 VIA ORTEGA

JUDICIAL SYSTEM

443 VIA ORTEGA

STANFORD, CA 94305

443 VIA ORTEGA

STANFORD, CA 94305

500 E. CAPITOL AVE.

NA

NA

NA

NA

NA

PC

PC

GOV

PC

PC

EFFECTS OF AN

EFFECTS OF AN

SD UNIFIED JUDICIAL





SYSTEM CRIMINAL


CALORIE DIET ON

1,468,724.


CALORIE DIET ON

JUSTICE RESPONSES TO

331,803.

376,108.

397,018.

STICHTING PHARMACCESS INTERNATIONALAHTC, TOWER C4, PAASHEUVELWEG 25





NA



OVERTOOM 60/II

PC INVESTING IN QUALITYHEALTHCARE THROUGHSAFECARE


NA

NA

NA

GOV

GOV

PC

1,527,931.

418,840.

FIRST RESPONDER

FIRST RESPONDER

ADDRESSING THE

AUTOMATED EXTERNAL

AUTOMATED EXTERNAL

CHALLENGE OF INSULIN

294,000.

178,000.

1,099,311.

STANFORD, CA 94305 WITH DIABETES

STANFORD, CA 94305 IN CROHN'S DISEASE

CROHN'S DISEASE

STANFORD, CA 94305 IN CROHN'S DISEASE

CROHN'S DISEASE

PIERRE, SD 57501 MENTAL ILLNESS

PIERRE, SD 57501 DEFIBRILLATOR PROJECT

PIERRE, SD 57501 DEFIBRILLATOR PROJECT

AMSTERDAM, NETHERLANDS SOURCES AND SUPPLY


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


STICHTING PHARMACCESS INTERNATIONALAHTC, TOWER C4, PAASHEUVELWEG 25

822,634.

NA PC IMPROVING MEDICINEQUALITY THROUGH

T1D EXCHANGE, INC

T1D EXCHANGE, INC

T1D EXCHANGE, INC

T1D EXCHANGE, INC







BOSTON, MA 02111

BOSTON, MA 02111

BOSTON, MA 02111

BOSTON, MA 02111

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

DATA APPROACH TO

DATA APPROACH TO

DATA APPROACH TO

DATA APPROACH TO

INVESTING IN QUALITY

IMPROVE QUALITY AND

IMPROVE QUALITY AND

IMPROVE QUALITY AND

IMPROVE QUALITY AND

HEALTHCARE THROUGH

OUTCOMES FOR

536,441.

OUTCOMES FOR

OUTCOMES FOR

OUTCOMES FOR

354,000.

3,386,424.

T1D EXCHANGE, INC

T1D EXCHANGE, INC

354,000.

T1D EXCHANGE, INC

T1D EXCHANGE, INC11 AVENUE DE LAFAYETTEBOSTON, MA 02111




NA

BOSTON, MA 02111

BOSTON, MA 02111

BOSTON, MA 02111

PC DATA APPROACH TOIMPROVE QUALITY ANDOUTCOMES FOR

NA

NA

NA

INDIVIDUALS WITH T1D


PC

PC

PC

752,710.

655,806.

DATA APPROACH TO

DATA APPROACH TO

DATA APPROACH TO

IMPROVE QUALITY AND

IMPROVE QUALITY AND

IMPROVE QUALITY AND

OUTCOMES FOR

OUTCOMES FOR

OUTCOMES FOR

354,000.

3,686,424.

354,000.

AMSTERDAM, NETHERLANDS DIGITAL PROCUREMENT

AMSTERDAM, NETHERLANDS SAFECARE









92363504-01-19

3




RecipientFoundation

status ofrecipient



��


T1D EXCHANGE, INC11 AVENUE DE LAFAYETTEBOSTON, MA 02111

261,908.

NA PC DATA APPROACH TOIMPROVE QUALITY ANDOUTCOMES FOR

TECHNISCHE UNIVERSITAET MUENCHEN

THE ACADEMIC COLLEGE AT TEL-HAI

THE ACADEMIC COLLEGE AT TEL-HAI



ARCISSTRAE 21

TEL-HAI COLLEGE

TEL-HAI COLLEGE

PORIYA

PORIYA

MUNICH, GERMANY

TEL-HAI COLLEGE, UPPER GALILEE,

TEL-HAI COLLEGE, UPPER GALILEE,



NA

NA

NA

NA

NA

GOV

PC

PC

PC

PC

FECAL MICROBIOTA

BUILDING FOR HEALTH,

BUILDING FOR HEALTH,

CONSTRUCTION OF THE

CONSTRUCTION OF THE

TRANSPLANTATION FOR

ENVIRONMENT AND

ENVIRONMENT AND



TREATMENT OF CROHN'S

BIOTECHNOLOGY STUDIES

177,980.

BIOTECHNOLOGY STUDIES



1,077,334.

689,200.

479,666.





CAMBRIDGE, MA 02142

NA

415 MAIN STREET

415 MAIN STREET

415 MAIN STREET

PC HUMAN COLON AND SMALLINTESTINE CELL ATLASAND CROHN'S


NA

NA

NA

PC

PC

PC

1,929,800.

2,321,666.

HUMAN COLON AND SMALL

NOVEL THERAPEUTIC


INTESTINE CELL ATLAS

APPROACHES FOR CROHN'S


100,868.

1,387,769.

479,286.


DISEASE

ISRAEL

ISRAEL

TIBERIAS, ISRAEL

TIBERIAS, ISRAEL

CAMBRIDGE, MA 02142 IN HEALTH AND CROHN'S

CAMBRIDGE, MA 02142 DISEASE

CAMBRIDGE, MA 02142 IN HEALTH


92363504-01-19

3




RecipientFoundation

status ofrecipient



��



476,319.

NA PC HUMAN COLON AND SMALLINTESTINE CELL ATLAS

THE CHANCELLOR, MASTERS AND SCHOLARS

THE CHANCELLOR, MASTERS AND SCHOLARS




OF THE UNIVERSITY OF CAMBRIDGE

OF THE UNIVERSITY OF CAMBRIDGE

PI CH'IU BUILDING

415 MAIN STREET

415 MAIN STREET

THE OLD SCHOOLS

THE OLD SCHOOLS


NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CLOSED LOOP INSULIN

CLOSED LOOP INSULIN




DELIVERY IN NEWLY

DELIVERY IN NEWLY




463,751.

DIAGNOSED YOUTH WITH



247,545.

463,755.



304,248.


THE CLEVELAND CLINIC FOUNDATION9500 EUCLID AVENUE

PI CH'IU BUILDING

PI CH'IU BUILDING

PI CH'IU BUILDING

CLEVELAND, OH 44195

NA




PC STENOSIS THERAPY ANDANTI-FIBROTIC RESEARCH

NA

NA

NA

CONSORTIUM


PC

PC

PC

170,680.

533,765.










481,225.

506,838.

492,017.

CAMBRIDGE, MA 02142 AND CROHN'S

CAMBRIDGE, MA 02142 IN CROHN

CAMBRIDGE, MA 02142 IN CROHN'S

CAMBRIDGE, UNITED KINGDOM T1D


IN CROHNS

IN CROHNS

IN CROHNS

IN CROHNS


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE CLEVELAND CLINIC FOUNDATION9500 EUCLID AVENUE

155,544.

NA PC STENOSIS THERAPY ANDANTI-FIBROTIC RESEARCH



THE LEGATUM INSTITUTE FOUNDATION



555 UNIVERSITY AVE

555 UNIVERSITY AVE

11 CHARLES STREET

804 HAIGHT ST

804 HAIGHT ST

TORONTO, CANADA

TORONTO, CANADA


NA

NA

NA

NA

NA

PC

PC

NC

PC

PC

DEFINING AND

DEFINING AND

UNITED STATES

DIATRIBE LEARN

DIATRIBE LEARN

DEVELOPING THE

DEVELOPING THE

PROSPERITY INDEX -

300,000.



PUBLIC HEALTH

271,920.

200,000.



325,002.


THE MILKEN INSTITUTE1250 FOURTH STREET



CITY

SANTA MONICA, CA 90401

NA

YEZREEL VALLEY

YEZREEL VALLEY


PC CURES FOR LIFE:PATIENT ACCESS TO CELL

NA

NA

NA

AND GENE THERAPY


PC

PC

PC

262,028.

236,923.

UPGRADING AND

PROVIDING ETHIOPIAN

A CONCEPTUAL PLAN FOR

EXPANDING THE

WITH THE RESOURCES,

NYC NEIGHBORHOOD

EQUIPMENT AND SYSTEMS

SUPPORT AND TOOLS

GREENWAYS

183,251.

200,000.

550,000.

CLEVELAND, OH 44195 CONSORTIUM



FOR VEO-IBD

FOR VEO-IBD

INDICATORS

YEZREEL VALLEY, ISRAEL

YEZREEL VALLEY, ISRAEL

NEW YORK, NY 10007


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE MILKEN INSTITUTE1250 FOURTH STREET

174,998.

NA PC CURES FOR LIFE:PATIENT ACCESS TO CELL





THE ONE LOVE FOUNDATION










NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

3D MEDICAL IMAGING

PERSONALIZING CROHN'S



CAPACITY BUILDING

PILOT TO IMPROVE

DISEASE THERAPEUTICS



PROJECT SUPPORT

OUTCOMES FOR CROHN'S

500,000.

THROUGH HUMAN TRIALS593,026.

295,887.



230,900.


THE REGENTS OF THE UNIVERSITY OFCALIFORNIA, SAN FRANCISCO3333 CALIFORNIA STREET, SUITE 315,





NA




PC RITUXIMAB FOLLOWED BYABATACEPT FORPREVENTION OR REVERSAL

NA

NA

NA

OF T1D


PC

PC

PC

575,441.

593,024.




ABATACEPT FOR


ABATACEPT FOR

PREVENTION T1D

BETA CELLS IN T1D

PREVENTION OR REVERSAL

230,900.

108,185.

230,900.

SANTA MONICA, CA 90401 AND GENE THERAPY


LA JOLLA, CA 92093 PATIENTS

LA JOLLA, CA 92093

LA JOLLA, CA 92093

LA JOLLA, CA 92093



BOX 0962 SAN FRANCISCO, CA 94143 OF T1D


92363504-01-19

3




RecipientFoundation

status ofrecipient



��



319,036.

NA PC DEVELOPMENT OF ACONTINUOUSINSULIN-GLUCOSE SENSOR






COLORADO, DENVER

COLORADO, DENVER

COLORADO, DENVER

COLORADO, DENVER

COLORADO, DENVER






NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CLINIC MODEL FOR

CONTINUOUS GLUCOSE

DEVELOPMENT OF A

SINGLE PERSISTENT

DEVELOPMENT OF A

DIABETES CARE FOR

MONITORING IN DIABETES

CONTINUOUS

ISLET AUTOANTIBODY

CONTINUOUS

LATINO PATIENTS729,878.

INSULIN-GLUCOSE SENSOR

(SPIA) PHENOTYPE

INSULIN-GLUCOSE SENSOR

317,365.

90,839.


THE REGENTS OF THE UNIVERSITY OF NEW

184,286.

THE REGENTS OF THE UNIVERSITY OF NEW

THE SDEROT DEVELOPMENT FOUNDATION6 BAR LEV STREETSDEROT, ISRAEL

COLORADO, DENVER

MEXICO

MEXICO

NA


SPONSORED PROJECTS - PREAWARD

SPONSORED PROJECTS - PREAWARD

PC SDEROT RESILIENCECOMPLEX, RESILIENCECENTER AND PARENTHOOD

NA

NA

NA

HOUSE


PC

GOV

GOV

313,924.

200,000.

SINGLE PERSISTENT

ADDRESSING GLOBAL

ADDRESSING GLOBAL

ISLET AUTOANTIBODY

HEALTHCARE DISPARITIES

HEALTHCARE DISPARITIES

(SPIA) PHENOTYPE

THROUGHTHE ECHO MODEL

378,921.

1,413,438.

1,188,238.

AURORA, CO 80045

AURORA, CO 80045

AURORA, CO 80045

AURORA, CO 80045

AURORA, CO 80045

AURORA, CO 80045

AURORA, CO 80045

ALBUQUERQUE, NM 87131-0001

ALBUQUERQUE, NM 87131-0001


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE SDEROT DEVELOPMENT FOUNDATION6 BAR LEV STREETSDEROT, ISRAEL

1,615,714.

NA PC SDEROT RESILIENCECOMPLEX, RESILIENCECENTER AND PARENTHOOD






AND RESEARCH (R.A.)

AND RESEARCH (R.A.)

AND RESEARCH

AND RESEARCH

AND RESEARCH

TEL-HASHOMER

TEL-HASHOMER

TEL-HASHOMER

TEL-HASHOMER

TEL-HASHOMER

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CRITICAL CORONA CARE -

COMPREHENSIVE

"MSR ON WHEELS" TO

COMPREHENSIVE

COMPREHENSIVE

INTENSIVE CARE UNIT

INDIVIDUALIZED

SERVE NORTHERN

INDIVIDUALIZED

INDIVIDUALIZED

(CCC-ICU) AT SHEBA


1,000,000.

ISRAEL'S HEALTH CARE



228,294.

255,306.

423,798.

THE TRUSTEES OF BOSTON UNIVERSITY881 COMMONWEALTH AVENUE

THE TEL AVIV JAFFA ACADEMIC COLLEGE



BOSTON, MA 02215

NA

RABENU YERUHAM ST., P.O.B 8401



PC USE OF AUTOMATEDINSULIN DELIVERYSYSTEM IN PRIMARY CARE


NA

NA

NA

PC

PC

PC

120,544.

224,330.

SCHOLARSHIP SUPPORT

USE OF AUTOMATED

USE OF AUTOMATED

FOR B.S. DEGREES IN

INSULIN DELIVERY

INSULIN DELIVERY

573,359.

209,798.

209,799.

HOUSE

RAMAT GAN, ISRAEL MEDICAL CENTER


RAMAT GAN, ISRAEL SYSTEM



TEL AVIV YAFFO, ISRAEL NURSING




92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE UNITED NATIONS INSTITUTE FORTRAINING AND RESEARCHUNITED NATIONS INSTITUTE FOR TRAINING

2,000,000.

NA PC ACCELERATING ACCESS:TREATMENT FOR NCDS INLOW /MIDDLE-INCOME

THE UNITED NATIONS INSTITUTE FOR


TRAINING AND RESEARCH





UNITED NATIONS INSTITUTE FOR TRAINING



CHICAGO, IL 60637


NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

ACCELERATING ACCESS:

IMMUNO

TREATMENT FOR NCDS IN

IMMUNO

A CELL ATLAS OF THE

PHARMACOGENOMICS TO

A CELL ATLAS OF THE

LOW /MIDDLE-INCOME

PHARMACOGENOMICS IN

1,000,000.


UNDERSTAND BIOLOGICS


411,939.

411,939.


487,806.


THE UNIVERSITY OF CHICAGO5801 SOUTH ELLIS AVENUE




CHICAGO, IL 60637

NA

CHICAGO, IL 60637


CHICAGO, IL 60637

PC A CELL ATLAS OF THEILEAL COLONIC CROHN'S

NA

NA

DISEASE


NA

PC

PC

PC

487,806.

487,806.

IMMUNO

IMMUNO

PHARMACOGENOMICS TO

A CELL ATLAS OF THE

PHARMACOGENOMICS TO

UNDERSTAND BIOLOGICS


BIOLOGICS IN CROHN'S

411,939.

487,806.

305,349.



CHICAGO, IL 60637 CROHN'S DISEASE


IN CROHN'S


IN CROHN'S


DISEASE


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE UNIVERSITY OF CHICAGO5801 SOUTH ELLIS AVENUE

THE UNIVERSITY OF EDINBURGH305,353.

NA PC IMMUNOPHARMACOGENOMICS TO














NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

MITOCHONDRIALMECHANISTIC BIOMARKERS

UNDERSTANDING ALPHA



OF MUCOSAL

CELL AND CORRECTING

ATLAS - NORMAL

ATLAS - NORMAL

MITOCHONDRIAL DAMPS AS

INFLAMMATION IN


575,466.



MECHANISTIC BIOMARKERS

382,456.

199,487.

407,790.

THE UNIVERSITY OF OXFORDUNIVERSITY OFFICES, WELLINGTON SQUAREOXFORD, UNITED KINGDOM




NA




PC PHARMACOLOGICALMODULATION TO RESTOREGLUCAGON SECRETION INT1D


NA

NA

NA

PC

PC

PC

400,400.

603,211.

UNDERSTANDING ALPHA



CELL AND GLUCAGON

ATLAS - NORMAL

ATLAS - NORMAL

205,309.

444,247.

444,246.

CHICAGO, IL 60637 UNDERSTAND IN CROHN'S

CROHN'S

T1D

DISEASE

DISEASE

EDINBURGH, UNITED KINGDOM IN CROHN'S

EDINBURGH, UNITED KINGDOM SECRETION IN T1D

EDINBURGH, UNITED KINGDOM INTESTINE AND CROHN'S

EDINBURGH, UNITED KINGDOM INTESTINE AND CROHN'S


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


THE UNIVERSITY OF OXFORDUNIVERSITY OFFICES, WELLINGTON SQUAREOXFORD, UNITED KINGDOM

110,000.

NA PC INNATE AND ADAPTIVETHERAPEUTIC TARGETS OFVEO-IBD - OXFORD

THE UNIVERSITY OF OXFORDUNIVERSITY OFFICES, WELLINGTON SQUARE




TOWNSEND HEALTH SYSTEMS, INC.

OXFORD, UNITED KINGDOM

234 HERZEL ST

234 HERZEL ST

234 HERZEL ST

110 NORTH OAK

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

MODULATION FORCOUNTERREGULATORY

DECODING PERSONALIZED

THE WEIZMANN QUANTUM

DECODING PERSONALIZED

EEMERGENCY AT


NUTRITION IMPACTING

287,947.

NANO-PHYSICS

NUTRITIONAL AND HOST

BROADWATER HEALTH

1,421,110.

1,576,171.


443,916.


UNIVERSITY COLLEGE LONDONGOWER STREET

TOWNSEND HEALTH SYSTEMS, INC.




NA

110 NORTH OAK



PC SPIT-C: USING SALIVATO PREDICT CROHN'S

NA

NA

DISEASE


NA

PC

PC

PC

159,809.

32,329.

STUDY OF MECHANISMS

STUDY OF DIRECT AND

EEMERGENCY AT

RESPONSIBLE FOR THE

INDIRECT MECHANISMS

BROADWATER HEALTH

IMPAIRED GLUCAGON IN

FOR GLUCAGON SECRETION

12,933.

243,257.

246,186.

STUDIES

T1D

REHOVOT, ISRAEL CROHN'S


REHOVOT, ISRAEL PATTERNS IN CROHN'S

TOWNSEND, MT 59644 CENTER

TOWNSEND, MT 59644 CENTER

T1D

IN T1D


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF BIRMINGHAMINSTITUTE OF IMMUNOLOGY

102,647.

NA PC ANTIGEN SPECIFICIMMUNOTHERAPY IN T1D

UNIVERSITY OF CAMBRIDGE


THE OLD SCHOOLS


THE OLD SCHOOLS

UNIVERSITY OF DUNDEE



THE OLD SCHOOLS


NETHERGATE

219 GRINTER HALL

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

CLOSED LOOP INSULIN

CLOSED LOOP INSULIN

DELIVERY IN NEWLY

CLOSED LOOP INSULIN

DELIVERY IN NEWLY

UNDERSTANDING ORGAN

COLLABORATIVE T1D


DELIVERY IN YOUTH WITH

353,223.


SPECIFIC CONSEQUENCES

RESEARCH PROJECT

279,562.

500,000.


1,043,638.


UNIVERSITY OF FLORIDA219 GRINTER HALLGAINESVILLE, FL 32611-5500

219 GRINTER HALL


219 GRINTER HALL

NA


219 GRINTER HALL


PC HUMAN ATLAS NEONATALDEVELOPMENTAL EARLYLIFE PANCREAS/IMMUNITY

NA

NA

CON'T


NA

PC

PC

PC

496,568.

1,208,349.

HUMAN ATLAS OF

HUMAN ATLAS NEONATAL


T CELL RECEPTOR

DEVELOPMENTAL EARLY

AND EARLY

SEQUENCING IN T1D

LIFE PANCREAS/IMMUNITY

379,382.

298,682.

1,034,449.

BIRMINGHAM, UNITED KINGDOM

T1D


T1D

DUNDEE, UNITED KINGDOM OF HYPOGLYCEMIA


LIFE-IMMUNITY


CON'T


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF GLASGOW COURTUNIVERSITY AVENUE

652,150.

NA PC THE CLINICALEFFECTIVENESS OF

UNIVERSITY OF MIAMI

UNIVERSITY OF MIAMI

UNIVERSITY OF IOWA

UNIVERSITY OF IOWA

1320 S DIXIE HWY

1320 S DIXIE HWY

UNIVERSITY OF MIAMI





1320 SOUTH DIXIE HIGHWAY, SUITE 650

NA

NA

NA

NA

NA

PC

PC

GOV

GOV

PC

A HOLISTIC DIET

A HOLISTIC DIET

RUPRI HEALTH PANEL

RUPRI HEALTH PANEL

INTERVENTION FOR

INTERVENTION FOR

DEVELOP A NEW METHOD

SUPPORT

SUPPORT

167,554.

PEOPLE WITH CROHN'S

PEOPLE WITH CROHN'S

OF STUDYING FUNCTION

637,761.

174,321.


487,302.


UNIVERSITY OF TEXAS SYSTEM1616 GUADALUPE STREET

UNIVERSITY OF MIAMI

CHAPEL HILL

CHAPEL HILL

AUSTIN, TX 78701

NA

1320 SOUTH DIXIE HIGHWAY, SUITE 650



GOV A CROHN'SDISEASE-ON-A-CHIP FOR

NA

NA

MAPPING IMMUNE AXIS


NA

PC

PC

PC

374,435.

250,000.



DEVELOP A NEW METHOD

CLINICAL TRIAL IN

CLINICAL TRIAL IN

OF STUDYING ALPHA CELL

PEDIATRIC CROHN'S

PEDIATRIC CROHN'S

250,000.

91,810.

42,022.

GLASGOW, UNITED KINGDOM CD-TREAT

IOWA CITY, IA 52442

IOWA CITY, IA 52442

DISEASE

DISEASE

CORAL GABLES, FL 33146 IN PANCREATIC SLICES

CORAL GABLES, FL 33146 FUNCTION




92363504-01-19

3




RecipientFoundation

status ofrecipient



��


UNIVERSITY OF TEXAS SYSTEM1616 GUADALUPE STREET

378,343.

NA GOV A CROHN'SDISEASE-ON-A-CHIP FOR

UNIVERSITY OF UTAH

UNIVERSITY OF UTAH

UNIVERSITY OF UTAH

UNIVERSITY OF UTAH











NA

NA

NA

NA

NA

PC

PC

PC

PC

GOV





CROHNS DISEASE

CROHNS DISEASE

CROHNS DISEASE

CROHNS DISEASE

SKIN PATHOLOGY IN

DIAGNOSIS AND

DIAGNOSIS AND

245,583.

DIAGNOSIS AND

DIAGNOSIS AND

PEOPLE WITH T1D

249,717.

246,267.

249,929.

UPPSALA UNIVERSITETBOX 256




UPPSALA, SWEDEN

NA


HEIDELBERGLAAN 100

HEIDELBERGLAAN 100

GOV ALPHA-CELL SIGNALINGFOR GLUCAGON SECRETION


NA

NA

NA

GOV

PC

PC

246,267.

323,566.

COMPUTATIONAL DESIGN

EPITHELIAL BASED

EPITHELIAL BASED

OF GLUCOSE RESPONSIVE

DIAGNOSTICS FOR

DIAGNOSTICS FOR

274,851.

82,500.

82,500.

AUSTIN, TX 78701 MAPPING

TREATMENT RESPONSE

TREATMENT RESPONSE

TREATMENT RESPONSE

TREATMENT RESPONSE


SEATTLE, WA 98195-9472 CYCLIC PEPTIDES




92363504-01-19

3




RecipientFoundation

status ofrecipient



��


UPPSALA UNIVERSITETBOX 256

249,929.

NA GOV ALPHA-CELL SIGNALINGFOR GLUCAGON SECRETION






304 FRANKLIN STREET

304 FRANKLIN STREET




NA

NA

NA

NA

NA

GOV

GOV

PC

PC

PC

EEMERGENCY AT VAN

EEMERGENCY AT VAN

DEVELOPING AN ISLET

SINGLE CELL STRATEGIES

COMBINATORIAL SINGLE



44,413.


FOR CROHN'S DISEASE

CELL STRATEGIES FOR

509,159.

17,766.

225,833.

VANDERBILT UNIVERSITY2201 WEST END AVENASHVILLE, TN 37235




NA




PC UNDERSTAND THEMECHANISMS THAT DRIVECALCIUM SIGNALING INT1D


NA

NA

NA

PC

PC

PC

250,000.

509,159.

DEVELOPING AN ISLET

SINGLE CELL STRATEGIES

COMBINATORIAL CELL


FOR CROHN'S DISEASE

STRATEGIES FOR CROHN'S

250,000.

509,159.

509,159.

UPPSALA, SWEDEN

KEOSAUQUA, IA 52565

KEOSAUQUA, IA 52565

NASHVILLE, TN 37203

NASHVILLE, TN 37203 GUT CELL ATLAS

NASHVILLE, TN 37203 CROHN'S GUT CELL ATLAS

NASHVILLE, TN 37203

NASHVILLE, TN 37203 GUT CELL ATLAS

NASHVILLE, TN 37203 DISEASE GUT CELL ATLAS


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


VANDERBILT UNIVERSITY2201 WEST END AVENASHVILLE, TN 37235

231,831.

NA PC UNDERSTAND THEMECHANISMS THAT DRIVECALCIUM SIGNALING IN



VIVLI, INC.

WASHINGTON UNIVERSITY

WASHINGTON UNIVERSITY

UNIVERSITY

UNIVERSITY

14 STORY STREET, SUITE 406

660 S EUCLID AVE.

660 S EUCLID AVE.

1300 YORK AVENUE

1300 YORK AVENUE

NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

TARGETING THE

TARGETING THE

EXECUTING ON THE

RESTORATION OF NORMAL

RESTORATION OF NORMAL



VISION OF THE VIVLI

GLUCAGON SECRETORY

200,918.

GLUCAGON SECRETORY

DISEASE

DISEASE

283,902.

250,000.

269,693.

WYOMING DEPARTMENT OF HEALTH6101 YELLOWSTONE RD. SUITE 400

WEST PARK HOSPITAL DISTRICT

WORLD VISION, INC.

WYOMING DEPARTMENT OF HEALTH

CHEYENNE, WY 82009

NA

707 SHERIDAN AVENUE

34834 WEYERHAEUSER WAY SOUTH

6101 YELLOWSTONE RD. SUITE 400

GOV WYOMING FIRSTRESPONDER AED PROJECT


NA

NA

NA

GOV

PC

GOV

250,000.

283,903.

CODY CARDIOLOGY CENTER

FLOOD MITIGATION AND

WYOMING FIRST

CATHETERIZATION

COMMUNITY RESILIENCE


95,674.

615,413.

3,731,196.

T1D

CAMBRIDGE , MA 02138 GLOBAL PLATFORM

ST LOUIS, MI 63110 DYNAMICS

ST LOUIS, MO 63110 MANIPULATION

NEW YORK, NY 10065-4805

NEW YORK, NY 10065-4805

CODY, WY 82414 LABORATORY PROJECT

FEDERAL WAY, WA 98001 PHASE 2

CHEYENNE, ISRAEL


92363504-01-19

3




RecipientFoundation

status ofrecipient



��


WYOMING DEPARTMENT OF HEALTH6101 YELLOWSTONE RD. SUITE 400

183,693.

NA GOV WYOMING FIRSTRESPONDER AED PROJECT

YALE UNIVERSITY

YALE UNIVERSITY

YALE UNIVERSITY

YAD SARAH





124 HERZL BLVD. 9618722





NA

NA

NA

NA

NA

PC

PC

PC

PC

PC

IDENTIFYING

NOVEL APPROACHES FOR

NOVEL APPROACHES FOR

MOBILE DENTAL CLINICS

THERAPEUTIC TARGETS

IDENTIFYING

IDENTIFYING

EDUCATION AND

FOR ISRAEL'S PERIPHERY

FOR THE TREATMENT OF

136,850.

THERAPEUTIC TARGETS IN

THERAPEUTIC TARGETS IN


336,846.

330,798.


ZEFAT ACADEMIC COLLEGE

ZIV MEDICAL CENTER


11 JERUSALEM STREET, POB 160

RAMBAM ST.


NA

NA

NA

PC

PC

PC

330,246.

200,000.

EDUCATION AND

EQUIPPING THE MEDICAL

REINFORCEMENT OF


SIMULATION & TRAINING

CRUCIAL SITES DURING

14,516.

1,103,914.

1,503,124.

CHEYENNE, WY 82009

JERUSALEM, ISRAEL

CROHN'S

CROHN'S

CROHN'S



ZEFAT, ISRAEL CENTER

ZEFAT, ISRAEL EMERGENCIES


OMB No. 1545-0123

Department of the TreasuryInternal Revenue Service

912801 01-14-20

| Attach to the corporation's tax return.| Go to www.irs.gov/Form2220 for instructions and the latest information.

Employer identification number

1

2

3

4

5

1

2d

3

4

5

a

b

c

d

2a

2b

2c

Total.

do not

Caution:

Required annual payment. smaller

must

6

7

8

(a) (b) (c) (d)

9

10

11

12

13

14

15

16

17

18

Installment due dates. Form 990-PF filers:

9

10

11

12

13

14

15

16

17

18

Required installments.

Complete lines 12 through 18 of one column

before going to the next column.

Underpayment.

Overpayment.

Go to Part IV on page 2 to figure the penalty. Do not go to Part IV if there are no entries on line 17 - no penalty is owed.

For Paperwork Reduction Act Notice, see separate instructions. 2220

Note:

do not

Form

Name

Total tax (see instructions)

Personal holding company tax (Schedule PH (Form 1120), line 26) included on line 1

Look-back interest included on line 1 under section 460(b)(2) for completed long-term

contracts or section 167(g) for depreciation under the income forecast method

Credit for federal tax paid on fuels (see instructions)

Add lines 2a through 2c

Subtract line 2d from line 1. If the result is less than $500, complete or file this form. The corporation

does not owe the penalty

Enter the tax shown on the corporation's 2018 income tax return. See instructions. If the tax is zero

or the tax year was for less than 12 months, skip this line and enter the amount from line 3 on line 5

Enter the of line 3 or line 4. If the corporation is required to skip line 4,

enter the amount from line 3 ��

Check the boxes below that apply. If any boxes are checked, the corporation file Form 2220even if it does not owe a penalty. See instructions.

The corporation is using the adjusted seasonal installment method.

The corporation is using the annualized income installment method.

The corporation is a "large corporation" figuring its first required installment based on the prior year's tax.

Enter in columns (a) through(d) the 15th day of the 4th (Use 5th month), 6th, 9th, and 12th months of thecorporation's tax year ~~~~~~~~~~~~~~~~

If the box on line 6 and/or line 7

above is checked, enter the amounts from Sch A, line 38. If

the box on line 8 (but not 6 or 7) is checked, see instructions

for the amounts to enter. If none of these boxes are checked,

enter 25% (0.25) of line 5 above in each column

Estimated tax paid or credited for each period. For

column (a) only, enter the amount from line 11 on line 15.

See instructions

Enter amount, if any, from line 18 of the preceding column

Add lines 11 and 12

Add amounts on lines 16 and 17 of the preceding column

Subtract line 14 from line 13. If zero or less, enter -0-

If the amount on line 15 is zero, subtract line 13 from line

14. Otherwise, enter -0-

If line 15 is less than or equal to line 10,

subtract line 15 from line 10. Then go to line 12 of the next

column. Otherwise, go to line 18

If line 10 is less than line 15, subtract line 10

from line 15. Then go to line 12 of the next column ��

Form (2019)

Generally, the corporation is not required to file Form 2220 (see Part II below for exceptions) because the IRS will figure any penalty owed andbill the corporation. However, the corporation may still use Form 2220 to figure the penalty. If so, enter the amount from page 2, line 38, on theestimated tax penalty line of the corporation's income tax return, but attach Form 2220.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~

~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~

~~~~

~~~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~

~~

~~~~~~~~~~~~~~~

~~~~~~~~~~~

LHA

Part I Required Annual Payment

Reasons for Filing - Part II

Part III Figuring the Underpayment

Underpayment of Estimated Tax by Corporations2220

2019

CHARITABLE TRUST 13-7184401

6,911,639.

6,911,639.

1,062,718. 1,727,910.1,727,910.2,393,102.

6,150,139. 3,900,000. 1,000,000. 8,000,000.

5,087,421. 6,594,319. 5,866,409.8,987,421. 7,594,319. 13,866,409.

6,150,139. 8,987,421. 7,594,319. 13,866,409.

0. 0.

5,087,421. 6,594,319. 5,866,409.


4,250,872.

4,250,872.

FORM 990-PF

XX

08/15/19 09/15/19 12/15/19 03/15/20


Number of days from due date of installment on line 9 to the

date shown on line 19

Number of days on line 20 after 4/15/2019 and before 7/1/2019

Underpayment on line 17 x Number of days on line 21 x 6% (0.06)365


Underpayment on line 17 x Number of days on line 23 x 5% (0.05)

365



365



366


Underpayment on line 17 x Number of days on line 29 x *%

366



366



366



365

Add lines 22, 24, 26, 28, 30, 32, 34, and 36

912802 01-14-20

(a) (b) (c) (d)

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

(C corporations with tax years ending June 30and S corporations: Form 990-PF and Form 990-T filers:

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

Penalty.

38

www.irs.gov.

2220

Form 2220 (2019) Page

Enter the date of payment or the 15th day of the 4th monthafter the close of the tax year, whichever is earlier.

Use 3rd month instead of 4th month.Use 5th month

instead of 4th month.) See instructions

~~~~~~~~~~~~~~~~~

~~

~ $

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

$

~

~

~~

~

~

~

~~

~~~

~

~~~

~~

~~~

~

~~~

~~~~~~~~~

Add columns (a) through (d) of line 37. Enter the total here and on Form 1120, line 34; or the comparable

line for other income tax returns

* Use the penalty interest rate for each calendar quarter, which the IRS will determine during the first month in the preceding quarter.These rates are published quarterly in an IRS News Release and in a revenue ruling in the Internal Revenue Bulletin. To obtain thisinformation on the Internet, access the IRS website at You can also call 1-800-829-4933 to get interest rate information.

Form (2019)

~~~~~~~~

��

2

Part IV Figuring the Penalty

0.

13-7184401CHARITABLE TRUSTTHE LEONA M. AND HARRY B. HELMSLEYFORM 990-PF


Enter taxable income for each period for the tax year beginning in

2019. See the instructions for the treatment of extraordinary items

912821 01-14-20

3

Form 1120-S filers:

(a) (b) (c) (d)

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

a

b

c

a

b

c

a

b

c

a

b

c

1a

1b

1c

2

3a

3b

3c

4

5

6

7

8

9a

9b

9c

10

11a

11b

11c

12

13

14

15

16

17

18

19

2220

For lines 1, 2, 3, and 21, "taxable income" refers to excess net passive income or the amount on which tax isimposed under section 1374(a), whichever applies.

Form 2220 (2019) Page

See instructions.

Enter taxable income for the following periods.

Tax year beginning in 2016



First 3 months First 5 months First 8 months First 11 months

~~~~~~~~~~~~

~~~~~~~~~~~~

~~~~~~~~~~~~

First 4 months First 6 months First 9 months Entire yearEnter taxable income for the following periods.




~~~~~~~~~~~~

~~~~~~~~~~~~

~~~~~~~~~~~~

Divide the amount in each column on line 1a by the

amount in column (d) on line 3a

Divide the amount in each column on line 1b by the

amount in column (d) on line 3b

Divide the amount in each column on line 1c by the

amount in column (d) on line 3c

~~~~~~~~~~

~~~~~~~~~~

~~~~~~~~~~

Add lines 4 through 6

Divide line 7 by 3.0

Divide line 2 by line 8

Extraordinary items (see instructions)

Add lines 9a and 9b

Figure the tax on the amt on ln 9c using the instr for Form

1120, Sch J, line 2, or comparable line of corp's return

~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~

~~~~~~~~

~~~~~~~~~~~~~~~~

~

Divide the amount in columns (a) through (c) on line 3a

by the amount in column (d) on line 3a

Divide the amount in columns (a) through (c) on line 3b

by the amount in column (d) on line 3b

Divide the amount in columns (a) through (c) on line 3c

by the amount in column (d) on line 3c

Add lines 11a through 11c

~~~~~~~

~~~~~~~

~~~~~~~

~~~~~~~~~~~~~

Divide line 12 by 3.0

Multiply the amount in columns (a) through (c) of line 10

by columns (a) through (c) of line 13. In column (d), enter

the amount from line 10, column (d)

Enter any alternative minimum tax (trusts only) for each

payment period. See instructions

Enter any other taxes for each payment period. See instr.

Add lines 14 through 16

~~~~~~~~~~~~~~~~

~~~~~~~~

~~~~~~~~~~

~~~~~~~~~~~~~~

For each period, enter the same type of credits as allowed

on Form 2220, lines 1 and 2c. See instructions

Total tax after credits. Subtract line 18 from line 17. If

zero or less, enter -0-

~~~~

��

Form (2019)

Use this method only if the base period percentage for any 6 consecutive months is at least 70%.See instructions.

Schedule A Adjusted Seasonal Installment Method and Annualized Income Installment Method

Part I Adjusted Seasonal Installment MethodCaution:

FORM 990-PF

13-7184401THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST


912822 01-14-20

4

(a) (b) (c) (d)

20

21

22

23

24

25

26

27

28

29

30

31

20

21

22

23a

23b

23c

24

25

26

27

28

29

30

31

a

b

c

Note:

32

33

34

35

36

37

38

smaller

Adjusted seasonal or annualized income installments.

32

33

34

35

36

37

38

Note:

Required installments. smaller

2220

Form 2220 (2019) Page

First

months

First

months

First

months

First

monthsAnnualization periods (see instructions)

Enter taxable income for each annualization period. See

instructions for the treatment of extraordinary items

Annualization amounts (see instructions)

Annualized taxable income. Multiply line 21 by line 22

Extraordinary items (see instructions)

Add lines 23a and 23b

~~~~~~~

~~

~~~~~~

~

~~~~~~~~

~~~~~~~~~~~~~~

Figure the tax on the amount on line 23c using the

instructions for Form 1120, Schedule J, line 2,

or comparable line of corporation's return

Enter any alternative minimum tax (trusts only) for each

payment period (see instructions)

Enter any other taxes for each payment period. See instr.

Total tax. Add lines 24 through 26

~~~~~~

~~~~~~~~~~

~~~~~~~~~

For each period, enter the same type of credits as allowed

on Form 2220, lines 1 and 2c. See instructions

Total tax after credits. Subtract line 28 from line 27. If

zero or less, enter -0-

Applicable percentage

~~~~

~~~~~~~~~~~~~~~

~~~~~~~~~~~~~~ 25% 50% 75% 100%

Multiply line 29 by line 30 ��

Complete lines 32 through 38 of one column

before completing the next column.

1st

installment

2nd

installment

3rd

installment

4th

installment

If only Part I or Part II is completed, enter the amount in

each column from line 19 or line 31. If both parts are

completed, enter the of the amounts in each

column from line 19 or line 31

Add the amounts in all preceding columns of line 38.

See instructions

Subtract line 33 from line 32. If zero or less, enter -0-

~~~~~~~~~~~

~~~~~~~~~~~~~~~~~

~

Enter 25% (0.25) of line 5 on page 1 of Form 2220 in

each column. "Large corporations," see the

instructions for line 10 for the amounts to enter ~~~~

Subtract line 38 of the preceding column from line 37 of

the preceding column

Add lines 35 and 36

Enter the of line 34 or

line 37 here and on page 1 of Form 2220, line 10.

See instructions

~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~

��

Form (2019)

Part II Annualized Income Installment Method

Part III Required Installments

144,935,980. 360,569,655. 710,281,315.

6.000000 4.000000 2.000000

11,754,479. 11,594,878. 14,422,786. 18,940,788.

587,723,952.

5,797,439. 10,817,090. 18,940,788.

579,743,920.

1,062,718. 3,455,820. 5,183,730.

721,139,310. 947,039,386.

4,734,721. 7,361,270. 13,757,058.

2,938,620. 5,797,439.

**

10,817,090.

FORM 990-PF

18,940,788.

11,754,479. 11,594,878. 14,422,786.

1.333330

11,754,479. 11,594,878. 14,422,786.

18,940,788.

18,940,788.

2,938,620.

2,938,620.

1,062,718. 2,393,102. 1,727,910. 1,727,910.

1,062,718. 2,393,102. 1,727,910. 1,727,910.

1,062,718. 2,393,102. 1,727,910. 1,727,910.

13-7184401THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST

** ANNUALIZED INCOME INSTALLMENT METHOD USING STANDARD OPTION

97,953,992.

2 3 6 9

587,723,952.

579,743,920.

721,139,310.

947,039,386.


}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}THE LEONA M. AND HARRY B. HELMSLEY CHARI 13-7184401

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 1FORM 990-PF INTEREST ON SAVINGS AND TEMPORARY CASH INVESTMENTS

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

(A) (B) (C) REVENUE NET INVESTMENT ADJUSTEDSOURCE PER BOOKS INCOME NET INCOME}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}INTEREST FROM SAVINGS 1,503,764. 1,503,764.

}}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}TOTAL TO PART I, LINE 3 1,503,764. 1,503,764. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 2FORM 990-PF DIVIDENDS AND INTEREST FROM SECURITIES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} CAPITAL (A) (B) (C) GROSS GAINS REVENUE NET INVEST- ADJUSTEDSOURCE AMOUNT DIVIDENDS PER BOOKS MENT INCOME NET INCOME}}}}}} }}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}}DIVIDENDS ANDINTEREST FROMSECURITIES 68,465,481. 27,323,282. 41,142,199. 116,587,584.

}}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}}TO PART I, LINE 4 68,465,481. 27,323,282. 41,142,199. 116,587,584. ~~~~~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~~~~ ~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 3FORM 990-PF OTHER INCOME

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} (A) (B) (C) REVENUE NET INVEST- ADJUSTEDDESCRIPTION PER BOOKS MENT INCOME NET INCOME}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}}FX TRANSACTION NET LOSS -672,933. -724,108. CLASS ACTION PROCEEDS, NET 66,233. 66,233. OTHER PARTNERSHIP INCOME 30,240,792. 14,651,902. SECTION 951(A) INCOME INCLUSION 0. 6,107,396. PRI LOAN INTEREST 8,723. 8,723. GRANT RECOVERIES 32,358. 0. OTHER TAXABLE INCOME 16,116. 16,116. RENTAL INCOME SUBTENANT 305,476. 305,476.

}}}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}}TOTAL TO FORM 990-PF, PART I, LINE 11 29,996,765. 20,431,738. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~

STATEMENT(S) 1, 2, 3140 11020115 756359 1622860.000 2019.05020 THE LEONA M. AND HARRY B. 16228601


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 4FORM 990-PF LEGAL FEES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

(A) (B) (C) (D) EXPENSES NET INVEST- ADJUSTED CHARITABLEDESCRIPTION PER BOOKS MENT INCOME NET INCOME PURPOSES}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}CAPLIN & DRYSDALE,CHARTERED 0. 0. 20,000.CUMMINGS & LOCKWOOD LLC 8,500. 0. 8,500.CURLEY, HURTGEN & JOHNSRUDLLP 2,000. 0. 0.DAVIS WRIGHT TREMAINE LLP 2,269. 0. 2,269.HAROLD A. MERIAM III 7,072. 7,072. 0.LOEB & LOEB LLP 40,424. 0. 27,690.PATTERSON BELKNAP WEBB &TYLER LLP 132,008. 0. 103,314.ROPES & GRAY LLP 92,923. 92,923. 0.SHARI PATRICK 15,561. 0. 15,561.SKADDEN, ARPS, SLATE,MEAGHER & FLOM LLP 7,853. 0. 14,116.

}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}TO FM 990-PF, PG 1, LN 16A 308,610. 99,995. 191,450. ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 5FORM 990-PF ACCOUNTING FEES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} (A) (B) (C) (D) EXPENSES NET INVEST- ADJUSTED CHARITABLEDESCRIPTION PER BOOKS MENT INCOME NET INCOME PURPOSES}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}CLIFTONLARSONALLEN LLP 19,500. 19,500. 0.DEMASCO, SENA & JAHELKA LLP 43,009. 8,343. 31,779.PKF O'CONNOR DAVIES, LLP 467,547. 292,079. 131,668.

}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}TO FORM 990-PF, PG 1, LN 16B 530,056. 319,922. 163,447. ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~

STATEMENT(S) 4, 5141 11020115 756359 1622860.000 2019.05020 THE LEONA M. AND HARRY B. 16228601


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 6FORM 990-PF OTHER PROFESSIONAL FEES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

(A) (B) (C) (D) EXPENSES NET INVEST- ADJUSTED CHARITABLEDESCRIPTION PER BOOKS MENT INCOME NET INCOME PURPOSES}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}APCO WORLDWIDE SARL (BEVENDOR) (PROGRAMCONSULTING) 379,313. 0. 457,636.BERLIN ROSEN LTD (PUBLICRELATIONS) 381,479. 0. 381,479.COLLER VI (INVESTMENTMANAGEMENT) 687,333. 687,333. 0.COLLER VII (INVESTMENTMANAGEMENT) 737,936. 737,936. 0.DALBERG CONSULTING US LLC(PROGRAM CONSULTING) 442,125. 0. 442,125.DARUMA SMID (INVESTMENTMANAGEMENT) 275,793. 275,793. 0.DF DENT & COMPANY, INC.(INVESTMENT MANAGEMENT) 853,401. 853,401. 0.FIDUCIARY MANAGEMENT, INC.(INVESTMENT MANAGEMENT) 964,709. 964,709. 0.HIG BAYSIDE III(INVESTMENT MANAGEMENT) 389,651. 389,651. 0.IFP GLOBAL EQUITY LP(INVESTMENT MANAGEMENT) 1,676,537. 1,676,537. 0.MARINER IIFC (INVESTMENTMANAGEMENT) 256,016. 256,016. 0.OTHER CONSULTING FEES -GENERAL MANAGEMENT 94,500. 0. 92,164.OTHER CONSULTING FEES -GRANTS MANAGEMENT 147,486. 0. 218,338.OTHER CONSULTING FEES -HUMAN RESOURCES 22,802. 0. 22,802.OTHER CONSULTING FEES - INFORMATION TECHNOLOGY 42,620. 0. 42,208.OTHER INVESTMENT RELATEDCONSULTING FEES 6,150. 6,150. 0.OTHER PROGRAM RELATEDCONSULTING FEES 404,838. 0. 387,411.OTHER PUBLIC RELATIONSCONSULTING FEES 283,717. 0. 279,980.OTHER RECRUITMENT FEES 103,010. 3,699. 94,232.SCOTT KAHN (PROGRAMCONSULTING) 204,105. 0. 227,205.SOLUTION SIMPLE(INFORMATION TECHNOLOGY) 260,918. 30,158. 183,480.T. ROWE PRICE ASSOCIATESINC. (INVESTMENTMANAGEMENT) 313,559. 313,559. 0.WILSHIRE ASSOCIATESINCORPORATED (INVESTMENTADVISORY) 416,871. 416,871. 0.

STATEMENT(S) 6142 11020115 756359 1622860.000 2019.05020 THE LEONA M. AND HARRY B. 16228601


}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}TO FORM 990-PF, PG 1, LN 16C 9,344,869. 6,611,813. 2,829,060. ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 7FORM 990-PF TAXES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} (A) (B) (C) (D) EXPENSES NET INVEST- ADJUSTED CHARITABLEDESCRIPTION PER BOOKS MENT INCOME NET INCOME PURPOSES}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}FEDERAL EXCISE TAXES 12,747,737. 0. 0.STATE UNRELATED BUSINESSINCOME TAX 202,371. 0. 0.FOREIGN TAXES WITHHELD 1,044,726. 2,780,468. 0.FEDERAL UBIT 100,000. 0. 0.

}}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}TO FORM 990-PF, PG 1, LN 18 14,094,834. 2,780,468. 0. ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 8FORM 990-PF OTHER EXPENSES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} (A) (B) (C) (D) EXPENSES NET INVEST- ADJUSTED CHARITABLEDESCRIPTION PER BOOKS MENT INCOME NET INCOME PURPOSES}}}}}}}}}}} }}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}INSURANCE 203,365. 23,179. 208,771.INFORMATIONTECHNOLOGY/COMPUTERS 1,267,466. 212,126. 1,253,323.CUSTODY, BANK, & PERFORMANCEREPORTING FEES 918,804. 659,210. 337,719.OFFICE EXPENSES 626,369. 309,171. 393,117.AMERICAN DEPOSITARY RECEIPTFEE 7,943. 7,943. 0.PORTFOLIO DEDUCTIONS 13,208,488. 48,169,164. 0.CONSULTING REIMBURSEMENTS 241,417. 0. 138,029.TEMPORARY OFFICE HELP 21,282. 0. 12,182.FILING FEES AND PENALTIES 11,397. 0. 1,500.

}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}} }}}}}}}}}}}TO FORM 990-PF, PG 1, LN 23 16,506,531. 49,380,793. 2,344,641. ~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~~ ~~~~~~~~~~~



~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 9FORM 990-PF CORPORATE STOCK

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

FAIR MARKETDESCRIPTION BOOK VALUE VALUE}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}CORPORATE STOCK (SEE ATTACHMENT A-1 PAGE 3 OF 3) 524,476,973. 524,476,973.

}}}}}}}}}}}}}} }}}}}}}}}}}}}}TOTAL TO FORM 990-PF, PART II, LINE 10B 524,476,973. 524,476,973. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 10FORM 990-PF OTHER INVESTMENTS

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} VALUATION FAIR MARKETDESCRIPTION METHOD BOOK VALUE VALUE}}}}}}}}}}} }}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}FIXED INCOME FUNDS (SEE ATTACHMENTA-2)

FMV1,187,170,838. 1,187,170,838.

HEDGE FUNDS (SEE ATTACHMENT A-3) FMV 659,789,017. 659,789,017.OTHER EQUITIES (SEE ATTACHMENT A-1PAGE 3 OF 3)

FMV272,543,213. 272,543,213.

COMMINGLED FUNDS (SEE ATTACHMENTA-4)

FMV859,974,805. 859,974,805.

PRIVATE CAPITAL (SEE ATTACHMENTA-5, PAGE 3 OF 3)

FMV2,237,868,592. 2,237,868,592.

}}}}}}}}}}}}}} }}}}}}}}}}}}}}TOTAL TO FORM 990-PF, PART II, LINE 13 5,217,346,465. 5,217,346,465. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 11FORM 990-PF DEPRECIATION OF ASSETS NOT HELD FOR INVESTMENT

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} COST OR ACCUMULATEDDESCRIPTION OTHER BASIS DEPRECIATION BOOK VALUE}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}FURNITURE, FIXTURES ANDEQUIPMENT 1,566,363. 1,523,836. 42,527.LEASEHOLD IMPROVEMENTS 1,480,123. 497,072. 983,051.

}}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}TOTAL TO FM 990-PF, PART II, LN 14 3,046,486. 2,020,908. 1,025,578. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~



~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 12FORM 990-PF OTHER ASSETS

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

BEGINNING OF END OF YEAR FAIR MARKETDESCRIPTION YR BOOK VALUE BOOK VALUE VALUE}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}ACCRUED INCOME RECEIVABLE 1,763,478. 2,164,139. 2,164,139.DUE FROM BROKER 34,543,360. 61,104,240. 61,104,240.RETIREMENT PLAN ASSET 1,091,899. 1,107,431. 1,107,431.ADVANCES AND OTHER RECEIVABLES 35,152. 28,748. 28,748.PREPAID FEDERAL EXCISE TAX 183,128. 2,785,391. 2,785,391.PROGRAM RELATED INVESTMENTS 8,670,700. 12,430,200. 12,430,200.DEFERRED RENTAL INCOME 11,281. 8,721. 8,721.ACCOUNTS RECEIVABLE OTHER - GRANTRECOVERY 4,752. 19,835. 19,835.ACCRUED INTEREST RECEIVABLE - PRIDEBT 2,932. 11,655. 11,655.

}}}}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}TO FORM 990-PF, PART II, LINE 15 46,306,682. 79,660,360. 79,660,360. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 13FORM 990-PF OTHER LIABILITIES

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} DESCRIPTION BOY AMOUNT EOY AMOUNT}}}}}}}}}}} }}}}}}}}}}}}}} }}}}}}}}}}}}}}DEFERRED FEDERAL EXCISE TAX 34,830,866. 23,452,152.RETIREMENT PLAN LIABILITY 1,685,991. 1,754,039.ACCRUED VACATION 507,476. 612,911.DEFERRED RENT EXPENSE 932,569. 946,933.REFUNDABLE DEPOSITS 315. 317.

}}}}}}}}}}}}}} }}}}}}}}}}}}}}TOTAL TO FORM 990-PF, PART II, LINE 22 37,957,217. 26,766,352. ~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~

STATEMENT(S) 12, 13145 11020115 756359 1622860.000 2019.05020 THE LEONA M. AND HARRY B. 16228601


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 14FORM 990-PF NAME OF FOREIGN COUNTRY IN WHICH

ORGANIZATION HAS FINANCIAL INTEREST}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF COUNTRY}}}}}}}}}}}}}}}AUSTRALIAAUSTRIABELGIUMBRAZILCANADACHILECHINACOLOMBIACZECH REPUBLICDENMARKFINLANDFRANCEGERMANYGREECEHONG KONGINDIAINDONESIAISRAELITALYJAPANMALAYSIAMEXICONETHERLANDSNEW ZEALANDNORWAYPHILIPPINESPOLANDPORTUGALQATARRUSSIASINGAPOREKOREA (SOUTH)SPAINSWEDENSWITZERLANDTAIWANTHAILANDUNITED ARAB EMIRATESUNITED KINGDOM



~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 15FORM 990-PF TRANSFERS TO CONTROLLED ENTITIES

PART VII-A, LINE 11}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANYFEEDER, L.P.

98-1142649

ADDRESS}}}}}}}2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104

DESCRIPTION OF TRANSFER}}}}}}}}}}}}}}}}}}}}}}}MANAGEMENT FEES

AMOUNT OF TRANSFER }}}}}}}}}}}}}}

323,875.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}LACM WORLD SMALL CAP EQUITY FUND, L.P. 83-2888004

ADDRESS}}}}}}}11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025

DESCRIPTION OF TRANSFER}}}}}}}}}}}}}}}}}}}}}}}CONTRIBUTION OF CAPITAL


30,000,000.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}


NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}MARATHON GLOBAL 61-1915057

ADDRESS}}}}}}}ORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UNITED KINGDOM



100,000,000.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}MHR LONGEVITY PARTNERS 98-1471155

ADDRESS}}}}}}}1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105



27,200,000.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}PITANGO SPV 98-1492234

ADDRESS}}}}}}}BEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAEL



7,610,000.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}

STATEMENT(S) 15

THE LEONA M. AND HARRY B. HELMSLEY CHARI 13-7184401}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}



TOTAL AMOUNT OF TRANSFERS TO CONTROLLED ENTITIES 165,133,875. ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 16FORM 990-PF TRANSFERS FROM CONTROLLED ENTITIES

PART VII-A, LINE 11}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANYFEEDER, L.P.

98-1142649

ADDRESS}}}}}}}2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104 DESCRIPTION OF TRANSFER}}}}}}}}}}}}}}}}}}}}}}}RETURN OF CAPITAL: $48,514,307; INCOME: $10,382,879 AMOUNT OF TRANSFER }}}}}}}}}}}}}}

58,897,186.}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}

TOTAL AMOUNT OF TRANSFERS FROM CONTROLLED ENTITIES 58,897,186. ~~~~~~~~~~~~~~

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 17FORM 990-PF SCHEDULE OF CONTROLLED ENTITIES

PART VII-A, LINE 11}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}ESTATE OF LEONA M. HELMSLEY 20-7535047

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}230 PARK AVENUE, SUITE 659NEW YORK, NY 10169

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}HELMSLEY ENTERPRISES, INC. 13-2665914

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}230 PARK AVENUE, SUITE 659NEW YORK, NY 10169

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}


NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}NEWMARKET INTERNATIONAL INFRASTRUCTURE FINANCE COMPANYFEEDER, L.P.

98-1142649

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}2929 ARCH STREET 17TH FLOORPHILADELPHIA, PA 19104

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}LACM GLOBAL EQUITY FUND, LP 45-3646231

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}LACM WORLD SMALL CAP EQUITY FUND, L.P. 83-2888004

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}11150 SANTA MONICA BLVD., STE. 200LOS ANGELES, CA 90025

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}MARATHON GLOBAL 61-1915057

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}ORION HOUSE, 5 UPPER ST. MARTIN'S LANELONDON, UNITED KINGDOM

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}MHR LONGEVITY PARTNERS 98-1471155

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}1345 AVENUE OF THE AMERICAS 42ND FLOORNEW YORK, NY 10105

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

STATEMENT(S) 17



NAME OF CONTROLLED ENTITY EMPLOYER ID NO}}}}}}}}}}}}}}}}}}}}}}}}}} }}}}}}}}}}}}}}PITANGO SPV 98-1492234

ADDRESS EXCESS BUSINESS HOLDING [ ] YES [ ] NOX}}}}}}}BEIT ACKERSHTEIN - BLDG. B, 11 HAMENOFIM ST. 11TH FL.HERZLIYA, ISRAEL

}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}




~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 18FORM 990-PF PART VIII - LIST OF OFFICERS, DIRECTORS

TRUSTEES AND FOUNDATION MANAGERS}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

EMPLOYEETITLE AND COMPEN- BEN PLAN EXPENSE

NAME AND ADDRESS AVRG HRS/WK SATION CONTRIB ACCOUNT}}}}}}}}}}}}}}}} }}}}}}}}}}}}} }}}}}}}}}}} }}}}}}}} }}}}}}}}SANDOR FRANKEL TRUSTEEC/O TRUST, 230 PARK AVENUE 20-25 125,000. 0. 0.NEW YORK, NY 10169

DAVID PANZIRER TRUSTEEC/O TRUST, 230 PARK AVENUE 35.00 125,000. 0. 0.NEW YORK, NY 10169

WALTER PANZIRER TRUSTEEC/O TRUST, 230 PARK AVENUE 32.00 125,000. 0. 0.NEW YORK, NY 10169

STEPHANIE A. CUSKLEY CHIEF EXECUTIVE OFFICERC/O TRUST, 230 PARK AVENUE 40.00 919,370. 177,540. 0.NEW YORK, NY 10169

ROSALIND M. HEWSENIAN CHIEF INVESTMENT OFFICERC/O TRUST, 230 PARK AVENUE 40.00 1,726,236. 221,186. 0.NEW YORK, NY 10169

SARAH E. PAUL GENERAL COUNSELC/O TRUST, 230 PARK AVENUE 40.00 549,122. 129,235. 0.NEW YORK, NY 10169

NICHOLAS J. SCHIAVO CHIEF FINANCIAL OFFICERC/O TRUST, 230 PARK AVENUE 40.00 349,007. 102,038. 0.NEW YORK, NY 10169

}}}}}}}}}}} }}}}}}}} }}}}}}}}TOTALS INCLUDED ON 990-PF, PAGE 6, PART VIII 3,918,735. 629,999. 0.

~~~~~~~~~~~ ~~~~~~~~ ~~~~~~~~


ALL REPORTED COMPENSATION AMOUNTS INCLUDE "SALARY, FEES, BONUSES AND SEVERNCE PAYMENTS RECEIVED BY EACH PERSON LISTED," AS WELL AS CURRENT YEAR PAYMENTS OF AMOUNTS REPORTED OR REPORTABLE AS DEFERRED COMPENSATION IN CURRENT OR PRIOR YEARS.

*

*


~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 19FORM 990-PF EXPENDITURE RESPONSIBILITY STATEMENT

PART VII-B, LINE 5C}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

GRANTEE'S NAME}}}}}}}}}}}}}}A GLIMMER OF HOPE FOUNDATION

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}3600 N CAPITAL OF TEXAS HWY, BLDG B, SUITE 330AUSTIN, TX 78746

GRANT AMOUNT DATE OF GRANT AMOUNT EXPENDED}}}}}}}}}}}}}}} }}}}}}}}}}}}} }}}}}}}}}}}}}}}

7,923,870. 09/09/19 110,044.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}INTEGRATED COMMUNITY DEVELOPMENT IN ODA BULTUM, ETHIOPIA

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}1/2020, 7/2020

ANY DIVERSION BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}NONE


GRANTEE'S NAME}}}}}}}}}}}}}}A GLIMMER OF HOPE FOUNDATION

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}3600 N CAPITAL OF TEXAS HWY, BLDG B, SUITE 330AUSTIN, TX 78746


5,000,000. 02/20/18 3,890,502.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}INTEGRATED COMMUNITY DEVELOPMENT IN AMHARA, ETHIOPIA



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}AKSTON BIOSCIENCES CORPORATION

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}100 CUMMINGS CENTER, SUITE 454CBEVERLY, MA 01915


6,194,000. 03/01/17 4,559,899.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}PRECLINICAL TRIAL OF INSULIN-FUSION TO END AUTOIMMUNITY & IMPROVE T1D

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}9/2017, 3/2018, 5/2018, 7/2018, 10/2018, 1/2019, 4/2019, 8/2019, 10/2019,3/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}ALIMENTIV INC. (FKA ROBARTS)

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}100 DUNDAS STREETLONDON, ON, CANADA, N6A5B6


3,390,428. 11/20/18 671,491.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}1/2019, 8/2019, 12/2019, 1/2020, 6/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}AMERICAN ASSOCIATION OF DIABETES EDUCATORS, INC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}125 S WACKER DRIVE, SUITE 600CHICAGO, IL 60606


2,679,637. 07/11/18 1,143,294.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCED NETWORK ACCESS

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}2/2019, 8/2019, 1/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}ASITY MADAGASCAR

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}LOT IAB 39 TER C ANALAMHINTSYANTANANARIVO, MADAGASCAR, 101


284,790. 03/01/17 279,290.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}IMPLEMENT SUSTAINABLE MANAGEMENT STRATEGIES FOR WETLAND CONSERVATION



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}ASSOCIATION VAHATRA

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}BP 3972ANTANANARIVO, MADAGASCAR, 101


421,097. 11/17/16 421,097.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DEVELOPMENT OF SCIENTIFIC CAPACITY FOR MALAGASY CONSERVATION BIOLOGISTS

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}1/2018, 1/2019, 1/2020, 7/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}LEVEL 2, 55 VICTORIA PARADEFITZROY, AUSTRALIA, 3065


2,309,216. 07/23/20 0.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE: THE MIRO STUDY

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}PENDING


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}AUSTRALASIAN GASTRO INTESTINAL RESEARCH FOUNDATION LTD.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}LEVEL 2, 55 VICTORIA PARADEFITZROY, AUSTRALIA, 3065


3,719,569. 02/15/17 3,137,324.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}THE ENIGMA STUDIES - EASTERN INFLAMMATORY BOWEL DISEASE GUT MICROBIOTA

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}3/2018, 5/2018, 7/2018, 9/2018, 3/2019, 7/2019, 11/2019, 1/2020, 4/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}BIORASIS, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}1392 STORRS RD U4213, ATL ROOM 106STORRS, CT 06269


3,016,000. 02/06/18 828,500.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}EARLY FEASIBILITY STUDIES OF THE GLUCOWIZZARD

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}12/2018, 1/2019, 7/2019, 9/2019, 2/2020, 5/2020, 8/2020


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}CELL AND MOLECULAR TISSUE ENGINEERING LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}14 HIGHWOOD DRIVEAVON, CT 06001


996,000. 12/03/12 996,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}TO DEVELOP AND VALIDATE COATINGS TO EXTEND CGM SENSOR & IMPROVE T1D CARE



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}DIABETOMICS, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}2345 NE OVERLOOK DRIVE, SUITE #140HILLSBORO, OR 97006


4,031,900. 01/11/18 2,936,143.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}POINT-OF-CARE RAPID TESTS FOR TID SCREENING AND INTERVENTION



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}DREAMED DIABETES LTD.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}5 MOTA GUR ST.PETAH TIKVA, ISRAEL, 4952701


3,585,828. 02/01/16 3,546,253.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}MD-LOGIC PUMP GUIDE4U - ADVISORY SYSTEM TO IMPROVE CARE OF T1D

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}10/2016, 1/2017, 7/2017, 9/2017, 2/2018, 6/2018, 9/2018, 12/2019


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}DURRELL WILDLIFE CONSERVATION TRUST

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}LES AUGRES MANOR, TRINITYJERSEY, UNITED KINGDOM, JE3 5BP


283,560. 03/16/17 283,560.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DEVELOPMENT & SUSTAINABILITY OF CONSERVATION ZONES IN MADAGASCAR



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}FEROX THERAPEUTICS

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}111 TOWN SQUARE PLACE, SUITE 1203 PMB 1034JERSEY CITY, NJ 07310


872,300. 11/20/18 793,185.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}INSULIN INDUCED HYPOGLYCEMIA PREVENTION PROGRAM



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}GARVAN INSTITUTE OF MEDICAL RESEARCH

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}384 VICTORIA STREETDARLINGHURST, AUSTRALIA, 2010


122,300. 01/19/16 122,300.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DE NOVO MUTATIONS AS DRIVERS OF TYPE 1 DIABETES



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}GCF GROUP LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}4805 N. ILLINOIS ST.INDIANAPOLIS, IN 46208


389,000. 12/08/14 389,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}IMPROVING EMERGENCY FOOD ASSISTANCE IN NYC



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}HERLEV GENTOFTE HOSPITAL, REGION HOVEDSTADEN

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}KILDEGARDSVEJ 28, STAIRWELL 7, 3RD FLOORHELLERUP, DENMARK, 2900


430,309. 10/05/17 430,309.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}PREVENTING HYPOGLYCEMIA IN TYPE 1 DIABETES WITH THE HORMONE GIP

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}10/2019


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}INTEGRATED BIOBANK OF LUXEMBOURG ("IBBL") LUXEMBOURG

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}1, RUE LOUIS RECHDUDELANGE, LUXEMBOURG, L-3555


500,817. 12/19/17 67,666.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL TO IMPROVE T1D CARE



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}JDRF INTERNATIONAL

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}200 VESEY STREET, 28TH FLOORNEW YORK, NY 10281


8,200,000. 05/21/12 8,200,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}ORTHOGONALLY REDUNDANT GLUCOSE SENSOR TO IMPROVE CARE OF T1D



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}LATITUDE PHARMACEUTICALS, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}9675 BUSINESSPARK AVENUESAN DIEGO, CA 92131


694,220. 12/03/12 694,220.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}STABILIZED GLUCAGON FORMULATIONS TO IMPROVE CARE OF T1D



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}MEDIZINISCHE HOCHSCHULE HANNOVER

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}CARL NEUBERG STREET 1HANNOVER, GERMANY, 30625


420,804. 12/19/17 274,410.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}CREATING T1D-SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR REGULATORY T-CELLS



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}NEWS DEEPLY, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}115 5TH AVENUENEW YORK, NY 10003


79,775. 05/15/19 79,775.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}A STRATEGIC ROADMAP FOR COMMUNITY CREATION OF 'CROHN'S DISEASE DEEPLY'



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}NURU INTERNATIONAL

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}2020 PENNSYLVANIA AVE NWWASHINGTON, DC 20006


4,680,506. 11/25/13 4,680,506.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}CREATING A SELF-SUSTAINING, SCALING, AGRICULTURE-BASED DEVELOPMENT MODEL



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}PACIFIC DIABETES TECHNOLOGIES

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}12154 SW GARDEN PLACEPORTLAND, OR 97223


2,867,072. 09/08/14 2,867,072.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DUAL USE CATHETER FOR INSULIN DELIVERY & SENSING TO IMPROVE CARE OF T1D



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}PACIFIC DIABETES TECHNOLOGIES

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}12154 SW GARDEN PLACEPORTLAND, OR 97223


999,800. 12/03/12 999,800.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}GLUCOSE SENSING & HORMONE DELIVERY CATHETER FOR ARTIFICIAL PANCREAS



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}REDSTONE STRATEGY GROUP, LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}3223 ARAPAHOE AVENUE, SUITE 210BOULDER, CO 80303


650,000. 12/08/14 650,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}IMPROVING EMERGENCY FOOD ASSISTANCE IN NYC



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}REDSTONE STRATEGY GROUP, LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}3223 ARAPAHOE AVENUE, SUITE 210BOULDER, CO 80303


1,425,000. 10/07/14 1,425,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}IMPROVE THE STRATEGIC CAPACITY FOR EDUCATION INITIATIVES



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}THABYAY EDUCATION FOUNDATION

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}NO. 9 KAN STREET, QUARTER 10, HLAING TOWNSHIPYANGON, BURMA, 100110


840,516. 02/15/17 840,516.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}EMPOWERING MYANMAR CONSERVATION EFFORTS



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}THE ACHIEVEMENT NETWORK LTD

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}ONE BEACON STREETBOSTON, MA 02108


1,875,000. 09/09/15 1,875,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}SUPPORTING AMERICA'S EDUCATORS IN THE ERA OF HIGHER STANDARDS



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}THE DANIELSON GROUP, LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}1720 W. DIVISION STREETCHICAGO, IL 60622


451,400. 09/28/15 451,400.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}FRAMEWORK FOR TEACHING CLUSTERS REFINEMENT IN EDUCATION



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}THE LEGATUM INSTITUTE FOUNDATION

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}11 CHARLES STREETLONDON, UNITED KINGDOM, W1J 5DW


1,013,551. 12/04/17 679,752.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}UNITED STATES PROSPERITY INDEX



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}THERANOVA, LLC

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}101 MISSISSIPPI STREETSAN FRANCISCO, CA 94107


937,000. 06/03/13 937,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}STUDY OF GLUCOSE KINETICS IN THE PERITONEAL CAVITY TO IMPROVE T1D CARE

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}2/2014, 11/2014, 1/2015, 6/2015, 10/2015,11/2015


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}XERIS PHARMACEUTICALS, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}180 NORTH LASALLE STREET, SUITE 1600CHICAGO, IL 60601


1,004,475. 05/27/15 1,004,475.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DEVELOPMENT OF A STABLE LIQUID GLUCAGON TO IMPROVE T1D CARE



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}XERIS PHARMACEUTICALS, INC.

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}180 NORTH LASALLE STREET, SUITE 1600CHICAGO, IL 60601


421,600. 02/19/14 421,600.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}RAPID ACTING INSULIN FORMULATIONS FOR TREATMENT OF DIABETES

DATES OF REPORTS BY GRANTEE}}}}}}}}}}}}}}}}}}}}}}}}}}}7/2014, 8/2014, 3/2015, 7/2015, 9/2015, 5/2016


STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}ZEALAND PHARMA

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}SYDMARKEN 11SOBORG, DENMARK, 2860


1,833,000. 05/07/15 1,833,000.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}DEVELOPMENT OF A STABLE LIQUID GLUCAGON TO IMPROVE T1D CARE



STATEMENT(S) 19



GRANTEE'S NAME}}}}}}}}}}}}}}ZUCARA THERAPEUTICS

GRANTEE'S ADDRESS}}}}}}}}}}}}}}}}}1300-661 UNIVERSITY AVENUETORONTO, ON, CANADA, M5G 0B7


3,900,000. 02/06/18 3,349,989.

PURPOSE OF GRANT}}}}}}}}}}}}}}}}PRECLINICAL DEVELOPMENT OF ZT-01 TO PREVENT HYPOGLYCEMIA IN T1D






~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~STATEMENT 20990-PF INVOLVEMENT WITH NONCHARITABLE ORGANIZATIONS

PART XVII, LINE 1, COLUMN (D) }}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

NAME OF NONCHARITABLE EXEMPT ORGANIZATION}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}AMERICAN ASSOCIATION OF DIABETES EDUCATORS, INC.

DESCRIPTION OF TRANSFERS, TRANSACTIONS, AND SHARING ARRANGEMENTS}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}GRANT IN SUPPORT OF AADE TECHNOLOGY INSTITUTE: DANA - DIABETES ADVANCEDNETWORK ACCESS


Department of the TreasuryInternal Revenue Service

File by thedue date forfiling yourreturn. Seeinstructions.

923841 12-30-19

| File a separate application for each return.

| Go to www.irs.gov/Form8868 for the latest information.

Electronic filing (e-file).

Type or

print

Application

Is For

Return

Code

Application

Is For

Return

Code

1

2

3a

b

c

3a

3b

3c

$

$

$

Balance due.

Caution:

For Privacy Act and Paperwork Reduction Act Notice, see instructions. 8868

www.irs.gov/e-file-providers/e-file-for-charities-and-non-profits.

Form

(Rev. January 2020)OMB No. 1545-0047

You can electronically file Form 8868 to request a 6-month automatic extension of time to file any of the

forms listed below with the exception of Form 8870, Information Return for Transfers Associated With Certain Personal Benefit

Contracts, for which an extension request must be sent to the IRS in paper format (see instructions). For more details on the electronic

filing of this form, visit

All corporations required to file an income tax return other than Form 990-T (including 1120-C filers), partnerships, REMICs, and trusts

must use Form 7004 to request an extension of time to file income tax returns.

Name of exempt organization or other filer, see instructions. Taxpayer identification number (TIN)

Number, street, and room or suite no. If a P.O. box, see instructions.

City, town or post office, state, and ZIP code. For a foreign address, see instructions.

Enter the Return Code for the return that this application is for (file a separate application for each return) ��

Form 990 or Form 990-EZ

Form 990-BL

Form 4720 (individual)

Form 990-PF

01

02

03

04

05

06

Form 990-T (corporation) 07

08

09

10

11

12

Form 1041-A

Form 4720 (other than individual)

Form 5227

Form 6069

Form 8870

Form 990-T (sec. 401(a) or 408(a) trust)

Form 990-T (trust other than above)

¥ The books are in the care of |

Telephone No. | Fax No. |

¥ If the organization does not have an office or place of business in the United States, check this box ~~~~~~~~~~~~~~~~~ |

¥ If this is for a Group Return, enter the organization's four digit Group Exemption Number (GEN) . If this is for the whole group, check this

box . If it is for part of the group, check this box and attach a list with the names and TINs of all members the extension is for.| |

I request an automatic 6-month extension of time until , to file the exempt organization return for

the organization named above. The extension is for the organization's return for:

|

|

calendar year or

tax year beginning , and ending .

If the tax year entered in line 1 is for less than 12 months, check reason: Initial return Final return

Change in accounting period

If this application is for Forms 990-BL, 990-PF, 990-T, 4720, or 6069, enter the tentative tax, less

any nonrefundable credits. See instructions.

If this application is for Forms 990-PF, 990-T, 4720, or 6069, enter any refundable credits and

estimated tax payments made. Include any prior year overpayment allowed as a credit.

Subtract line 3b from line 3a. Include your payment with this form, if required, by

using EFTPS (Electronic Federal Tax Payment System). See instructions.

If you are going to make an electronic funds withdrawal (direct debit) with this Form 8868, see Form 8453-EO and Form 8879-EO for paymentinstructions.

LHA Form (Rev. 1-2020)

Automatic 6-Month Extension of Time. Only submit original (no copies needed).

8868 Application for Automatic Extension of Time To File anExempt Organization Return

THE LEONA M. AND HARRY B. HELMSLEYCHARITABLE TRUST

NICHOLAS J. SCHIAVO, CFO

X

21,050,139.

19,050,139.

2,000,000.

212-679-3600

230 PARK AVENUE, NO. 659

NEW YORK, NY 10169

13-7184401

FEBRUARY 16, 2021

APR 1, 2019 MAR 31, 2020

230 PARK AVENUE, SUITE 659 - NEW YORK, NY 10169

0 4


The Leona M. and Harry B. Helmsley Charitable TrustEIN: 13-7184401March 31, 2020

Description Shares Amount Corporate Stock

SCHLUMBERGER LTD 187,935 2,535,243 ACCENTURE PLC 30,907 5,045,877 EATON CORP PLC 80,463 6,251,170 KONINKLIJKE PHILIPS NV 148,045 5,945,487 CHUBB LTD 65,582 7,324,854 NESTLE SA 61,264 6,297,020 TE CONNECTIVITY LTD 65,775 4,142,510 SMITH & NEPHEW PLC 176,880 6,344,686 UNILEVER PLC 141,010 7,130,876 BERKSHIRE HATHAWAY INC 81,241 14,853,292 BOOKING HOLDINGS INC 5,874 7,902,410 CHARLES SCHWAB CORP/THE 198,580 6,676,260 COMCAST CORP 185,510 6,377,834 DOLLAR GENERAL CORP 63,211 9,545,493 DOLLAR TREE INC 88,185 6,478,952 EMERSON ELECTRIC CO 46,290 2,205,719 EXPEDITORS INTERNATIONAL OF WA 92,700 6,184,944 HD SUPPLY HOLDINGS INC 158,515 4,506,581 HONEYWELL INTERNATIONAL INC 65,785 8,801,375 JPMORGAN CHASE & CO 75,447 6,792,493 MASCO CORP 245,570 8,489,355 NORTHERN TRUST CORP 84,134 6,348,752 OMNICOM GROUP INC 114,880 6,306,912 PACCAR INC 91,260 5,578,724 PEPSICO INC 51,147 6,142,755 PPG INDUSTRIES INC 60,007 5,016,585 QUEST DIAGNOSTICS INC 107,478 8,630,483 SOUTHWEST AIRLINES CO 130,635 4,651,912 TJX COS INC/THE 144,220 6,895,158 UNITEDHEALTH GROUP INC 49,786 12,415,633

EQUITIES

FMI (SMA Manager) Multiple Equities

ATTACHMENT A-1PAGE 1 OF 3


Description Shares Amount

EQUITIES

WASTE CONNECTIONS INC 59,467 4,608,693 ATLASSIAN CORP PLC 4,851 665,848 ALPHABET INC-CL C 4,559 5,301,251 AMAZON.COM INC 2,763 5,387,076 AMERICAN TOWER CORP 14,368 3,128,632 ANSYS INC 19,818 4,607,090 BIO-TECHNE CORP 20,584 3,903,138 BLACK KNIGHT INC 54,847 3,184,417 BLACKLINE INC 66,822 3,515,505 BROOKS AUTOMATION INC 61,097 1,863,459 CABLE ONE INC 1,031 1,694,974 CARMAX INC 42,551 2,290,520 CBRE GROUP INC 111,169 4,192,183 COSTAR GROUP INC 3,157 1,853,822 DANAHER CORP 32,743 4,531,959 DOLLAR GENERAL CORP 10,819 1,633,777 ECOLAB INC 26,484 4,127,002 ENVESTNET INC 24,621 1,324,117 FASTENAL CO 97,122 3,035,063 HEICO CORP 29,628 1,893,229 ILLUMINA INC 17,816 4,865,906 INTUITIVE SURGICAL INC 10,556 5,227,437 MARKEL CORP 6,094 5,654,562 MASTERCARD INC 22,053 5,327,123 MOODY'S CORP 12,174 2,574,801 OKTA INC 14,782 1,807,247 PROS HOLDINGS INC 85,891 2,665,198 QUALYS INC 25,144 2,187,277 ROPER TECHNOLOGIES INC 13,677 4,264,625 S&P GLOBAL INC 21,758 5,331,798 SBA COMMUNICATIONS CORP 11,882 3,207,784 TELEFLEX INC 12,178 3,566,449 THERMO FISHER SCIENTIFIC INC 16,717 4,740,941 TRANSDIGM GROUP INC 11,355 3,635,757 TWILIO INC 8,289 741,783 TYLER TECHNOLOGIES INC 7,504 2,225,386 VEEVA SYSTEMS INC 4,006 626,418 VERISK ANALYTICS INC 19,295 2,689,337 VISA INC 50,674 8,164,595 VULCAN MATERIALS CO 45,312 4,896,868

DF Dent (SMA Manager) Multiple Equities



Description Shares Amount

EQUITIES

ACCENTURE PLC 53 8,653 ACCENTURE PLC 19,456 3,176,387 JAPAN TOBACCO INC 169,032 3,125,264 KIRIN HOLDINGS CO LTD 328,030 6,494,967 NINTENDO CO LTD 27,700 10,676,643 ALCON INC 85,738 4,371,304 CIE FINANCIERE RICHEMONT SA 120,085 6,585,407 NESTLE SA 55,901 5,745,806 NOVARTIS AG 103,225 8,518,956 BRITISH AMERICAN TOBACCO PLC 255,538 8,742,011 IMPERIAL BRANDS PLC 155,923 2,893,864 INFORMA PLC 533,524 2,927,990 RECKITT BENCKISER GROUP PLC 73,736 5,622,881 ALPHABET INC-CL A 2,571 2,987,373 ALTRIA GROUP INC 100,329 3,879,722 APPLE INC 22,756 5,786,623 AUTODESK INC 2,846 444,261 BOOKING HOLDINGS INC 4,669 6,281,299 BRISTOL-MYERS SQUIBB CO 113,622 6,333,290 CORTEVA INC 201,231 4,728,929 EBAY INC 85,851 2,580,681 ELECTRONIC ARTS INC 54,345 5,443,739 EQUIFAX INC 20,706 2,473,332 FACEBOOK INC 19,239 3,209,065 FOX CORP 288,549 6,818,413 INTERNATIONAL BUSINESS MACHINE 41,707 4,626,558 JOHNSON & JOHNSON 65,094 8,535,776 MICROSOFT CORP 40,282 6,352,874 MOLSON COORS BEVERAGE CO 67,448 2,631,146 NEWS CORP 375,335 3,368,632 NEWS CORP 114,285 1,027,422 ORACLE CORP 93,061 4,497,638 PHILIP MORRIS INTERNATIONAL IN 62,240 4,541,030 S&P GLOBAL INC 13,917 3,410,361 WESTERN UNION CO/THE 247,570 4,488,444

Individual EquitiesCROWDSTRIKE HOLDINGS INC 51,433 2,863,789 FACEBOOK INC 41,325 6,893,010 GUARDANT HEALTH INC 28,705 1,997,868 HEALTH CATALYST INC 2,755 72,043 LYFT INC 30,397 816,159 OKTA INC 10,800 1,320,408 PAGERDUTY INC 172,940 2,988,403 PINTEREST INC 31,336 483,828 SLACK TECHNOLOGIES INC 176,689 4,742,333

524,476,973

Other Equities

JP MORGAN US LARGE CAP CORE PLUSJP MORGAN US LARGE CAP CORE PLUS 111,875,009

SPDR S&P 500 ETF TRUSTSPDR S&P 500 ETF TRUST 160,668,205

Total Other Equities 272,543,213

Total Equities 797,020,186

IFP (SMA Manager) Multiple Equities

Total Corporate Stock



Description Amount

JPM CORE BOND OPEN 791,754,718 JPM SHORT DURATION BOND 395,416,120

TOTAL FIXED INCOME 1,187,170,838

FIXED INCOME FUNDS

ATTACHMENT A-2


Description Amount

BRILLIANT PARTNERS 83,855,339 CAMBER CAPITAL OFFSHORE FUND LTD. 102,623,383 CHATHAM 87,064,617 CHATHAM OFFSHORE 86,834,306 GOLDENTREE OFFSHORE LTD 5,233,849 JERICHO 162,539,559 SEQUOIA CAP GLOBAL 131,637,964

TOTAL HEDGE FUNDS 659,789,017

HEDGE FUNDS

ATTACHMENT A-3


Descripti Amount

ACADIAN FRONTIER 81,749,466 BLACKROCK US DEBT 213,515,711 HIGHCLERE INTL SC 104,111,401 HIGHCLERE INTL SMID 98,857,514 LA CAPITAL GLOBAL 151,058,322 LACM WORLD SMALL CAP 37,263,421 MARATHON GLOBAL 137,173,953 SILCHESTER INTL 36,245,017

TOTAL COMMINGLED FUNDS 859,974,805

COMMINGLED FUNDS

ATTACHMENT A-4


Description Amount

Private EquityACCEL GROWTH FUND IV 18,421,984 ACCEL GROWTH FUND V 7,377,506 ACCEL GROWTH III 16,091,811 ACCEL INDIA V 5,101,579 ACCEL INDIA VI 639,043 ACCEL LEADERS FUND 8,002,134 ACCEL LEADERS II 3,313,775 ACCEL XII 11,070,329 ACCEL XIII 5,423,441 ACCEL XIV 1,796,062 ACCEL GROWTH II 16,392,079 ACCEL XI 8,555,051 AH BIO FUND I 5,282,228 AH BIO FUND II LP 7,707,694 AH BIO III 1,152,644 AH III 19,024,153 AH III PARALLEL 8,048,628 AH IV 23,858,217 AH IV PARALLEL 12,699,155 AH LSV I 8,313,133 AH V 15,923,163 AH V PARALLEL 9,147,594 AH VI 3,281,791 ANGELENO INV III 13,868,224 ARBORETUM IV 20,838,261 ARBORETUM V 1,366,139 ARBORETUM III 14,909,866 COLLER VI 11,019,799 COLLER VII 47,495,995 COLLER VIII 581,785 CRESTVIEW ELO 4,409,111 CRESTVIEW IV 10,210 CRESTVIEW III 22,652,117 EIG ENERGY XVII 6,330,779 EMERGENCE V 6,271,881 EMERGENCE III 209,857,345 EMERGENCE IV 27,452,891 EPIRIS II 6,617,040 FORTISSIMO 18,912,171 FRAZIER IX 10,870,180 FRAZIER X 1,798,155 GAVEA IV 1,325,283 GAVEA V 6,422,196 GAVEA V PLUS 3,827,538 GENERL ATLANTIC 2013 91,338,668 GENERL ATLANTIC 2018 52,770,218

PRIVATE CAPITAL



Description Amount

Private Equity

PRIVATE CAPITAL

GOLDEN GATE OPPS 165,665,636 HARBOUR ENERGY 145,597,181 HIG BIOVENTURES II 27,716,289 HIG BRAZIL 3,874,947 HIG BRAZIL LATAM B 8,276,080 HIG BRAZIL LATAM C 8,276,080 HIG CAPITAL V 17,807,562 HIG GROWTH II 22,675,603 HIG GROWTH III 315,924 HIG MID MARKET II 18,646,838 HIG MID MARKET III 18,690 IDG CHINA CAP III 18,841,292 IDG CHINA VTR IV 29,359,417 IDG CHINA VTR V 17,028,264 IDG-ACCEL CHINA CAP 23,188,379 IDG-ACCEL CHINA GROWTH 31,524,789 IRON POINT IV 3,061,507 JPM PEG SECONDARY 4,516,499 JPM PEG SECONDARY III 6,479,979 JPM PEG SECONDARY II 9,769,143 MHR LONGEVITY PARTNERS 28,271,255 ORBIMED ASIA III 22,805,641 ORBIMED ISRAEL 8,351,126 ORBIMED ISRAEL II 12,892,130 ORBIMED PI VI 14,057,482 ORBIMED PI VII 9,972,254 PEP IV CORE 217,589 PEP IV SUPPL 145,870 PITANGO GROWTH 38,341,469 PITANGO HEALTHTECH I 2,117,323 PITANGO SPV 7,484,749 PITANGO VI, LP 29,640,964 PITANGO VTR VII 20,947,279 PITANGO VTR VIII 300,053 RIDGEWOOD III 19,581,731 S CAPITAL 5,563,522 SEQUOIA CHINA GR III 33,874,617 SEQUOIA CHINA GR IV 20,466,757 SEQUOIA CHINA GRTH V 12,720,349 SEQUOIA CHINA VTR IV 8,037,671 SEQUOIA CHINA VTR V 9,029,663 SEQUOIA CHINA VTR VI 5,311,852 SEQUOIA CHINA VTR VII 4,601,155 SEQUOIA GLB GROWTH 22,908,205 SEQUOIA GLB GRWTH II 29,948,738 SEQUOIA GLB GRWTH III 24,171,771



Description Amount

Private Equity

PRIVATE CAPITAL

SEQUOIA INDIA V 7,714,672 SEQUOIA INDIA VI 3,562,683 SEQUOIA ISRAEL V 5,309,995 SEQUOIA SCOUT III 614,607 SEQUOIA US GROWTH V 4,222,904 SEQUOIA US GRTH VIII 4,930,081 SEQUOIA US GRWTH VII 8,198,468 SEQUOIA US GWTH VI 5,500,655 SEQUOIA US VTR XIV 10,270,141 SEQUOIA US VTR XV 3,116,134 SEQUOIA US VTR XVI 1,257,890 STARWOOD X 38,753,881 STARWOOD XI 8,994,824 TAURUS RESOURCES II 23,151,422 WTI VLL IX 6,283,777 WTI VLL VII 10,194,200 WTI VLL VIII 20,438,390 YORK CO-INVEST 1 3,319,773

TOTAL PRIVATE EQUITY 1,917,804,857

Private Debt

BAYVIEW 48,771,079 EIG ENERGY XVI 47,542,795 EIG ENERGY XV 13,897,392 GSO CAPITAL SOLUTIONS III 2,291,641 GSO CAPITAL SOLS II 3,902,552 GSO CAPITAL SOLUTION 683,404 HIG BAYSIDE III 8,777,427 MARINER IIFC 40,327,283 MHR INST PARTNERS IV 31,510,511 ORBIMED ROYALTY II 13,073,448 YORK DISTRESSED III 48,544,277 YORK DISTRESSED IV 12,509,203 YORK EUROPEAN 10,395,007 YORK EUROPEAN II 37,837,716

TOTAL PRIVATE DEBT 320,063,735

TOTAL PRIVATE CAPITAL 2,237,868,592


Form 8992(December 2018)

Department of the Treasury Internal Revenue Service

U.S. Shareholder Calculation of Global Intangible Low-Taxed Income (GILTI)

▶ Go to www.irs.gov/Form8992 for instructions and the latest information.

OMB No. 1545-0123

Attachment Sequence No. 992

Name of person filing this return A Identifying number

Name of U.S. shareholder B Identifying number

Part I Net Controlled Foreign Corporation (CFC) Tested Income (see instructions)1 Sum of Pro Rata Share of Net Tested Income (total from Form 8992–Schedule A, line 1, column (e)) . 12 Sum of Pro Rata Share of Net Tested Loss (total from Form 8992–Schedule A, line 1, column (f)) . . 2 ( )

3 Net CFC Tested Income (combine line 1 and line 2) (if zero or negative, stop here) . . . . . . . 3Part II Calculation of Global Intangible Low-Taxed Income (GILTI)

1 Net CFC Tested Income (from Part I, line 3) . . . . . . . . . . . . . . . . . . . . 12a Pro Rata Share of QBAI multiplied by 10% (total from Form 8992–Schedule A,

line 1, column (g)) . . . . . . . . . . . . . . . . . . . . 2ab Specified Interest Expense (total from Form 8992–Schedule A, line 1,

column (i)) . . . . . . . . . . . . . . . . . . . . . . . 2bc Net Deemed Tangible Income Return (DTIR) (subtract line 2b from line 2a) (if zero or less, enter -0-

here) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2c3 GILTI (subtract line 2c from line 1) (see instructions) . . . . . . . . . . . . . . . . . 3

For Paperwork Reduction Act Notice, see separate instructions. Cat. No. 37816Y Form 8992 (12-2018)

The Leona M. and Harry B. Helmsley Charitable Trust 13-7184401


0

0

0

Form 8992 (12-2018) Page 2Schedule A Schedule A for U.S. Shareholder Calculation of Global Intangible Low-Taxed Income (GILTI)

Name of person filing this form A Identifying number

Name of U.S. shareholder B Identifying number

Calculations for Net Tested Income (see instructions)

GILTI Allocated to Tested Income CFCs

(see instructions)

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )

(a) Name of CFC

(b) EIN or

Reference ID

(c) Tested Income

(d) Tested Loss

(e) Pro Rata Share

of Tested Income

(f) Pro Rata Share of

(Tested Loss)

(g) Pro Rata Share

of Qualified Business Asset

Investment (QBAI) Multiplied

by 10% (0.10)

(h) Pro Rata

Share of Interest Expense

(i) Specified Interest

Expense

(j) GILTI

Allocation Ratio

(Divide Col. (e)

by Col. (e), Line 1 Total)

(k) GILTI Allocated to

Tested Income CFCs (Multiply

Form 8992, Part II, Line 3,

by Col. (j))

1. Totals (see instructions) . . . . . . . ( ) ( ) Totals on line 1 should include the totals from any continuation sheets.

Form 8992 (12-2018)



Taurus Resources Fund No.2 Ltd 98-0650506 0

Jericho Capital International Jerichocap 0

International Infrastructure F 98-1142649 0

0

990-PF - Helmsley Charitable Trust

Documents

Transcript of 990-PF - Helmsley Charitable Trust